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     Skeletal muscle tissue damage costs the US government hundreds of billions of 
dollars annually, and there are currently no suitable tissue replacements for skeletal 
muscle. In addition, there is great potential to use skeletal muscle as a scalable actuator 
system, covering wide length scales, frequencies, and force regimes.  Hence, the interest 
in soft robotics and regenerative medicine methods to engineer skeletal muscle has 
increased in recent years. The challenges to generate a functional muscle strip are typical 
to those of tissue engineering, where common issues such as cell source, material 
scaffold, bioreactor method or configuration play key roles. Specifically, it is important 
to translate myogenesis knowledge into engineering constructs by examining the impact 
of the cell microenvironment on growth, alignment, fusion, and differentiation of skeletal 
muscle cells. The motivation behind this thesis was to generate a contractile 3D skeletal 
muscle construct utilizing biochemical and physical cues to guide muscle cell 
differentiation and maturation. Such a construct is expected to play an important role in 
medical applications and the development of soft robotics. To do this, 3D, swollen 
hydrogels were chosen to provide tailorable platforms that support cellular activities to 
similar extents as native matrices.  
      
     We utilized an engineered bio-functionalized poly(ethylene glycol)-(PEG)-hydrogel 
with maleimide (MAL) cross-linking reaction chemistry that gels rapidly with high 
reaction efficiency under cytocompatible reaction conditions. To develop an effective 
soft biomaterial for the development of an aligned, functional muscle construct, we (i) 
 xv 
screened hydrogel properties for differentiation, (ii) recreated alignment of skeletal 
muscle cells, (iii) determined effective generated force upon action of an external 
agonist. The impact of this study will be significant in the construction of biological 








CHAPTER I: SPECIFIC AIMS 
 
     The overall goal of this project is to create a functional skeletal muscle construct for 
the development of (i) skeletal muscle tissue engineering therapies when native tissue is 
lost due to trauma and age-related muscle loss, and (ii) soft actuators for biological 
machines.  
     First, the development of a contractile muscle unit for regenerative medicine 
applications would play a significant role in ameliorating conditions due to skeletal 
muscle damage, and further the field of tissue engineering. Volumetric muscle loss 
(VML), is an example of skeletal muscle damage that occurs as a result of trauma from 
accidents, sports or surgery; degenerative disease (cachexia); aging (sarcopenia); or 
inactivity (atrophy). Although skeletal muscle has an innate capacity to regenerate, this 
ability is compromised in conditions of severe trauma [8]. Available therapeutic options 
for VML are limited due to the complex process of skeletal muscle regeneration [8].     
Second, utilizing skeletal muscle powered soft actuators in combination with a variety of 
cell types such as endothelial cells, fibroblasts, and neurons would enable the 
construction of biological machines. These machines will consist of sensing, information 
processing, actuation, protein expression and transport elements that can be effectively 
combined to create functional units [9, 10].   
 
     With increasing knowledge of the cellular and biochemical mechanisms associated 
with cell growth and maturation, there is greater interest in materials that provide 
biochemical cues to modify the in vitro microenvironment to facilitate development of 
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differentiated tissue, suggesting the viability of a skeletal muscle construct in a bio-
functionalized scaffold [11].  
 
     Engineered bio-functionalized poly(ethylene glycol)-[PEG]-hydrogels with maleimide 
(MAL) cross-linking reaction chemistry gel rapidly with high cytocompatibility while 
still allowing “plug-and-play” design variation [12]. The non-fouling hydrogel network 
requires bioadhesive proteins to promote cell attachment, while its rate of degradation is 
controlled using protease-cleavable cross-linkers, creating a matrix capable of being 
tuned to support a variety of cell types. This project focuses on engineering a 
microenvironment, using these PEG-MAL hydrogels, to promote the development of 
differentiated contractile muscle tissue from skeletal muscle progenitor cells.  
     Preliminary data with these gel systems demonstrate that 3D gels of 5% (w/v) 4-arm 
PEG-maleimide (PEG-MAL) macromers functionalized with 2 mM RGDS adhesion 
peptide, and cross-linked by the addition of cysteine-flanked MMP-degradable peptide 
sequences (VPM) provide an optimized matrix for C2C12 mouse myoblast proliferation 
and differentiation.  Based on this, we hypothesize that modulating matrix elasticity, 
adhesion, rate of degradation, and physical configuration of the hydrogel will enable 
us to create a critical microenvironment for the attachment, proliferation, 
differentiation and stable formation of multinucleated myotubes for functional skeletal 




Specific Aim 1: To elucidate the effects of 3D PEG-MAL hydrogel properties on 
C2C12 skeletal muscle cell proliferation and differentiation. In this aim, we varied 
hydrogel parameters (polymer density, adhesive ligand type/concentration, rate of 
hydrogel degradation) and cell density for skeletal muscle progenitor C2C12 cell 
differentiation and contractile function within 3D poly(ethylene glycol)-[PEG]- 
hydrogels. We assessed viability of the cells with a range of hydrogel stiffness using 
periodic live/dead stains. Next, we observed the extent of differentiation by analyzing 
images of samples stained for sarcomeric myosin. We hypothesized that hydrogel 
properties will influence the viability and differentiation of encapsulated cells, allowing 
us to engineer the desired outcome: functional muscle tissue within a hydrogel scaffold. 
By varying the gel parameters mentioned, we were able to generate gel-muscle constructs 
containing myotubes and identify conditions that promoted myogenesis.    
 
Specific Aim 2: To create an aligned muscle construct capable of contraction and 
measure the force generated due to the action of an external contractile agonist.  In 
this aim, we established polymer microfabrication techniques using 
polydimethylsiloxane (PDMS) stamps for use with gels to align embedded cells in 3D, 
generating gel-muscle patches that can be separated from the original PDMS scaffold. We 
hypothesized that physical cues in conjunction with the bioadhesive ligands and a 
mechanically supportive hydrogel microenvironment would aid in aligning differentiated 
myotubes and provide a cellular construct capable of agonist-induced contraction. 
Alignment and maturation of cells was assessed by quantifying orientation of cellular 
actin using a combination of image analysis software and custom MATLAB code. It is 
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also important to be able to characterize contractile output with magnitude and frequency 
of force generated in order to create a functional and controllable contractile muscle strip 
or gel patch. We assessed force generated by the gel-muscle construct as it relates to 
change in length obtained by the excitation of muscle constructs using a custom-built 
device. During these studies, use of a contractile agonist and inhibitor further 
demonstrated effective contractile ability of the gel-muscle actuator. We hypothesized 
that the muscle strip will be able to produce myosin-dependent contractile forces.  
 
     The impact of this study in generating a controllable force actuator will be significant 
in the construction of biological machines. Concomitantly, this study will provide a 








Skeletal Muscle Physiology 
     Skeletal muscles are one of the largest organs of the human body accounting for up to 
40-50% of body weight. Their functions involve force production for locomotion, 
breathing, and postural support while contributing to heat production during cold stress 
[2]. This highly complex tissue contains an organized structure essential to its contractile 
function: each muscle is made up of bundles of long, cylindrical, multi-nucleated muscle 
fibers aligned in parallel. These muscle fibers consist of myofibrils that contain the 
sarcomere contractile units. Myofibrils, and consequently, muscle tissue, are uniaxially 
aligned to ensure efficient contraction as well as load transfer to the skeleton and 
ligaments (Fig.1A). Hence, skeletal muscle alignment is a classic example of the 
correlation of structure and function [2].      
     Cells within skeletal muscle tissue can be classified into two main groups: 
undifferentiated, normally quiescent, satellite cells and mature, adult myotubes which 
constitute 95% of myonuclei in healthy adult muscle tissue. [13] 
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Figure 1: A. Muscle tissue consists of fascicles made of muscle fibers that contain 
myofibrils. The filaments within myofibrils are responsible for contraction as part of 
the sarcomere. Muscle fascicles are bound with connective tissue, in close proximity 
with neurons and blood vessels, and arranged with their long axes in parallel. B. 
Organization of a sarcomere and necessary proteins involved in cross-bridge cycling 
involving calcium ion (Ca
2+
) . C. Schematic composition of acetylcholine (ACh)-
evoked Ca
2+ 
influx into the cytoplasm. The percentages represent the relative 
contribution of each Ca
2+
 source to the total peak change in intercellular Ca
2+
 as 
determined experimentally by Grassi et al. The activation of nicotinic ACh receptor 
(nAChR) causes current influx (IACh) and membrane depolarization (Vm). 
Intercellular calcium ion stores are the inositol triphosphate sensitive stores (InsP3-
SS) and the ryanodine senstivei sores (Ry-SS). IACh stimulates InsP3 and ΔVm triggers 
the opening of the voltage-gated  Ca
2+
 channels and release of calcium from Ry-SS.  
[2-4]   
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     Myofibers appear striated due to a highly organized arrangement of subcellular 
structures: sarcomeres (Fig.1B). A sarcomere consists of thick and thin filament arrays 
which form the basic contractile unit, and these arrays repeat in each myofibril. The 
sliding filament model is most commonly used to describe the muscle contraction at a 
molecular scale. [13-15] The model states that the molecular motors of muscle are the 
‘heads’ of the myosin molecules (thick filament) which hydrolyze ATP and interact with 
other proteins, namely, actin (thin filament), in a process known as cross-bridge cycling, 
causing the filaments to slide past each other and muscle to shorten in length. [16, 17] 
The signal to contract is delivered via depolarized motor neurons to muscle fibers 
through the release of acetylcholine (ACh), a neurotransmitter, at the neuromuscular 
junction, causing the subsequent depolarization of muscle fibers. There are two types of 
ACh receptors: muscarinic and nicotinic, the latter being more involved in muscle 
physiological processes, localized at neuro-muscular junctions. In adult mammalian 
skeletal tissue, the rates of release and re-uptake of calcium ions from the sarcoplasmic 
reticulum play a vital role in defining the length and intensity of muscular contractions. 
Calcium ion influx into the bulk cytoplasm gives rise to an upstroke of the calcium 
transient [2, 3].  
     Using a specific model of differentiated C2C12 myotubes, it has been shown that 
nicotinic AChR (nAChR) activation prompts elementary cation currents for Ca
2+
 entry 
into the muscle fiber. ACh induced depolarization further elicits Ca
2+
 entry through the 
voltage activated channels, but more prominently, Ca
2+ 
mobilization from the 
sarcoplasmic reticulum mediated by voltage and ryanodine-sensitive stores  [4]. Calcium 
influx through voltage gated channels allows troponin C to bind to calcium ions, 
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allosterically modulating tropomyosin, which unblocks myosin binding sites for cross-
bridge cycling to occur (Fig 1) [2, 3]. Magnesium ions are involved in closing calcium 
channels to restore resting state [2, 3]. 
 
Gene Regulation of Skeletal Muscle Development 
     The development of striated muscle is orchestrated by a complex series of 
mechanisms that reprogram gene expression and drive the reorganization of cellular 
structures [18-20].  This process occurs through the regulation of a network of 
intracellular signaling pathways that impact certain sequence-specific myogenic 
transcription factors (Table 1) [21-24]. 
     Satellite cells are present in an undifferentiated, quiescent state around individual 
muscle fibers. The regulation of transcription factors Pax3 and Pax7 (paired box proteins 
3 and 7) activate these cells to exit dormancy and expand, generating large numbers of 
myogenic progenitor cells. Quiescent satellite cells are held in undifferentiated state by 
the positive expression of Pax7, which is downregulated to limit proliferation and form 
myotubes. This process can be triggered during embryonic myogenesis or muscle 
regeneration after injury. [25]  
     In the intermediate stages of myogenesis, MyoD and/or Myf5 genes are expressed in 
these proliferative myogenic cells which are then termed myoblasts [26-28]. Myoblasts 
express secondary myogenic regulatory factors (MRF’s) and acquire a long, tubular 
structure to become myocytes [29, 30]. Finally, mononucleated myocytes fuse with each 
other to form multinucleated syncytium, which mature into contracting muscle fibers [29-
31]. Throughout the process, a subpopulation of myoblasts, the satellite cells, remain 
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undifferentiated and associate with the surface of developing myofibers [26]. The 
embryonic origin of satellite cells remains to be determined; however, Pax7 expression is 
essential for the specification and expansion of the satellite cell population. Cells failing 
to express Pax3 or Pax7 die or assume a non-myogenic fate. [26, 32]  
     Full differentiation entails skeletal muscle becoming a stable tissue characterized by 
multinucleated post-mitotic muscle fibers [33]. Mature myofibers, or individual 
myotubes, contain markers of  functional differentiation that include sarcomeric myosin 
(which includes MHC, thick filament), troponin, desmin, titin, nebulin, and α-actin (thin 
filament) [34]. 
      









     Pax3 Mesodermal somitic cells  Shift from quiescent into activated 
state, proliferation of which is 
termed myogenic precursor cell 
(mpc) expansion [26-28] 
Early 
(0) 
     Pax7
 
      
Somitic cells and/or endothelial 
cells 
Activation of satellite cells [26-28] 
Expansion of mpc population  [26] 
Mid 
 
     MEF2D Skeletal muscle-specific genes  
 
MAPK pathway genes, EP300 
Upregulation of creatine kinase and 
troponin production [35, 36] 




Primary MRF’s:  
     Myf5 
     MyoD 
Mesodermal somitic cells 
(during embryonic 
development) 
Myogenic precursor cell 
Commitment to myogenic leniage, 
cells are termed myoblasts [26-28] 
Late Secondary MRF’s: 
     Myogenin 
     MRF 4 
Myoblasts Terminal differentiation into 
myocytes  [29, 30] 
Full      Myogenin  
     MRF4 
Myocytes  Myocyte fusion, production of 




Skeletal Muscle Extracellular Matrix 
     The extracellular matrix (ECM) of skeletal muscle plays an important role in muscle 
fiber force transmission, maintenance, and repair [40]. There is increasing evidence to 
suggest that the ECM strongly regulates muscle’s normal function, its load-bearing 
ability, its adaptability, and the reservoir of muscle stem cells it provides [40]. 
Pathological changes in muscle tissue are to some degree associated with ECM fibrosis, 
underlying its importance in a functional role [7]. Current knowledge suggests the 
division of the complex geometry of muscle ECM into three main categories: endomysial 
(around the muscle cell), perimysial (around groups of muscle cells) and epimysial 
(around the whole muscle) [7]. The most prominent features visualized in 3D through 
tissue sections indicate the presence of highly organized and extensive structure that 
cannot be appreciated in 2D.  However, due to a lack of objective information about this 
ECM compared to that of other connective tissues, it is suggested that a higher order of 
muscle ECM organization exists that is yet to be defined. Figure 2 shows the 
endomysium as an array of tubes which surround the digested (not shown) muscle fibers. 
[7, 40, 41] 
 
Figure 2: Scanning Electron Microscope Images at A, low, and B, high power 
magnification of the collagenous endomysial network around muscle fibers observed 
after NaOH digestion [7].  
 11 
     Key components of skeletal muscle ECM  include (i) collagen, of which types I and 
III are most abundant, accounting for up to 10% of dry muscle mass; (ii) proteoglycans 
(PG) and glycosaminoglycans, mainly from the small leucine-rich proteoglycans (SLRPs) 
family; and (iii) matrix remodeling enzymes, namely MMP-2 and MMP-9.  Comprising 
major structural components, there are notable collagen-proteoglycan interactions, 
including those of type I collagen with the major PG decorin and biglycan [40]. The most 
important specific interaction of skeletal muscle cells and its basement membrane is with 
laminin-211.  Laminin-211 is a cell adhesion molecule and ligand for both the integrin 
isoform α7ß1 and dystroglycan. This interaction is believed to protect the muscle fiber 
from damage under the constant stress of contraction and influence signal transmission 
events [42].  
  
Skeletal Muscle Contraction 
     The smallest functional skeletal muscle unit that can generate contractile force is the 
sarcomere. These are self-assembled in uniform alignment within a single myotube. 
Hence, functionality of muscle tissue can be examined, in order of increasing scale, by 
observing the response to stimuli of (i) sarcomeres, (ii) individual myotubes (multi-
nucleated cells that share a cytoplasm), (iii) more mature muscle fibers, consisting of 
several myofibrils, and (iv)whole muscle tissue. Muscle contraction is characterized by 
the relationship between movement velocity and the amount of force exerted during 
muscular contraction. A single unit contraction in response to a stimulus is known as a 
‘twitch’. In humans, a single muscle twitch with an average of 40 ms contraction, 50 ms 
relaxation is produced (Figure 3A). Tests on single muscle fibers isolated from mouse 
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hind limb muscle (flexor brevis) show twitch forces of comparable time scale with 40 ms 
contraction periods in response to electrical field stimulation [43]. Increasing frequency 
of the stimulus results in a sustained, fused contraction response known as ‘tetanus’ as 
depicted in Figure 3B. Tetanic contractions correspond with maximal force produced by 
the contracting tissue [44].  
     Muscle tissue can act isometrically, without changing length to maintain a position, or 
isotonically, in a dynamic fashion (Figure 3C, D). In the force-length graph, considering 
the context of thick/thin filament overlap and ability of cross-bridge formation: the 
ascending limb represents the decreasing force output of the muscle as it is shortened 
beyond resting length. Peak muscle force is generated at the plateau: when length is equal 
 
Figure 3: A. Force-time curve to show a single twitch, B. Force-time to show the 
approach towards tetanus force from repeated, high frequency stimulation. C. 
Force(F)-Velocity(V) graphs for power(P)=FxV, D. Force-Length(dL) curve for work 
done(W)=FxdL [2].  
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to resting length (L0), where there is greatest cross-bridge overlap. The descending limb 
represents the decreasing active tension of a muscle when elongated beyond resting 
length [44].  
     In summary, the amount of force generated during muscular contraction is dependent 
on the following factors: (1) types and number of motor units recruited, (2) the nature of 
the motor units’ neural stimulation and (3) the initial muscle length. The peak force 
generated by muscle decreases as the speed of movement increases. However, in general, 
the amount of power generated by a muscle group increases as a function of movement 
velocity [2]. 
 
Clinical Motivation for Skeletal Muscle Regeneration 
 
     In 2000, the World Health Organization estimated the total cost of musculoskeletal 
disease in the United States to be $254 billion and, in developing countries, the figure is 
estimated at $100 billion [45]. In 2004, the total estimated cost to the US Healthcare 
system (including lost wages) associated with musculoskeletal diseases was $949 billion 
[46].  
     Skeletal muscle tissue impairment can occur due to atrophy, neuromuscular disorders, 
or trauma [47, 48]. Muscle atrophy is the loss or wasting away of unused muscle tissue as 
a result of lack of activity, or poor neurological innervation [49]. Aging (sarcopenia) is 
responsible for some muscle atrophy cases, while others occur due to malnutrition, 
immobilization, injuries, and diseases such as osteoarthritis, rheumatoid arthritis, 
muscular dystrophy and myositis [49]. Neurogenic disorders result in a sustained 
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disassembly of tissue – due to disease or loss of nerves that control muscles – and include 
spinal cord injury (SCI), stroke, amyotrophic lateral sclerosis (ALS), Guillain-Barre 
syndrome, neuropathy and polio [50].  Finally, traumatic muscle injuries can result in 
both direct muscle tissue loss, and indirect muscle damage from poor innervation. 
Injuries commonly occur to the extremities during sports, resulting in contusions or 
strains, or from motor vehicle accidents, causing volumetric muscle loss (VML) [48]. Up 
to 88% of combat wounds in previous US armed conflicts involved traumatic soft tissue 
injuries, including VML, to the extremities [51]. VML is the traumatic or surgical loss of 
skeletal muscle resulting in severe functional impairment [52, 53]. Left untreated, or after 
deficient therapy, regional skeletal muscle atrophy can exacerbate muscle weakness 
throughout the limb that can persist for years [53].  
     VML treatment options vary with the severity and bodily location of muscle damage, 
though a universal consensus on how to manage such injuries and resulting functional 
deficits, has not been clearly defined [54]. Current treatments include (some combination 
of): (i) surgical options - functional free muscle transfer (autologous muscle flaps), 
debridement or muscle sarcoma excision [13, 48], (ii) growth factor delivery [54], (iii) 
amputation followed by the use of prosthetics [48], (iv) advanced bracing with 
stimulation (power-bracing) [55], and (v) physical therapy.  
     Surgical treatment options typically entail autologous muscle grafts (fasciocutaneous 
flaps) or muscle transposition that restore muscle mass and function [48, 56]. However, 
these approaches do not regenerate the lost muscle tissue, and are limited by associated 
donor site morbidity having caused alterations of the anatomy and biomechanics for both 
the recipient and the donor sites. Approximately 50% of patients suffer from pain and 
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37% report problems with physical activities 7-10 years after treatment [57, 58]. Patients 
that received radical debridement after a severe crush injury were more likely to suffer 
from motor disability [59]. In a study that compared limb function after excision of a 
muscle sarcoma, larger muscle excisions resulted in lower functional scores compared to 
partial muscle excisions [60], indicating the overall insufficiency of current surgical 
treatment options. Cell-based therapies are in their infancy and, to date, have largely 
focused on hereditary disorders such as Duchenne muscular dystrophy [48]. 
      
     Soft tissue injuries begin with inflammation and edema compromising the vascular 
supply, resulting in hypoxia and tissue necrosis [61]. Skeletal muscle possesses a robust 
capacity to repair itself from minor traumas (tears, lacerations, and contusions). However, 
the endogenous repair mechanisms fail when 20% of total muscle volume is damaged, 
resulting in the accumulation of scar, denervation of distal skeletal muscle, and overall 
loss of function [54, 62]. The ability to enhance the inherent skeletal muscle repair 
process would significantly advance the treatment of congenital muscle disorders and 
severe muscle trauma for which, even with the best of present-day treatments, result in 
some form of physical handicap ranging from minor muscle asymmetries to permanent 
impaired function. Severe trauma patients often experience damage to ancillary systems, 
leaving amputation as a last resort limb-salvage technique.[48]. For endogenous repair 
therapies to advance, it is essential to build understanding of the biochemical, cellular and 
mechanical cues that promote skeletal muscle repair while minimizing scar formation to 
improve the potential for muscle regeneration [48]. Treatment options to promote the 
natural repair process include (i) the direct use of human recombinant growth factors 
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(IGF-1 [63], HGF [64], LIF [65]), (ii) gene therapy for growth factor delivery [66], (iii) 
inhibition of fibrosis through operative procedures [67], (iv) reduced fibrosis through 
antibiotic therapy by blocking overexpression of TGF-ß1, gamma-interferon [68, 69]. 
While these techniques were used in the clinical setting with good outcomes, the 
functional recovery of injured skeletal muscle remains limited [70-74], highlighting the 
need for further basic research into muscle regeneration. 
     VML can also be ameliorated by advanced bracing designs, electrical stimulation and 
physical therapy [52]. However, these techniques are unable to fully restore lost muscle 
and are often limited to VML below the knee.  
 
     The described unmet clinical need for skeletal muscle repair and limited treatment 
options has resulted in the exploration of regenerative medicine as an alternative or 
supplemental therapeutic option in the future [52]. 
 
Skeletal Muscle Tissue Engineering 
 
     Key considerations in skeletal muscle tissue engineering (SMTE) include the choice 
of an appropriate base matrix, a viable cell source, the incorporation of alignment cues 
for directed functionality, and vascularization to abet transport concerns with larger 
tissues. 
     Properties of the cell microenvironment such as matrix elasticity, amenability for 
degradation and presence of adhesive ligands play an important role in the cell 
physiology, or pathophysiology, affecting migration, proliferation, morphogenesis and 
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differentiation [75-80]. The process of myogenesis involves well-defined biochemical 
and physical cues to direct myoblast migration and proliferation as prerequisites to 
alignment and fusion of neighboring myotubes [26, 81]. Previous studies have 
demonstrated the importance of geometric cues [82] and the extracellular matrix (ECM) 
in controlling myogenic cell differentiation for skeletal muscle development  [83], 
function [84], and structure [85]. Hence, the interest in engineering biomaterials to 
modify cellular microenvironment in vitro and facilitate the development of differentiated 
skeletal muscle tissue constructs [48].  
     Naturally-derived acellular scaffolds from mammalian tissues or components from 
non-mammalian sources (alginate, chitosan) provide structural properties in addition to 
signals and molecules that augment many aspects of cell behavior. Preclinical animal 
studies have shown that materials derived from small intestinal submucosa (SIS) and 
urinary bladder matrix (UBM) facilitate constructive remodeling of skeletal muscle tissue 
when implanted into a site of muscle injury [86]. Fibrin [87, 88], alginate [89], gelatin  
[90], keratin [91], and collagen [92, 93] have also been explored as matrices for muscle 
constructs. However, widespread application of naturally derived ECM scaffolds has 
been limited by variability in batch composition, potential immunogenicity, and 
challenges with modification, characterization and presentation of natural ECM 
materials.  
     Synthetic materials offer certain advantages over naturally derived materials in that 
they can be precisely characterized and fabricated with great control over physical and 
chemical properties. Synthetic scaffolds or materials used for SMTE include: 
polypropylene, polyesters such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), 
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poly(ε-caprolactone) (PCL) [94, 95], and their copolymers [96, 97], and various 
polyurethanes [98, 99]. These polymers have a limited efficacy with SMTE due to their 
non-physiological methods of manufacture for viable cell encapsulation during synthesis 
(as opposed to cell seeding after scaffold generation), and lack of biochemically relevant 
components.  
     Hybrid materials incorporating synthetic configurations in combination with naturally 
occurring components such as peptides show great promise for modulating bio-
architecture as multi-component polymer matrices can be created by exploiting simple 
physiological reaction mechanisms [75]. Synthetic hydrogels that are closely related to 
biopolymer systems provide a platform to decouple material properties such as elasticity, 
degradation, and presence of adhesive ligands to examine ECM properties in a modular 
fashion [100]. The mechanical and chemical properties of synthetic polymers are 
typically easier to control; they can be non-toxic, readily available and consistently 
reproducible [101].  
     In vitro, muscle stem cells have been shown to contribute to muscle regeneration on 
soft 2D poly(ethylene-glycol) (PEG) hydrogel substrates [102], and within 3D PEG-
based hydrogel constructs [103]. In vivo, PEG-fibrinogen hydrogel scaffolds for tissue 
engineering offer a potential therapeutic solution by providing biomaterial adjuvants that 
improve survival and engraftment of donor cells [104].  
     Producing highly organized, uniaxial microstructure during SMTE is essential for 
effective muscular contraction. This can be achieved by generating (i) cell-scaffold 
constructs of several uniformly aligned layers, (ii) scaffold constructs with uniform 
alignment, later seeded with cells, (iii) homogenous matrix and cell suspension to which 
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appropriate boundary conditions (mechanical tension, electrical stimulation, free 
surfaces) are applied when the construct is developing to direct remodeling and generate 
the desired structure, or (iv) enable 3-D alignment within a matrix seeded with 
homogenous cell suspension and allow cells to align within the construct during 
development [105]. Rapid vascularization of engineered muscle is critical as cells more 
than a few hundred microns from a blood supply are typically metabolically inactive or 
necrotic due to limited nutrient diffusion [106].  
 
Applications of Skeletal Muscle to Biological Machines 
 
     Robotics is an important and rapidly growing feature of science and technology, 
dominated by robots constructed using hard materials such as metals (aluminum, steel) 
and ceramics (silicon, silicon oxide), with joints regulated by electrical, pneumatic, or 
hydraulic signals [107]. Hard robotics have several limitations: some are mechanical, 
causing instability on rough terrain or limited ranges of motion due to structural design. 
Others are due to control complexities: hard robotic plans are not able to handle fragile, 
anomalous-shaped objects (for example, internal organs during surgery).  
     Hence, soft robotics emerged as a field inspired by biology that attempts to build upon 
the abilities of traditional robotics, but with polymeric components that mimic biological 
actuators [107]. Elastomeric materials for force actuators can be reproducibly developed 
from tunable components that can modulate material properties for high strength and 
strain sustainability without fracture, enabling the production of soft robots that are 
flexible and strong.  
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     While there is no current technology that can replicate the balanced performance of 
muscle [107], muscle-like contraction and dilation can occur in polymeric gels with 
changes in pH or salinity of a surrounding solution [108]. Electroactive polymers (EAPs) 
include dielectric elastomers, electrolytically active polymers [109], polyelectrolyte gels 
[110], and gel-metal composites [108]. Soft, acellular pneumatically-driven robots are 
still in the development phase but are able to walk [111, 112], swim [108], grip [113], 
bend and manipulate objects [114]. 
     As the development of soft actuators potentially progresses fields from machine 
assembly to intricate surgery [107], opportunities for the use of biological machines arise. 
Biological soft robots incorporate cellular components to create force actuators as basic 
machine constituents. Biological machines explore an environmentally friendly 
technology that is renewable and biodegradable, while furthering the understanding of the 
science of emergent behaviors that will need to be employed to build such machines [5]. 
It is believed that biological machines will enhance our ability to accomplish tasks such 
as detecting and removing unwanted species from a food or drug, harvesting energy, 
monitoring the environment, or mimicking certain aspects of organ function [5].  
 
     Skeletal muscle serves as a primary actuator system in animals, performing tasks over 
a wide range of length and time scales, spatial configurations and force regimes [115]. 
The potential scalability of skeletal muscle makes it an ideal candidate for soft robotics 
and related applications. The unique performance metrics of skeletal muscle, namely, 
superior power-to-weight ratio, force-to-weight ratio, mechancial compliance and 
systems control compared to traditional mechanical actuators [116]. Specfically, muscle 
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fibers can be selectively activated and spatial and temporal signal summation allows the 
control and modulation of force generation in a dynamic fashion [117]. Lastly, an 
advantage of biological soft actuators as opposed to man-made actuators is the potential 
ability of self-repair.    
     The long-term goal of the Science and Technology Center (STC) on Emergent 
Behavior of Integrated Cellular Systems (EBICS) is to develop millimeter scale 
biological machines constructed with polymers and living cells that consist of sensing, 
information processing, actuation, protein expression and transport elements that can be 
effectively combined to create functional units (Fig.4) [5]. 
     The development of such integrated cellular system has been a challenge due to 
technical issues that remain unaddressed. These include: controlled 2 and 3 dimensional 
patterning of living cells in bio-instructive materials; development of these biomaterials 
that allow cell growth and proliferation in 3D; alignment of cells to create muscle strips 
for desired actuation; development of in-vitro neuro-muscular junction and neuronal 
circuit to control the actuation of the muscle strips; coordination of the biological 
actuators for net movement; sensing of target neuro-toxins; release of the neutralization 
agents by cell-based factories embedded in the biomaterials, just to name a few [5].  
     With regards to force generation for locomotion, different processing units will 
require distinct actuators in specific micro-environments [5].  In a liquid or viscoelastic 
environment for instance, a ‘swimming’ motion may be most viable. Meanwhile, for 
movement along a surface, or prescribed path, a ‘walker’ or ‘crawler’ would need to be 
designed.  
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     The microenvironment of cellular clusters is a critically important determinant of end 
cell fate. Hence, the creation of biologically relevant components for a cellular machine 
will require understanding of critical environmental features, modes of interaction for 
particular cell types, dominating growth and biochemical factors, and signaling 
mechanisms. It is expected that force actuators for the purposes of contractile function for 
locomotion will consist of myocytes (cardiac or skeletal). Myocytes will be studied to 
understand how they differentiate into myotubes to provide coordinated contractile 
function. A cellular-level understanding will then aid in the development of uniaxial 
muscle gel strips capable of efficient contraction mediated by external agonists. [5] 
     Recent attempts to engineer a robot capable of motion involved soft-lithography 
techniques to create acellular devices using poly(ethyleneglycol)-diacrylate (PEGDA) 
and polydimethylsiloxane (PDMS). In these cases, motion is generated by engineering 
 
Figure 4: Pathways to a Biological Machine:  A classical engineering approach 
involves defining the specifications for the cellular machine, desired functionalities 
and developing the necessary parts followed by assembly to construct machines. 
Meanwhile, a systems biology approach requires first understanding the emergent 
behaviors of cells and cell clusters to harness those properties to evolve interacting 
cell clusters that function within a biological machine with specific capabilities [5] 
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and exploiting unique properties of the polymer-based scaffolds [111, 118]. However, 
these constructs lack the biological component which is the core concept of cellular 
machines. Independent actuators utilizing living cells have till date, relied upon a non-
degradable 2D substrate or utilized natural, plant or animal-derived scaffolds [10, 119]. 
These technologies will be further explored in the next section. 
 
Relevant Work in Developing Muscle Constructs 
 
Skeletal Muscle Constructs 
     Cells used in the generation of skeletal muscle constructs include human primary 
skeletal myoblasts [120], primary adult rat myogenic precursors [121], primary adult rat 
skeletal muscle derived cells [122], primary neonatal rat skeletal muscle derived cells 
[123-127], and the C2C12 mouse myoblast cell line [120, 128, 129]. The usage of 
primary cell lines is limited by characterization difficulties, short lifespans, slow 
proliferation rates, and finally, the tendency to suffer from high variability, complicating 
comparisons across laboratories. On the other hand, the C2C12 skeletal muscle 
progenitor cell line was established for the exploration of stem cell use for regenerative 
purposes upon grafting or transplantation [130]. Previous work has shown that specific 
ECM molecules such as laminin [131], collagen [132], fibronectin [133], and the 
adhesive peptide sequence ‘G-RGD-SPC’ [134] are able to modulate proliferation and 
differentiation of C2C12 cells, into mature mouse myoblasts, making this a suitable cell 
line to use in conjunction with biofunctionalized materials for SMTE.  
 24 
     Past research utilizing C2C12 cells to generate muscle strips involved the use of 
micropatterned substrates to induce cell alignment [135] and multi-layering of cells on 
PDMS [136]. The use of non-degradable substrates limited these designs to cell 
monolayers, that is, two dimensions. Consequent attempts utilized scaffold-less structures 
[137], or centered on seeding myogenic cells in three-dimensional (3D) scaffolds [89, 
138], on surfaces of micro-threads [87], differentiating high-density myogenic cell pellets 
[139], and cell sheet tissue engineering with thermoresponsive polymer substrates for 3D 
oriented sheets of myotubes [140-143]. These methods have yielded ‘thicker than 2D’, 
and 3D constructs. Yet, while these studies show the production of skeletal muscle 
marker proteins and morphological suggestions of myogenesis they do not directly 
examine the influence of the scaffold and/or biological functionalization on myogenic 
differentiation in a modular manner. 
     Specifically, work involving seeding myogenic cells in 3D scaffolds of macroporous 
[89] or mesh form [138], do not produce densely populated constructs thicker than 1 mm. 
Furthermore, the extent of presented differentiation is intermediate, at the pre-myofibril 
stage [89, 138]. Meanwhile, Page et al.’s works involving microthreads [87] show 
incorporation of muscle cells into more differentiated muscle fibers, but this development 
is shown to occur in an in vivo microenvironment. In addition, the contractile function of 
the isolated microthreads themselves, in vitro, is not explicated [87].  Marquette et al. 
demonstrated the in vitro development of syncytia, unique to skeletal muscle, using 
C2C12 cells in a rotary cell culture system (RCCS) [139]. This work is unique in that it 
shows the development of 3D skeletal muscle from C2C12 without the presence of a 
scaffold, cell guidance, or growth factors. However, the syncytia detected is not aligned, 
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due to the lack of cell guidance cues and thus contractile function cannot be determined 
[139]. Cell sheet tissue engineering through thermoresponsive polymer substrates have 
enabled the development of anisotropic skeletal and cardiac muscle sheets [140-142] by 
the Okano lab in Japan. This method is able to generate aligned sheets of tissue-like cell 
layers, but the functionality of the skeletal muscle tissue stacks has not been described.   
     Notable examples of 3D skeletal muscle constructs (summarized in Table 2) that are 
amenable to force production and measurement include aligned ‘myooids’ [121, 122], 
muscle bundles with Velcro anchors [123], mesoscopic-scale porous cell networks [124, 
125], and magnetic force-based tissue engineered constructs  [128, 129]. Independent 
constructs, such as the free-floating collagen-muscle film strips by Fujita et al. [120, 
144], optogenetically controlled collagen-matrigel constructs by Sakar et al. [145], and 
the ‘miniature bio-artificial muscles’ (mBAMs) of collagen-fibrin scaffolds by 
Vandenburgh et al. [146], show promise for the development of similarly functional 
biosynthetic hydrogel-based devices. 
     The contractile function of the described 3D systems is summarized in Table 2. The 
matrix supports for the functional 3D constructs, when used, are naturally derived. The 
disadvantages of naturally-derived scaffolds considering clinical translation and 
engineerability have been previously discussed. At the time of this review, no purely 
synthetic soft tissue scaffolds exist for the benefits of functional skeletal muscle tissue 
engineering. The cell types utilized in these constructs range from C2C12 cell lines [120, 
144] to primary neonatal [124-127] and adult [122] rat skeletal muscle derived cells. 
Constructs also utilized muscle cells in combination with other cell types, such as mouse 
embryonic fibroblasts (MEFs) [146], or cells infected with GCaMP3 lentivirus [123]. The 
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force produced by these constructs covers a wide range from 0.88 µN (49.7 Pa for a 
tissue width of 150 µm) [144] to 26 mN (8.28 kPa for a tissue width of 1mm) [123].  
This encompasses the active tension generated by a single myotube to the force produced 
by muscle bundles at the end of a 4-week incubation period.  
     There do not appear to be specific trends linking cell type with measured force as the 
output is a function of several factors, including, but not limited to: construct 
configuration, time of incubation, and method of stimulation. To put these force values in 
context, the adult mouse extensor digitorum longus (EDL) produces a peak isometric 
force of about 500 mN in vitro (240 kPa on 2.1 mm
2
 cross sectional area, while the adult 
mouse soleus muscle can generate a peak isometric force of 200 mN (220 kPa on 1 mm
2
) 
[147]. In vitro, the twitch force of an isolated adult mouse EDL muscle fiber of 25 µm 
diameter is 200 µN (400 kPa) [148]. This force is on the same scale as constructs 
discussed here, but taking a representative diameter of 1 mm in comparison, the force 
generated by native tissue is 40-fold higher. This suggests significant tissue engineering 
and regenerative medicine (TERM) progress is required before in vitro generated 3D 
muscle constructs are able to recapitulate by natural tissue.  
     The skeletal muscle tissue engineering (SMTE) constructs discussed have succeeded 
with the use of biological, not synthetic, scaffolds and are not easily and independently 
handled without tether to a surface. Hence, the field of SMTE could be further progressed 
through the exploration of synthetic scaffolds for the generation of free-formed constructs 




Table 2: Summary of 3D skeletal muscle-based constructs, in order of increasing ‘cell 
layers’, as reported (1o = Primary, Ad = adult, NN = neonatal, Imm = Immortal, myob = 
myoblasts, SKM = skeletal muscle, L = Length, W = Width, D = diameter, H = 
height/thickness, SA: surface area, NR = not reported) 
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Methods to Determine Muscle Construct Functionality  
     The experimental set-up designed to measure force of a multinucleated muscular 
construct is dependent upon the construct size and design. Direct measurements of force 
typically involve the twitch or tetanic response and isometric force generation detected 
using a force transducer [120, 122, 123, 127, 143, 150, 151], or a high speed camera to 
relate the motion of muscle constructs to the force generated [152, 153], using known 
mechanical properties of materials used. For instance, to measure the forces produced by 
miniature Bioartificial Muscles (mBAMs), Vandenburgh’s group captured images 
monitoring the deflection of posts to which the mBAMs were anchored, at 4 frames per 
second (fps), to calculate the force that would have caused the observed displacement 
[146]. Similarly, the contractile function of microfabricated tissue gauges (µTUGs) was 
determined by examining the deflection of cantilever tips on which the constructs were 
formed [154]. 
     Indirect measurements include the use of lentiviral transduction with an intracellular 
sensor for calcium ion flux that is attributed as proportional to functional muscle activity 
[123], and tracking the movement of secondary objects of estimated mechanical 
properties due to the supposed action of the primary muscular construct.  
     Activating agents for the controlled contraction of myoblasts range from custom-made 
solutions with high calcium ion or ATP content [155] and Tyrode’s solution [43]; to 
small molecules such as dithiothreitol (DTT) [156, 157] and caffeine [43]; to the use of 
parallel platinum wire electrodes for electrical stimulation [121]. De-activating 
pharmacological treatments utilize agents such as blebbistatin [158], N-benzyl-p-toluene 
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sulphonamide (BTS), 2,3-Butanedione monoxime (BDM) [159], and tubocurarine 
chloride - an antagonist for the acetylcholine receptor [160]. 
 
Motivation for Research 
 
     Skeletal muscle tissue damage costs the US government hundreds of billions of 
dollars annually. Meanwhile, there is great potential to use skeletal muscle as a scalable 
actuator system, covering wide length scales, frequencies, and force regimes.  Hence, the 
interest in soft robotics and regenerative medicine methods to engineer skeletal muscle 
has increased in recent years. The challenges to generate a functional muscle strip are 
typical to those of tissue engineering, where the triad of common TERM issues: cell 
source, material scaffold, bioreactor method or configuration play key roles. Specifically, 
it is important to translate the existing body of myogenesis knowledge into engineering 
muscle constructs by examining the impact of the cell microenvironment on growth, 
alignment, fusion, and differentiation of skeletal muscle cells. Thus, the main motivation 
behind this thesis is to generate a contractile 3D skeletal muscle construct utilizing 
organized biochemical and physical cues to guide muscle cell differentiation and 
maturation. Such a construct is expected to play an important role in medical applications 
and the development of soft robotics. 
     3D, swollen hydrogels provide tailorable platforms that support cellular activities to 
similar extents as native matrices. For this work, we utilized an engineered bio-
functionalized poly(ethylene glycol)-(PEG)-hydrogel with maleimide (MAL) cross-
linking reaction chemistry that gels rapidly with high reaction efficiency under 
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cytocompatible reaction conditions [12]. PEG alone has been shown to have low protein 
adsorption, a minimal inflammatory profile, well established chemistry, and a long 
history of safety in vivo.  The PEG-MAL system in particular allows “plug-and-play” 
design variation, control over polymerization time, and small degradation products that 
are excreted via urine [161, 162]  
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CHAPTER III: BIOFUNCTIONAL HYDROGELS FOR SKELETAL 




     Hydrogel scaffolds encapsulating C2C12 mouse skeletal muscle cells have been 
engineered as in vitro constructs towards regenerative medicine therapies for the 
enhancement and inducement of functional skeletal muscle formation. Previous work has 
largely involved two-dimensional (2D) muscle strips, naturally occurring hydrogels and 
incomplete examination of the effects of the scaffold and/or biological functionalization 
on myogenic differentiation in a controllable manner. The goal of this study was to 
identify key properties in functionalized poly(ethylene glycol) (PEG)-maleimide (MAL) 
synthetic hydrogels that promote cell attachment, proliferation and differentiation for the 
formation of multinucleated myotubes and functional skeletal muscle tissue constructs. 
Significant differences in myoblast viability were observed as a function of cell seeding 
density, polymer weight percentage and bioadhesive ligands. The identified optimized 
conditions for cell survival, required for myotube development, were carried over for 
differentiation assays. PEG hydrogels (5% weight/volume), functionalized with 2.0 mm 
RGD adhesive peptide and crosslinked with protease-cleavable peptides, incubated for 
3 days before supplementation with 2% horse serum, significantly increased expression 
of differentiated skeletal muscle markers by 50%; 17% more multinucleated cells and a 
_________________________________________ 
* Adapted from: Salimath AS, Garcia AJ. Biofunctional hydrogels for skeletal 
muscle constructs. Journal of Tissue Engineering and Regenerative Medicine, 2014 
Feb 26. doi: 10.1002/term.1881. [6] 
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40% increase in the number of nuclei/differentiated cell compared to other conditions. 
Functionality of cell-laden hydrogels was demonstrated by a 20% decrease in the 
extruded length of the hydrogel when stimulated with a contractile agent, compared to 
7% for a saline control. This study provided strategies to engineer a three-dimensional 
(3D) microenvironment, using synthetic hydrogels to promote the development of 





     The development of a contractile muscle unit is significant to: (a) ameliorating 
impairment of morphological and physiological function conditions, such as volumetric 
muscle loss (VML) due to trauma; (b) aiding reconstructive and cosmetic faciomaxillary 
surgeries; and (c) engineering functional substitutions for lacking or deteriorated skeletal 
muscle in degenerative disease (cachexia), ageing (sarcopenia) or inactivity (atrophy) 
[52, 53]. Current therapeutic options are limited to skeletal muscle grafts, as in vitro-
engineered tissues are incapable of recapitulating natural muscle bundle architecture and 
function, hence necessitating research into innovative tissue-regeneration approaches 
[126]. Additionally, contractile muscle constructs provide actuators for emerging cell-
based machines [9]. 
     Skeletal muscle tissue consists of striated multinucleated myotubes, collectively called 
myofibrils, which form the contractile structures of a muscle fibre and are uniaxially 
aligned to ensure efficient contraction and load transfer to the skeleton and ligaments 
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[163]. The process of myogenesis involves well-defined biochemical and physical cues to 
direct myoblast migration and proliferation, as prerequisites to the alignment and fusion 
of neighboring myotubes [26, 164]. Previous studies have demonstrated the importance 
of geometric cues [82] and the extracellular matrix (ECM) in controlling myogenic cell 
differentiation for skeletal muscle development [83],  function  [84], and structure [165]. 
With increasing knowledge of the cellular and biochemical mechanisms associated with 
skeletal myoblast growth and maturation, there is greater interest in improving our 
understanding of suitable materials that provide biochemical cues to modify the in 
vitro microenvironment and facilitate development of differentiated tissue, suggesting the 
viability of a skeletal muscle construct in a biofunctionalized scaffold [48]. 
     In this study, we used the C2C12 skeletal muscle progenitor cell line, established for 
the exploration of stem cell use for regenerative purposes upon grafting or transplantation 
[130], to engineer 3D muscle constructs. Previous work has shown that specific ECM 
molecules, such as laminin[131], collagen [132], fibronectin [133]  and RGD [134] 
modulate the proliferation and differentiation of C2C12 cells. Past research utilizing 
C2C12 cells to generate muscle strips involved use of micropatterned substrates to induce 
cell alignment [135] and multilayering of cells on PDMS [136]. However, the use of non-
degradable substrates limits these designs to two dimensions. Therefore, efforts centered 
on seeding myogenic cells in 3D scaffolds [89, 138] or microthreads [87], differentiating 
high-density myogenic cell pellets [139], cell sheet tissue engineering [92] and 
thermoresponsive polymer substrates for 3D oriented sheets of myotubes myotubes [90] 
have been explored to yield 3D constructs. However, these studies did not directly 
examine the influence of the scaffold and/or biological functionalization on myogenic 
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differentiation in a controllable manner. Naturally occurring biological hydrogels are a 
popular choice, due to their resemblance to native tissue. Fibrin [87, 88], alginate  [89], 
gelatin [90], and collagen [92, 93] have been explored as matrices for muscle constructs 
using C2C12 cells, but these hydrogels are limited in terms of precisely controlling their 
properties, processing and biofunctionality. 
     Synthetic scaffolds such as hydrogels show great promise for modulating bio-
architecture, as multicomponent polymer matrices can be created by exploiting simple 
physiological reaction mechanisms [75]. The resulting 3D swollen hydrogels provide 
tailorable platforms that support cellular activities to a similar extent to native matrices. 
For this work, we utilized an engineered biofunctionalized poly(ethylene glycol)–(PEG) 
hydrogel with maleimide (MAL) crosslinking reaction chemistry, which gels rapidly, 
with high reaction efficiency, under cytocompatible reaction conditions (Figure 5) [12]. 
The PEG backbone has low protein adsorption, a minimal inflammatory profile, well-
established chemistry and a long history of safety in vivo. The PEG–MAL system in 
particular allows modular design variation, control over polymerization time and small 
and non-toxic/non-inflammatory degradation products that are excreted via the urine 
[161, 162]. This paper focuses on engineering a PEG–MAL hydrogel microenvironment 
to promote the development of differentiated contractile muscle tissue from skeletal 
muscle progenitor cells. The goal of this research was to generate a dense, yet self-
sustaining, cell–hydrogel composite with high cell viability and potential for proliferation 
and differentiation to develop a functional muscle strip. To this end, we examined the 
effects of hydrogel polymer weight concentration, adhesive ligands and growth and 
differentiation medium conditions in the development of a skeletal muscle construct. 
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Materials and Methods 
 
Cell culture 
     Skeletal murine myoblasts C2C12 cells were obtained from ATCC (Manassas, VA, 
USA). Dulbecco's modified Eagle's medium [DMEM; 4.5 g/l D-glucose, L-glutamine (+), 
sodium pyruvate (–)], insulin–transferrin–selenium (ITS-X), Dulbecco's phosphate-
buffered saline (PBS), penicillin/streptomycin, trypsin/EDTA and fetal bovine serum 
(FBS) were obtained from Life Technologies (Carlsbad, CA, USA). Horse serum was 
supplied by Hyclone (Logan, UT, USA). Cells were cultured in 20% FBS and 1% 
penicillin/streptomycin in DMEM (growth medium, GM) until passage 4, prior to 
hydrogel encapsulation, and further growth and differentiation in 2–10% horse serum 
(HS), 1% ITS-X and 1% penicillin/streptomycin in DMEM (differentiation medium, 
DM). 
 
Cell encapsulated hydrogel fabrication 
     C2C12 cells were encapsulated in collagen-I (3 mg/ml; BD Biosciences, San Jose, 
CA, USA) or protease-degradable PEG-based hydrogels, prepared as previously 
 
Figure 5: Formation of a hydrogel network to support encapsulated cells for tissue 
formation. PEG–MAL hydrogel network formation with encapsulated cells utilizing 




described (Figure 5) [12]. PEG–maleimide (PEG–MAL) four-arm macromers (20 kDa, > 
95% maleimide functionalization; Laysan Bio, Arab, AL, USA) and custom-synthesized 
peptides (AAPPTec, Louisville, KY, USA) were used. PEG–MAL macromers were 
prefunctionalized with GRGDSPC (RGD) adhesion peptide or GRDGSPC (RDG) non-
bioactive ligand in 2.0 mMtriethanolamine (TEA) solution for 30 min. PEG polymer 
density was varied in the range of 4–6% w/v, and RGD or RDG density was maintained 
at 2.0 mM. The precursor molecules and cell suspension solution (for a final 
concentration of 0.1–10 × 10
6
 cells/mL) were crosslinked into a 40 µl hydrogel by the 
addition of a cysteine-flanked protease-degradable peptide sequence, 
GCRDVPMSMRGGDRCG (VPM), for 15 min. The concentration of crosslinker peptide 
was proportional to the macromer concentration in order to react with the appropriate 
number of maleimide groups in the macromer and generate a fully crosslinked hydrogel 
network. The cast hydrogels had a 5.0 mm diameter × 2.0 mm thickness. The hydrogels 
were left to swell in growth medium overnight, and the medium was changed daily. The 
resulting gel phase is transparent, which allows visualization of cellular activity without 
disruption of the cellular microenvironment. 
 
Live/dead and immunofluorescence staining and image analysis 
     Hydrogels containing encapsulated cells to be analysed for cellular viability were 
incubated in PBS for 10 min to remove serum, followed by the live/dead stains calcein 
AM (2 µM) and TOTO-3 iodide (2 µM) (Life Technologies, Carlsbad, CA, USA) for 
10 min. Samples stained for sarcomeric myosin, as an indicator of differentiation, were 
fixed in 4% methanol-free paraformaldehyde for 30 min at room temperature, 
permeabilized and blocked with 0.5% Triton X-100 in 1% bovine serum albumin (BSA; 
 37 
Sigma-Aldrich, St. Louis, MO, USA) before being incubated with primary antibody. 
Monoclonal antibodies against sarcomeric myosin (MF20, 1:200) and Troponin-T (CT3, 
1:100) were obtained from the Developmental Studies Hybridoma Bank, Iowa City, IA, 
USA. Secondary antibody AlexaFluor 488-conjugated anti-rabbit IgG and DAPI were 
obtained from Life Technologies (Carlsbad, CA, USA) respectively. Gels were incubated 
in antibody solutions (10 and 1 µg/ml for secondary antibody and DAPI, respectively) 
overnight at room temperature and rinsed thoroughly between all steps in PBS containing 
0.05% Triton X-100 and 1% BSA. The hydrogels were transferred into fresh PBS 
solution and imaged in Lab-Tek chamber slides, using a Nikon-C2 laser scanning 
confocal microscope with a × 20 air objective. Z-stack projections through 100–300 µm 
thick sections of the hydrogels were rendered. Individual slices/image were analyzed 
using customized macros on ImageJ software (NIH, Bethesda, MD, USA), and projected 
into maximum-intensity images for the purposes of illustration. For samples stained for 
live/dead, the fractional viability was calculated as the number of live cells/total cells. 
The number of cells stained positively for Calcein (live only) was divided by the number 
of cells stained positive for TOTO-3 iodide (dead only), plus the number of Calcein -
positive cells. Projected spread area was determined as the total area occupied by Calcein 
stain. For samples stained for sarcomeric myosin and DAPI, percentage differentiation 
was calculated as the number of cells stained positive for myosin over the total number of 
cells/imaged plane. Number of multinucleated cells and number of nuclei/differentiated 
cell were determined using binary layers, applied with Nikon Instruments Software 
(NIS)-Elements. Image slices were chosen from stacks at 10 µm (z axis) intervals, to 
avoid counting the same cells more than once using ImageJ and NIS-Elements. For 
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multinucleation analysis, the NIS-Elements software was used to distinguish between 
DAPI and sarcomeric myosin by application of layers to individual image slices. In very 
few instances, images were discarded because multinucleated cells were found in close 
proximity to each other, resulting in poor discrimination by the program. Live/dead 
images were taken in LiveCell System (Pathology Devices, Westminster, MD, USA). All 
images were taken at the same settings and subjected to consistent threshold values 
during image processing. 
 
Muscle contractility assay 
     To induce gel contraction, a stimulant solution (5 mM CaCl2, 5 mM MgCl2, 
100 mM KCl, 5 mM EGTA, 1 mM ATP in PBS, pH 7.4) was used. Hydrogels in saline 
were used as controls. All gels were placed in 200 µl test solution and immediately 
extruded unidirectionally, using a transfer pipette, onto parafilm adhered to ruled paper. 
The change in length of the hydrogel along the horizontal axes was observed for up to 
15 min, although no visual changes were observed after the first 5 min. 
 
Statistics 
     Data are expressed as mean ± standard error of the mean (SEM). Statistical analysis 
was performed using t-test for comparison of two different groups, one-way ANOVA for 
comparisons among different groups, and two-way ANOVA for comparisons between 
different groups at different time points, using GraphPad Prism software. Significance 





Cell-seeding density influences encapsulated C2C12 cell viability and spreading 
     To generate cell-laden hydrogels, four-arm PEG–MAL macromers were 
functionalized with RGD and cells, followed by crosslinker, were added to form a gel 
(Figure 5). To create a functional, dense, hydrogel–tissue composite without vasculature, 
it was necessary to identify a cell density that would be high enough to promote sustained 
cell survival, as a prerequisite for cellular differentiation into skeletal muscle-like tissue. 
Initial cell encapsulation was confirmed to be uniform in a 3D field of view, according to 
live/dead staining with laser-scanning confocal microscopy (Figure 6).  





 cells/mL and constructs were stained for viability at days 1, 3 and 7, where day 0 
is the day when the hydrogels were formed. The images in Figure 6B show similar levels 
of cell viability and spreading at day 1. However, after a week in culture, differences 
among seeding densities become evident and visual observation suggested that the 
highest survival was obtained at 4–8 × 106 cells/ml and was limited in gels seeded with 
0.1, 1.0 and 10 × 10
6
 cells/mL.  
     Figure 6C shows quantification of live cells within gels, showing time- and cell 
density-dependent differences. The overall percentage of live cells decreased from day 1 
to day 3 and was restored by day 7, with the exception of the lowest cell-seeding density. 
Whereas significantly different from other groups, the 4 and 8 × 10
6
 cells/mL were not 




group was significantly different to all other conditions (p < 0.05). Cell spreading and 
extension of cell processes were assessed as projected spread area (Figure 6D). In 
general, the spread area decreased from day 1 to day 3, corresponding to decreases in the 
percentages of live cells, but then increased from day 3 to day 7. Whereas significantly 
different from other groups (p < 0.05), the groups for 4 and 8 × 10
6
cells/ml were not 
different from each other at days 1, 3 and 7.  
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The greater projected spread area for 10 × 10
6
 cells/mL throughout culture was related to 
the higher seeding density and the difficulty of using image analysis methods in this case 
to distinguish the two.  
     These data indicate a threshold for the concentration of cells that remain viable within 
a 40 µl hydrogel in the absence of a vascular network or convective culture conditions. 
 
Figure 6: Viability of C2C12 cells in 3D hydrogels to varying cell seeding densities. 
(A) Volume view of 400 µm stack of live/dead staining to show uniform cell seeding 
density throughout gel seeded at 8 × 106 cells/mL. (B) Representative maximum 
intensity projection confocal images stained for live/dead. (C) Highest percentage of 
viable cells existed in gels seeded with 8 × 106 cells/mL (~79%), with a significant 
difference between 8 × 106 and 10 × 106 densities and all other conditions at day 7. 
(D) Projected spread area occupied by live-cell stain is quantified as extent of 
spreading. All scale bars = 100 µm. n ≥ 5/condition/time point; *p < 0.05 
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As contact-dependent cells, C2C12 cells require a seeding density enabling intracellular 
interactions to mediate survival [166], which the densities of 0.1 and 1 × 10
6
 cells/mL are 
unable to provide. In contrast, at 10 × 10
6
 cells/mL, increased competition for nutrients 
and space results in lower levels of sustained survival. Hence, the 8 × 10
6
 cells/mL cell 
seeding density was chosen thereafter as a concentration with the greatest potential for 
dense tissue exhibiting low levels of long-term cell mortality. 
 
Polymer weight percentage influences encapsulated cell viability 
     It has been shown that matrix elasticity provides biophysical cues that impact skeletal 
muscle stem cell behavior, such as viability and lineage commitment [77, 78]. Varying 
the weight by volume proportion of polymer in the hydrogel modulates matrix elasticity, 
as well as crosslink density, rate of gel degradation and permeability for soluble factors. 
The range 0.45 kPa at 4 w/v% to 0.8 kPa at 6 w/v% Phelps et al., 2012 was selected on 
the basis of preliminary studies, which showed variations in C2C12 development 
dependent upon alterations of the polymer weight percentage used. To quantify C2C12 
response to hydrogel weight percentage (w/v%), we assessed the fraction of live cells in 
PEG hydrogels of various w/v% and a 3 mg/ml collagen type I gel (as a reference to 
natural matrices) at days 1, 3 and 7 (Figure 7). Fractional values calculated at days 3 and 
7 were normalized to day 1 values for each condition (Figure 7B). A fractional value of 
1.0 at day 1 reflects the highest levels of viability observed 24 h after encapsulation for 
that polymer w/v% condition. By day 7, the viabilities of cells in 5% PEG and collagen 
gels were not significantly different from each other, but were observed to be 
significantly higher than the rest of the groups (p < 0.05). Importantly, 5% PEG 
hydrogels supported higher levels of viability compared to 4% and 6% hydrogels, 
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showing an optimal polymer weight concentration for C2C12 culture in 3D. The lower 
viability for 4% hydrogels can be attributed to its weak mechanical structure from fewer 
crosslinks. Fewer protease-degradable crosslinks allow faster cell-mediated matrix 
degradation and loss of the physical scaffold. Conversely, the 6% hydrogels probably 
supported lower cell viability due to decreased permeability arising from the higher 
polymer network density. As previously described, the presence of protease-degradable 
sites in appropriate concentrations play a key role in cell viability and differentiation 
(Patterson and Hubbell, 2010; Phelps et al., 2012. In this case, fast-degrading VPM 
crosslinker at the concentration used to form networks with 5 w/v% PEG–MAL–RGD 
enables cells to remodel their microenvironment at a time scale appropriate for promoting 
C2C12 cell viability and proliferation, as precursors to differentiation. 
 44 
 
Skeletal muscle constructs require bio-adhesive cues within the scaffold to promote cell 
viability 
     To examine the impact of a bioadhesive ligand within the synthetic hydrogel 
environment, two peptides were used: the active RGD peptide from fibronectin, as a 
bioactive ligand to induce adhesion; and the scrambled RDG peptide, as an inactive 
substitute that would not alter hydrogel structure. 5% PEG and 3 mg/ml collagen type I 




Figure 7: Viability response of C2C12 cells in 3D hydrogels to varying polymer 
weight percentage. (A) Representative maximum intensity projection images of 
live/total cell stains in gels of varying polymer percentage and collagen type-I, used as 
a biological control. (B) Fraction of cells alive shows differences between 5% gels 
compared to 4% and 6% gels at day 7. No differences between collagen type-I and 5% 
gels was found. (C) Projected spread area occupied by live-cell stain is quantified as 
the extent of spreading, showing differences among gels at day 7. All scale bars = 100 
µm, n ≥ 5/condition/time point; *p < 0.05 
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mouse myoblasts showed high viability in the presence of RGD in a manner comparable 
to that of the natural collagen matrix. Significantly reduced viability was observed in 
RDG gels (Figure 8). These results demonstrate the need for cell–matrix adhesion, 
demonstrated with RGD in the synthetic environment. 
 
Horse serum concentration in differentiation medium influences the extent of C2C12 
differentiation 
     Determining the specific conditions that supported cell survival for up to 7 days was 
considered a prerequisite to studying the differentiation potential. Serum deprivation is a 
common approach to forcing myoblasts to exit the cell growth cycle and begin 
differentiation into skeletal muscle cells (Lawson and Purslow, 2000). We therefore 
examined the extent of differentiation for different serum concentrations in the culture 
medium, as quantified by: (a) degree of maturation, reflected in the number of cells 
expressing muscle-specific proteins divided by total number of cells (‘% differentiation’); 
 
Figure 8: Viability of C2C12 cells in 3D hydrogels in the presence and absence of 
bioadhesive ligands. (A) Representative maximum intensity projection images of 
live/dead cell stains in gels presenting RDG (non-adhesive), RGD (adhesive) peptides 
and collagen type-I, used as a biological control. (B) Percentage viable cells analysis 
shows differences between RDG and collagen-I groups, suggesting that cell viability 
is maintained in the presence of bioactive ligands. All scale bars = 100 µm; *p < 0.05  
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and (b) degree of fusion, analysed as the number of multinucleated cells and number of 
nuclei/cell stained positive for differentiation markers (Bajaj et al., 2011). 
Using the hydrogels in which C2C12 myoblasts showed good viability (5% PEG, 
2.0 mM RGD, 8 × 10
6
 cells/mL), up to 75% of cells were found to be differentiated over a 
period of 4 days in differentiation medium (DM) when the DM was supplemented with 
2% HS. Figure 9A, B shows immunofluorescence staining for sarcomeric myosin and 
troponin, used to assess differentiation markers, while Figure 9C, D shows quantification 
by image analysis. The percentage of differentiated cells in 2% HS was significantly 
different from other groups (p < 0.05). Low serum concentration conditions (0%, 0.1%) 
produced lower differentiation, with a maximum of approximately 60%, while high 
serum concentration (10%) resulted in the lowest levels of differentiation (30%) amongst 
 
Figure 9: Differentiation of C2C12 cells, as indicated by sarcomeric myosin and 
troponin expression is modulated by horse serum (HS) concentration in 
differentiation medium (DM): (A) presence of sarcomeric myosin; (B) troponin 
indicates differentiated skeletal muscle; (C) representative images of myosin and 
DAPI stain show that 2% HS concentration in DM improves the extent of 
differentiation, indicated by self-assembly and alignment of myotubes; (D) 
percentage differentiation is quantified as cells positive for differentiated marker out 
of total nuclei; > 75% cells were differentiated in 2% HS, significantly more than 
0%, 0.1% or 10% HS samples. All scale bars = 100 µm; *p < 0.05 
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all the groups tested. These results demonstrate an optimal serum concentration for 
differentiation. We attributed the lower differentiation for low serum concentrations to 
reduced cell viability, and the reduced differentiation in high serum concentrations to 
enhanced proliferation, which is antagonistic to differentiation. Hence, the impact of 
modifying soluble factor cues should be considered while engineering differentiated 
skeletal muscle tissue, and 2% HS was found to be optimal for this system. These results 
also show that differentiating skeletal muscle myoblasts and multinucleated cells possess 
the intrinsic ability to self-align in the absence of direct topographical cues (Figure 9A). 
 
Incubation period in growth medium prior to differentiation modulates the extent of 
C2C12 differentiation 
     We observed that the extent of myogenic differentiation varied with the incubation 
time in growth medium (GM) prior to induction of differentiation. To further examine 
these effects, we experimented with different incubation periods prior to using a fixed 
4 day differentiation protocol, where the DM contained 2% HS. Gels were created as 
previously determined with 5% PEG, 2.0 mM RGD and 8 × 10
6
 cells/mL. Zero-day 
incubations (0 days) refers to hydrogels that were cast and immediately transferred to 
DM. Figure 10A, B shows the benefit of an incubation time longer than 1 day, with an 
upper limit being reached at a 5 day incubation period, due to gel degradation and 
handling difficulties; 3 days in GM allowed the cells to reach differentiation levels 
exceeding 50%, which was significantly different to all other conditions (p < 0.05). The 
formation of multinucleated myotubes was analysed, as shown in Figure 10C, to show 
the number of multinucleated cells/unit area and the extent of multinucleation/cell 
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(Figure 10D, E). A 3 day incubation period resulted in the highest levels of 
multinucleated cells and extent of multinucleation/cell. An average of eight 
multinucleated cells/µm
2
 was observed, with at least two nuclei/cell. These results show 
that controlled growth and differentiation conditions, in combination with 
microenvironmental cues provided by the hydrogel, regulate C2C12 cell survival and 
eventual differentiation into self-aligning myotubes. In summary, biological and physical 
properties essential to skeletal muscle, shown by the degree of maturation and degree of 
fusion, respectively, can be engineered into synthetic hydrogel systems. 
 
Figure 10: Differentiation of C2C12 cells as indicated by sarcomeric myosin 
expression is modulated by incubation time in growth medium (GM) prior to 4 days 
in DM: (A) representative maximum intensity projection images of myosin and DAPI 
stain show that 3 days in GM improves extent of differentiation, indicated by self-
assembly and alignment of myotubes; (B) percentage differentiation is improved 
(~55%) and significantly different in 3 day-incubated samples compared to 0, 1 or 
5 days of incubation; (C) schematic of analysis for multinucleation extent, as assessed 
by number of multinucleated cells/unit area and number of nuclei/multinucleated cell 
(i = 7, ii = 5, iii = 3); (D) images obtained from GM incubation were also analysed for 
multinucleation extent, as described previously. Differences between 3 day incubation 




Hydrogel with differentiated cells exhibit contraction under external stimuli 
     Hydrogels with encapsulated cells differentiated under the previously described 
methodology were exposed to a contractile stimulant or PBS control before being 
immediately extruded into a rod-like shape (Figure 11). Changes in length were measured 
over a 15 min period, but no additional changes were observed beyond 5 min. In 
contractile solution, the extruded hydrogels began to decrease in length instantly. The 
average reduction in length was 18.4 ± 2.75% (n = 6), which was significantly different to 
the hydrogels in PBS, which decreased in length by 7.2 ± 3.15% (n = 4, p < 0.05). Cell-
free hydrogels did not contract upon exposure to contractile agonist or in the presence of 
PBS control. Although the myoblasts are not provided with direct signals for alignment 
and differentiate in random directions, they are functional by their ability to contract and 
reduce the length of an extruded hydrogel. These results demonstrate a simple functional 
response of the differentiated skeletal muscle cells acting upon the hydrogel constructs in 





    Limited treatment options for skeletal muscle repair have entailed exploration into 
regenerative biomaterials that encourage muscle cell growth, proliferation and 
differentiation in vitro. In particular, synthetic hydrogels can be controllably engineered 
to design a microenvironment that directs cell fate. We identified an optimal hydrogel 
formulation of 5% w/v four-arm PEG–MAL macromers functionalized with 
2.0 mM RGD adhesion peptide, and crosslinked by a MMP-degradable peptide that 
supports C2C12 mouse myoblast proliferation and differentiation. Additionally, 3 days of 
incubation in growth medium, prior to differentiation in 2% HS for 4 days, produced 
multinucleated cells that exhibited intrinsic alignment and demonstrated simple 
 
Figure 11: Functional response of 3D gels containing differentiated C2C12 cells to 
contraction-inducing conditions: (A) initial gel removed from solution; (B) gel in 
100 µl testing solution for 10 s, followed by immediate extrusion using transfer 
pipette; (C) contraction was induced using appropriate solutions; gels in contraction 
solution shortened in length (horizontal dimension); (D) quantification of 
contraction as a result of contractile agent or PBS control (SD); images at t = 0 and 




contractility. We note that the range of parameters presented in this study was derived 
from either our experience with other cell types in this hydrogel system, or from pilot 
experiments that are not included in this report. Unlike their naturally derived 
counterparts, synthetic hydrogel properties can be precisely tuned to study matrix 
requirements of a cell from its environment. Characteristics such as matrix elasticity, 
permeability and degradability arise from the balance between polymer weight 
percentage and the required number of protease-degradable crosslinks necessary to form 
the gel. It has been shown that the interactions of a cell with its hydrogel surroundings 
can dictate decisions of cell fate. Hence, the ability to control the extent of these 
interactions with the modular design variation afforded by this PEG–MAL system allows 
us to examine and recapitulate properties necessary for tissue regeneration. 
    We posit that C2C12 cells require a certain amount of time to remodel the hydrogel for 
higher differentiation potential, hence exploring the incubation period for cell 
acclimatization. In this particular system, 0–1 days of encapsulation prior to DM results 
in insufficient remodelling and reduced differentiation potential. However, 5 days of 
incubation and greater remodelling also result in lower differentiation values, due to 
reduced mechanical integrity of the scaffold hydrogel. Such incubation times may have to 
be optimized for differing systems of hydrogels and cells, but should be regarded as an 
important consideration during in vitro tissue regeneration. 
     The original hydrogels were cast as discs of 5.0 mm diameter × 2.0 mm thickness. 
During culture, the hydrogels swelled significantly until day 3 and then decreased in 
volume until days 7–11, as the embedded cells proliferated and contracted the hydrogels. 
It should be noted that, for a system of this size, mass transfer is expected to occur by 
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diffusion, without enhanced transport due to convection or vascularization. Potential 
scale-up for therapeutic use will necessitate a mechanism for adequate nutrient and waste 
transport, comparable to native vasculature. Indeed, we have previously used similar 
PEG–hydrogel formulations to deliver the vasculogenic factor VEGF and establish a 
robust in vivo vasculature within the implanted hydrogel [80, 161]. 
     While the hydrogel used in this study does not possess mechanical properties 
comparable to those of skeletal muscle or present physical cues, it does provide 
appropriate signals for the development and self-alignment of myotubes (Figure 9A) to 
begin to emulate native skeletal tissue. An inadequate degree of cell fusion and formation 
of self-aligned fibres limits the effectiveness of the current hydrogel system. Hence, 
future work will include investigation of topographical cues for directed alignment and 
improved contractile function. In addition, methods of incorporating vasculature are 
being considered to create self-sustained muscle actuators of greater dimensions. The 
hydrogel must be further engineered to support the infiltration of host cells, such as 
macrophages, fibroblasts and endothelial cells, while promoting vasculature through the 
release of growth factors or soluble mediators to promote cell survival and engraftment 
[167]. Beyond the development of skeletal muscle constructs for therapeutic applications, 
the use of synthetic hydrogels as scaffolds for the generation of muscle constructs 
provides an important step in engineering tailorable contractile units for cell-based 
actuators and machines. 
     C2C12 cells were employed as a well-characterized myogenic cell line and an 
established cell type to interface with neurons and use external signals for further studies. 
The techniques developed here can be translated to other cell lines, including human 
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primary or stem cell-derived cells, such that, in the future, an injectable or entirely ex 





     The goal of this study was to develop a scaffold as the first step towards building 
contractile muscle implants to mimic the cellular organization and physiological function 
of dense skeletal muscle, for the repair and replacement of lacking, diseased or damaged 
tissue. By modulating the compositional characteristics of a synthetic hydrogel, we 
identified key microenvironment cues to direct the adhesion, viability, growth, 
differentiation and formation of myotubes for functional skeletal muscle tissue 
constructs, as a regenerative solution to skeletal muscle loss, as well as a force actuator 
for cellular machines [9]. This study aims to add to the current knowledge of cooperative 
cellular behavior, leading to a deeper understanding and possible recapitulation of the 
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CHAPTER IV: TOROIDAL SHAPE PROVIDES GEOMETRIC CUES 
TO ALIGN MYOBLASTS WITHIN HYDROGEL CONSTRUCTS 
THAT DEMONSTRATE FUNCTIONAL CONTRACTION IN 




     Cellular alignment is crucial for the development of differentiated myotubes that 
support contractile machinery for functionality of in vitro generated constructs. Previous 
works to introduce anisotropy in 3D tissues have utilized geometric cues on scaffolds 
printed with microarchitecture for cell guidance, or utilized naturally-derived materials in 
combination with mechanical and electrical stimulation signals. Of the synthetic scaffolds 
available, hydrogels show great promise for modulating bio-architecture, as 
multifunctional polymer matrices can be created for highly viable cell populations after 
encapsulation [75]. The first goal of this study was to identify geometric cues for 
biofunctional poly(ethylene glycol) (PEG)-maleimide (MAL) hydrogels to prompt 
directed alignment to encapsulated cells in vitro. We found that toroidal shaped 
constructs (generated by casting the hydrogel around spires of defined sizes) containing 
C2C12 skeletal myoblasts increase cell viability and alignment over time compared to 
free floating or linear hydrogel constructs. Meanwhile, demonstration of functionality is 
essential for the development of skeletal muscle constructs intended for use in tissue 
engineering or soft robotics. Previously, constructs at this size scale have utilized 
secondary structures for the measurement of force as a result of the deflection of a 
construct anchor. The second goal of this study was to directly measure the forces 
generated by toroidal hydrogels of aligned cells, upon action of external agonists, using a 
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custom built setup and analysis method. We found that the 1.0 mm spire-toroids 
generated the highest alignment, as quantified using an alignment index, compared to 
other spire-toroid sizes. In addition, the 1.0 mm spire-toroids produced the greatest 
contractile force of 46.8±7.9 µN upon activation with a 50 mM caffeine solution, and this 
contractile force was completely abrogated in the presence of contractility inhibitors. 
Hence, we demonstrate a positive correlation with extent of alignment and efficiency of 
contraction. Overall, these two goals are aimed at developing alignment and 
demonstrating contractile functionality within skeletal muscle engineered constructs. 
Additionally, the techniques described here can be translated across cell and tissue types 




Uniaxially aligned myotubes that contain developed sarcomeric contractile 
machinery are key characteristics of skeletal muscle tissue [163]. For this study, we 
utilized previously generated biofunctional hydrogels to examine strategies to (1) 
promote cellular alignment and (2) measure contractile function. Typical in vitro 
strategies for skeletal muscle tissue engineering (SKMTE) utilize biomaterial substrates 
with added cells until the tissue has evolved into a functional form that can be 
transplanted in vivo or controlled by external stimulation [47, 123, 139, 145, 168-172]. 
     Challenges to generating mature and contractile constructs are multifold [8]. First, the 
construct must be able to withstand physical handling while maintaining a high 
concentration of differentiated, fused and aligned cells. Tractability is important as it 
enables the construct to be easily subjected to methods of preparation for microscopy, 
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visualization, and mechanical testing in vitro without relying on the support of an 
external substrate with different material properties that can confound force production 
results or make it difficult to directly measure force from the tissue itself. In addition, a 
tractable construct is more suitable for in vivo implantation. Although injectable 
hydrogels have been explored, their efficacy in skeletal muscle cell delivery has not been 
demonstrated as frequently as their ability to repair cardiac muscle, or deliver growth 
factors for limited skeletal muscle regeneration [104, 162, 173, 174].  Second, the 
construct needs to be amenable to mass transport by diffusion in the absence of well-
defined vascularization [175]. Third, the engineered tissue must be functionally able to 
generate physiologically relevant forces [176].  
     Biomaterial scaffolds are an important factor in muscle construct development as they 
enable the modulation of encapsulated cell behaviors through physical or biochemical 
cues, spatiotemporal drug release, and protection from immune response due to injury. 
These functional properties can be achieved by a combination of features, including the 
choice of biomaterial, its 3D architecture, chemical composition, functionalization with 
biological molecules, biodegradability, mechanical and physicochemical properties [8]. 
In the previous chapter, we established that synthetic PEG scaffolds provide a consistent, 
modularly controllable starting material for myotube differentiation. We previously 
showed engineering a specific microenvironment for C2C12 mouse skeletal myoblasts 
and modulating growth conditions would enable the development of biofunctional 
hydrogels for skeletal muscle constructs, here we examine the application of geometric 
cues on the development of alignment and consequent functionality [6]. We understand 
the limitations of using cell lines in replicating in vivo myogenesis, yet the widespread 
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use of C2C12 myoblasts and their ease of use make them an ideal choice for technology 
development platforms such as those described in this study. Furthermore, we have 
established the PEG-MAL material to be a suitable delivery system for in vivo use 
(Appendix A,[162]).  
     Typically, biomaterials can promote cellular alignment in static or dynamic form. 
Static physical cues include (i) topographical cues on flat, two dimensional (2D) surfaces 
[177-180], from which a cell-scaffold construct of several uniformly aligned layers can 
be constructed [136]; (ii) 3D anisotropic scaffolds generated prior to the addition of cells, 
such as electrospun fibrous meshes [87, 181], or anisotropic porous scaffolds [182], 
which promote alignment within the construct during development [105, 123, 168].  
     2D approaches to alignment are limited due to the production of cellular monolayers 
that cannot deliver the required tissue thickness for physiological functionality. 
Additionally, aligned monolayers cultured using contact guidance such as microcontact 
printing (μCP) of parallel grooves on a planar surface, are not easily separated from their 
substrate while maintaining physical integrity [177, 178]. The ability to strip monolayers 
from substrates is important to further process 2D tissues into 3D constructs for long-
term stability and physiological relevance [115]. 
     Millimeter scale, 3D skeletal muscle constructs have been engineered by embedding 
cells in scaffolds that contain anisotropic cues, often created using electrospinning [87, 
181]. Constructs have also been generated as anisotropic sheets using custom designed 
molds with intermittent polygonal posts to create porous networks of skeletal muscle 
[123]. Cylindrical tissue constructs such as myooids or bioartificial muscle (BAMs) were 
produced without scaffolds through the self-organization of muscle and fibroblast co-
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cultures. Muscle fascicles [169], microtissue gauges (µTUGS) [183], and myooids [121] 
demonstrate that it is possible to engineer functional 3D skeletal muscle as a linear 
muscle bundle with anchor points on two ends and a roughly circular cross-section, 
similar to that found in vivo. Fascicles and µTUGS are limited for use in practical or 
medical application due to their small-scale thickness of around 100 µm and lack of 
scalability potential. Other limitations of previously generated 3D constructs involve the 
use of anchorage for support, base elastomer for stability, and the use of naturally derived 
scaffold materials. Ideally, anchorage in SKMTE would be sufficient to induce tension as 
a static geometric cue or behave as conduits for dynamic stimulation. The use of least two 
anchorage points to provide mechanical stability and tension for aligning cells 
necessitates the design of a custom functional measurement setup [123, 132]. Yet the 
support provided should be amenable to removal on-demand, to allow facile detachment 
of the construct for use in contraction analyses or in vivo transplantation. Lastly, 
developed 3D constructs  are constrained by size to 1 mm or less due to the absence of a 
vascular network [115]. The resulting diversity in the exploration of SMTE constructs 
and measurement devices complicates comparisons between labs that likely use different 
materials and cell sources.  
     In terms of actuators developed for soft robotics, many structures consist of 2D layers 
of cells attached to a flexible elastomer, such as PDMS, that provides structural support 
and basal attachment for the cells as contractility is explored [10]. Resulting constructs 
adhere strongly to their elastomeric base materials and separation is not presented as 
possible, or important, though necessary for translation to tissue engineering applications.  
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     Dynamic signals for inducing alignment and myofiber hypertrophy include electrical 
stimulation [153, 184-188] or cyclic mechanical stretching [189, 190]. Electrical 
stimulation depolarizes the myotubes, causing contraction and mechanical stress that 
increase differentiation, alignment, and force generation [186]. Although these 
approaches improve morphology, force production and tissue density are still not 
comparable to native skeletal muscle: the peak stress generated was 60–120 Pa, 
considerably less than the 100 kPa and higher stress of native skeletal muscle [115, 147]. 
Meanwhile, several limitations accompany the continuous excitation of cell culture using 
electrodes, such as electrolysis of the media, consequent heating, pH changes, and 
electrode corrosion. Contactless and miniaturized electrodes are being explored to 
combat these issues but with limited success [191, 192].  
     Mechanical signals have been shown to increase force generation through the 
improvement of cellular anisotropy, increase in the myofiber diameter and relative cross-
sectional area compared with controls [186, 190, 193-195]. Work with C2C12 myoblasts 
prior to differentiation has shown mechanical signaling, through cytoskeletal remodeling, 
had significantly greater impact on alignment than electrical stimulation due to the lack 
of excitation-contraction mechanism development [196]. Dynamic, or cyclic, mechanical 
signals are created by stretching muscle constructs using an externally applied load, in a 
distinctly different manner than the mechanical stresses experienced as a secondary 
feature of electrical stimulation signaling. Further improvements to muscle construct 
alignment and force generation may be possible by changing the mechanical or electrical 
stimulation patterns, exploring drug release for hydrogels or taking a step back and 
improving the biomaterial from which the constructs are engineered [197]. Accordingly, 
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while the use of stimulation is an important tool, the availability of a simpler solution, 
such as biomaterial modification, may provide a facile and reproducible strategy without 
extensive custom equipment or stimulation profiles. Using fewer cues at initial stages 
may also force cells to rely on their inherent properties to align [6], which may be 
enhanced or developed further through the addition of dynamic signaling.  
     The first goal of this study was to further develop our cell–hydrogel composite to 
promote cellular alignment for the development of a functional muscle strip. To this end, 
we explored the utility of simple geometrical constraints that provide mechanical cues 
during fabrication of the cell-laden construct to align myotubes by utilizing the intrinsic 
ability of skeletal muscle cells to grow, differentiate, and fuse without excessive external 
aides. We used the C2C12 skeletal muscle progenitor cell line, encapsulated in 
biofunctional hydrogels cast with a spire mold to generate a toroidal shaped gel 
configuration for circumferential alignment (Figure 12). The resulting 3D swollen 
hydrogels provide tailorable platforms that support skeletal muscle progenitor cell 
alignment. We examined the effects of different spire configurations and hydrogel 
volumes for viability and degree of alignment. Initial choices for toroid dimensions were 
obtained from the positive results of Yamamoto et al. generating 12 mm outer diameter 
(OD) toroids gels using magnetic tissue engineering techniques [129] and the negative 
(unaligned) results seen in the 360 µm OD toroids of Bajaj et al [82]. From these 
experiments, we gather that spire dimensions provide geometric cues, that produce 
internal stresses, which could induce encapsulated C2C12 alignment when the OD is 
greater than 360 µm, but within 12 mm. We hypothesized that a toroidal shape would 
allow the generation of circumferential stresses [82] that would drive cell alignment and 
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further contractile potential. Our understanding of the term ‘geometric cues’ includes the 
effect of macroscopic properties such as the ratio of surface area to volume over time, gel 
swelling and compaction with the resultant mechanical, or Von Mises stresses, produced 
throughout the hydrogel-cell composite. Though encapsulated cells generate traction 
within a matrix, the toroidal geometry explored here should support greater 
circumferential, as opposed to radial, stresses, enabling tension within the construct 
despite the absence of externally applied tension.  
     Briefly, we cast hydrogels around a solid spire mold to generate toroidal constructs. 
We varied spire diameters of 0.5, 1.0 and 2.0 mm diameter, and initial hydrogel seeding 
volumes of 12.5 and 25 µL, and then determined DNA content, viability, and extent of 
alignment. We expected the spire sizes and gel volumes to be relevant design parameter 
through the modulation of stress patterns within the hydrogel with higher circumferential 
stress patterns inducing greater cell viability and alignment [82]. 
    Our second goal of measuring muscle functionality was vital to the development of 
bio-actuators. In this portion of the study, our aim was to measure the forces generated by 
toroidal hydrogels containing aligned and differentiated C2C12 myoblasts. 
Contractibility for differentiated C2C12 myotubes subject to 4-7 days of differentiation is 
dependent upon the extent of functional sarcomeric muscle protein development and 
presence of active calcium release channels on the membranes of the sarcolemma 
(sarcoplasmic reticulum (SR) and transverse-tubules). Previously, we have demonstrated 
the presence of sarcomeric myosin in upwards of 70% of all myoblasts [6], suggesting 
the potential for myosin-mediated contraction. 
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     Force production mechanisms in intact mammalian muscle is a chain of processes 
begun by a muscular action potential, that activates an excitation-contraction coupling 
causing myofibrils to contract [198]. Nicotinic acetylcholine receptors (nAChR), 
localized at neuro-muscular junctions, transmit signals from acetylcholine 
neurotransmitters to mediate the depolarization of the cell membrane and consequent 
calcium ion mobilization from intercellular SR stores as mediated by voltage and 
ryanodine-sensitive ion channels [2, 3]. An increase in cytoplasmic calcium ion 
concentration promotes binding to troponin C, allosterically modulating tropomyosin, 
which unblocks myosin binding sites for cross-bridge cycling to occur (Fig 1) as per the 
sliding filament theory [2, 3]. 
     Hence, the criteria necessary to measure contractibility in C2C12-based skeletal 
muscle constructs are (i) availability of nAChRs, and (ii) presence of functional 
sarcomeric units. Expected forces for native mouse tissue and C2C12-based constructs 
are provided in Table 3. Although the tissue constructs are of different dimensions, forces 
are normalized by cross-sectional area, a plane perpendicular to the direction of force 
production, and entered as stress values. It must also be noted that both representative 
examples in Table 3 were electrically stimulated. In this work, our use of an agonist is not 
expected to lengthen the time to peak force due to diffusion times on the scale of 
nanoseconds (Appendix B.4), while still enabling toroidal hydrogels to attain peak forces 
on a comparable scale. 
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Table 3: Measured contractile forces produced by mouse extensor digitorum longus 
(EDL) muscle and in vitro generated C2C12 myoblast constructs. Duration of contraction 
includes the time taken to reach peak contraction through the time taken to return to 
initial steady state. 







Time to peak 50 ms 500 ms 
Duration of contraction 140 ms 250 ms 
Peak Force 200 µN  15 µN 
Stress 407 kPa 1.06 kPa 
Tetanus 
Time to peak 50 ms 500 ms 
Duration of contraction 0.2 – 6.4 sec 4 sec  
Peak Force 1.8 N 33.2 µN 
Stress 1.2 GPa 2.35 kPa 
Force values provided for mouse EDL muscle are target values, though the C2C12 
construct values from in vitro work are most comparable to this project, mainly due to the 
use of the C2C12 cell line. It must be noted that there exists a 400-fold difference in 
twitch stress between native mouse tissue and engineered C2C12 constructs, though the 
contractions occur on similar time scales.  
     The experimental set-up designed to measure force of a multinucleated muscular 
construct is dependent upon the construct size and design. For this study, construct sizes 
ranging in length from 200 µm to 5 mm, and width from 100 µm to 2 mm are considered, 
because they constitute the bulk of existing work and are comparable in size to native 
mouse muscle tissues. Direct measurements of force typically involve the twitch or 
tetanic response and isometric force generation detected using a force transducer [120, 
122, 123, 127, 143, 150, 151], or a high speed camera to relate the motion of muscle 
constructs to the force generated [152, 153], using known mechanical properties of 
materials used. For instance, to measure the forces produced by miniature Bioartificial 
Muscles (mBAMs), Vandenburgh’s group captured images monitoring the deflection of 
posts to which the mBAMs were anchored, at 4 frames per second (fps), to calculate the 
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force that would have caused the observed displacement [146]. Similarly, the contractile 
function of microfabricated tissue gauges (µTUGs) was determined by examining the 
deflection of cantilever tips on which the constructs were formed [154]. Dennis and 
Kosnik measured the contractile ability of ‘myooids’ using an in-house designed force 
transducer that detected changes in muscle construct length with time upon the action of 
external agonists [121]. Notable examples of functional skeletal muscle constructs are 
summarized in the table below. 
Table 4: Measured forces from skeletal muscle constructs, (1
o
 = Primary, Ad = adult, 
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     Alternatively, indirect measurements include the use of lentiviral transduction with an 
intracellular sensor for calcium ion flux that is attributed as proportional to functional 
muscle activity [123], and tracking the movement of secondary objects of estimated 
mechanical properties due to the supposed action of the primary muscular construct. 
Ideally, direct force measurements would be made with a force transducer in response to 
biochemical agonists or electric pulse stimulation.  
     Activating agents for the controlled contraction of myoblasts range from custom-made 
solutions with high calcium ion or ATP content [155] in physiological solutions such as 
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Tyrode’s, Ringer’s, Dulbecco’s or Normal External Solution (NES); to small molecules 
such as caffeine and acetylcholine (ACh) [43]; to the use of parallel platinum wire 
electrodes for electrical stimulation [121]. Myosin inhibitors used to block force 
production without altering depolarization or calcium release include blebbistatin [158], 
N-benzyl-p-toluene sulphonamide (BTS) and 2,3-butanedione monoxime (BDM) [159]. 
Specific ACh inhibitors that block neuromuscular excitation include pancuronium 
bromide and tubocurarine chloride [160]. A hallmark of sarcomeric contraction is 
reversibility of the force production, once the stimulation is removed, to restore 
membrane potential and seize force production. 
     In this study, we used a custom-made measurement device to measure contraction 
produced by external agonists, ACh and caffeine, using the previously described toroidal 
gels. In this aim, we used the C2C12 skeletal muscle progenitor cell line, encapsulated in 
biofunctional hydrogels cast with a spire mold to generate a toroidal shaped gel 
configuration for circumferential alignment, and hooked the resulting 3D swollen 
hydrogels on the custom built setup. We hypothesized that the use of agonists will 
prompt sarcomeric contraction in the 1-4 kPa stress range, and removal of the contractile 
agents will cease force production. The goal of this research was to determine the 
functional output of the cell–hydrogel composite hydrogels and also develop a custom 
contraction measurement apparatus that could be used for other tissues generating forces 




Materials and Methods 
 
Spire Mold Production 
Aluminum negative molds (Figure 12) were designed in AutoCAD and milled 
using a CNC Lathe (Biomedical Engineering student machine shop, Georgia Institute of 
Technology, Atlanta, USA). Negative molds were sonicated with 100% ethanol to clean 
before pouring 10:1 ratio of SYLGARD® 184 elastomer to curing agent (Sigma Aldrich, 
MO, USA). Negative molds with PDMS were placed under vacuum for a minimum of 2 
hours to release air bubbles trapped in spires. PDMS was cured at 70
0
C for 3 hours or 
overnight and peeled off gently. The first two PDMS casts from aluminum were 
discarded due to the presence of metal dust adhered to its surface. Acceptable PDMS 
casts were cut to separate individual spire-reservoirs, and placed in glass dishes for 
















Table 5: Final mold dimensions where spire diameter, height and reservoir diameter as 
per milled aluminum mold and subsequent PDMS dimensions 
Spire Diameter 
(mm) 
Spire Height (mm) Reservoir Diameter (mm) 
0.5 8.0 8.0 
1.0 10.0 9.0 
2.0 5.0 11.0 
 
Cell Culture and Hydrogel Casting 
     Skeletal murine myoblasts C2C12 cells were obtained from ATCC (Manassas, VA, 
USA). Dulbecco's modified Eagle's medium [DMEM; 4.5 g/l D-glucose, L-glutamine (+), 
sodium pyruvate (–)], insulin–transferrin–selenium (ITS-X), Dulbecco's phosphate-
 
Figure 12: Toroidal gel construct summary: (A) proof-of-concept alignment with 5% 
w/v agarose molds, (B) production of PDMS molds from aluminum template, (C) 
sample gel-cell prototype, and amenability of gel configuration to be ‘hooked’ through 




buffered saline (PBS), penicillin/streptomycin, trypsin/EDTA and fetal bovine serum 
(FBS) were obtained from Life Technologies (Carlsbad, CA, USA). Horse serum was 
supplied by Hyclone (Logan, UT, USA). Cells were cultured in 20% FBS and 1% 
penicillin/streptomycin in DMEM (growth medium, GM) until passage 4, prior to 
hydrogel encapsulation, and further growth and differentiation in 2–10% horse serum 
(HS), 1% ITS-X and 1% penicillin/streptomycin in DMEM (differentiation medium, 
DM). 
     C2C12 cells were encapsulated in either collagen type I (3 mg/ml; BD Biosciences, 
San Jose, CA, USA) gels or protease-degradable PEG-based hydrogels, prepared as 
previously described [12]. PEG–maleimide (PEG–MAL) four-arm macromers (20 kDa, > 
95% maleimide functionalization; Laysan Bio, Arab, AL, USA) and custom-synthesized 
peptides (AAPPTec, Louisville, KY, USA) were used. PEG–MAL macromers were 
prefunctionalized with GRGDSPC (RGD) adhesion peptide in 2.0 mM triethanolamine 
(TEA) solution for 30 min. PEG polymer density was maintained at 5% w/v, and RGD 
density was maintained at 2.0 mM. The precursor molecules and cell suspension solution 
(for a final concentration of 8 × 10
6
 cells/mL) were crosslinked into a 25 µL or 12.5 µL 
hydrogel by the addition of a cysteine-flanked protease-degradable peptide sequence, 
GCRDVPMSMRGGDRCG (VPM), for 15 min. The concentration of crosslinker peptide 
was proportional to the macromer concentration in order to react with the appropriate 
number of maleimide groups in the macromer and generate a fully crosslinked hydrogel 
network. The hydrogels were left to swell in growth medium overnight, and the medium 
was changed daily. Hydrogels were cultured for 3 days in growth medium and 7-11 days 
in differentiation medium, dependent upon the assay. The resulting hydrogel phase is 
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transparent, which allows visualization of cellular activity without disruption of the 
cellular microenvironment.  
As geometrical controls, hydrogels were also cast on Parafilm and placed into wells as 
free-floating gels, hereon referred to as ‘free’ hydrogels and control without spires. 
‘Linear’ hydrogels were cast in 4 or 8 welled chambered coverglass and used as 
geometric controls. 
     To generate cell-laden hydrogels, four-arm PEG–MAL macromers were 
functionalized with RGD and cells, followed by crosslinker, and immediately cast around 
spires (Figure 13). Preliminary data (Figure 12A) shows toroidal gels cast on agarose 
 
Figure 13: (A) Macroscopic image showing PEG-4MAL gels cast in silanized PDMS 
spire-molds, prior to separation and swelling in growth media. Cloudy appearance of 
gels is due to high cell seeding density of 8 × 10
6
 cells/mL. (B&C) 3D confocal 
reconstruction of cell-encapsulated 2.0 mm spire-toroid on day 3 from a top-down and 
side-view, where C2C12 cells are fluorescent. 
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molds generate circumferentially aligned cells distributed evenly through the hydrogel as 
viewed by light microscope. Aluminum negative molds (Figure 12B) were milled with 
three different spire configurations to study the effect of different spire geometries on 
encapsulated cell alignment. PDMS molds were cast off the aluminum surface generating 
spires that gels could be cast around (Figure 12C, Figure 6). Spire configurations are 
henceforth referred to using the diameter of the central cylinder, or spire: 0.5 mm, 1.0 
mm and 2.0 mm spires. The hydrogels cast from around these spires are referred to using 
the spire dimension, and the term ‘toroidal hydrogels’, for example: 2.0 mm spire-
toroidal hydrogel.  
 
Measuring Hydrogel Surface Area and Volume  
    Hydrogels cast and swollen in growth media for at least 24 hours were imaged with 
engineering paper for scale using a digital camera. A sterile microcapillary pipette tip was 
graduated with a scale and slid vertically along the spire to determine gel height. 
Dimensions were measured as per the requirement of equations below and Figure 14, to 
be able to solve for volume and surface area of the hydrogels. 
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      Toroidal hydrogels, using torus formulae:𝑉𝑜𝑙𝑢𝑚𝑒 (𝑡𝑜𝑟𝑢𝑠) = (𝜋𝑟2)(2𝜋𝑅) ; 
𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝐴𝑟𝑒𝑎 (𝑡𝑜𝑟𝑢𝑠) = (2𝜋𝑟)(2𝜋𝑅). Free Floating hydrogels, using sphere formulae: 
 (𝑠𝑝ℎ𝑒𝑟𝑒) =  
4
3
𝜋𝑅3 ; 𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝐴𝑟𝑒𝑎 (𝑠𝑝ℎ𝑒𝑟𝑒) =  4𝜋𝑅2. Linear hydrogels, using 
cylinder formulae:𝑉𝑜𝑙𝑢𝑚𝑒 (𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟) = 𝜋𝑅2ℎ ; 𝑆𝑢𝑟𝑓𝑎𝑐𝑒 𝐴𝑟𝑒𝑎 (𝑐𝑦𝑙𝑖𝑛𝑑𝑒𝑟) =
 2𝜋𝑅ℎ + 2𝜋𝑅2. 
     Cross-sectional data of the toroid is shown in Figure 13.   
 
DNA Content Analysis 
     Gels were gently placed in microcentrifuge tubes containing 50 µL of 1 mg/mL 
collagenase-type I (Worthington Biochemical Corporation, Lakewood, NJ, USA), and 
incubated for 1 hour at 37
o
C to degrade completely. Whole cell lysate was extracted 
using Tris-HCL buffer and probe sonication. DNA content was assayed as per the 
instructions of the CyQUANT® Cell Proliferation Assay Kit (Life Technologies, 
Carlsbad, CA, USA). Plates containing samples along with collagenase and Tris buffer 




Figure 14: Dimensions used to estimate surface area and volumes of different gel 
configurations, A. Torus shape, B. Sphere, C. Cylinder. Equations used as described in 
text. 
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Live/dead and immunofluorescence staining and image analysis 
     Hydrogels containing encapsulated cells to be analyzed for cellular viability were 
incubated in PBS for 10 min to remove serum. Hydrogels removed from media and 
placed in PBS were observably different in color (between pink and orange) compared to 
the surrounding clear PBS solution. Hydrogels appeared translucent but colorless due to 
the diffusion of media out of the gel within 5 minutes, and an additional 5 minutes was 
provided to ensure more complete serum removal by diffusion. Next, the hydrogels were 
stained with the Live/Dead stains Calcein-AM (2 µM) and TOTO-3 iodide (2 µM) (Life 
Technologies, Carlsbad, CA, USA) for 10 min. Samples stained for sarcomeric myosin as 
a marker of muscle differentiation, and actin for alignment studies, were fixed in 4% 
methanol-free paraformaldehyde for 30 min at room temperature, permeabilized and 
blocked with 0.5% Triton X-100 in 1% bovine serum albumin (BSA; Sigma-Aldrich, St. 
Louis, MO, USA) before being incubated with primary antibody. Monoclonal antibodies 
against sarcomeric myosin (MF20, 1:200, 3 µg/mL) and actin (Alexa Fluor Phalloidin 
555, 1 µM) were obtained from the Developmental Studies Hybridoma Bank (Iowa City, 
IA, USA) and Life Technologies (Carlsbad, CA, USA) respectively. Secondary antibody 
AlexaFluor 488-conjugated anti-rabbit IgG and DAPI were obtained from Life 
Technologies (Carlsbad, CA, USA). Gels were incubated in antibody solutions (10 
µg/mL and 1 µg/mL for secondary antibody and DAPI, respectively) overnight at room 
temperature and rinsed thoroughly between all steps in PBS containing 0.05% Triton X-
100 and 1% BSA. The hydrogels were transferred into fresh PBS solution and imaged in 
Lab-Tek chamber slides, using a Nikon-C2 laser scanning confocal microscope with 
a 20X air objective, (0.75 NA). Live/dead images were taken in LiveCell System 
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(Pathology Devices, Westminster, MD, USA). All images were taken at the same settings 
and subjected to consistent threshold values during image processing. Z-stack projections 
through 100–300 µm thick sections of the hydrogels were rendered. Individual 
slices/image were analyzed using customized macros on ImageJ software (NIH, 
Bethesda, MD, USA), and projected into maximum-intensity images for the purposes of 
illustration. For samples stained for live/dead, the fractional viability was calculated as 
the number of live cells/total cells. The number of cells stained positively for Calcein 
(live only) was divided by the number of cells stained positive for TOTO-3 iodide (dead 
only) plus the number of Calcein-positive cells. Projected spread area was determined as 
the total area occupied by Calcein stain. For samples stained for sarcomeric myosin and 
DAPI, percentage differentiation was calculated as the number of cells stained positive 
for myosin over the total number of cells/imaged plane. Number of multinucleated cells 
and number of nuclei/differentiated cell were determined using binary layers, applied 
with Nikon Instruments Software (NIS)-Elements. Image slices were chosen from stacks 
at 10 µm (z axis) intervals, to avoid counting the same cells more than once using ImageJ 
and NIS-Elements. For multi-nucleation analysis, the NIS-Elements software was used to 
distinguish between DAPI and sarcomeric myosin by application of layers to individual 
image slices. In very few instances, images were discarded because multinucleated cells 







Image Analysis for Alignment Index 
     As outlined in Figure 15, Images were cropped into 100 squared pixels quadrants, 
imported to MATLAB, windowed, filtered, and binned into orientation histograms. The 
peak angle was detected, as measured by aligned pixels, and the fraction of fibers within 
a 20 degree range was included in the Alignment Factor determination. After normalizing 
to random data, the Alignment Index was obtained and imported into Microsoft Excel for 







Figure 15: Flowchart to determine extent of local alignment through the calculation of 





Force measurement setup 
     The overall force measurement setup is shown in Figure 16, and features three main 
components: the force transducer setup (Figure 16A), bread boarded circuit to provide 
power to the force transducer and amplify the signal generated (Figure 16B), and the 
personal computer (PC) to record and analyze signals (Figure 16C). The force transducer 
used was the Kronex AE 801 Multipurpose Sensor Element (Kronex, Oakland, 




Figure 16: The overall force measurement setup: (A) the transducer setup, (B) 
circuit and DAQ, (C) PC with waveform software and further MATLAB analysis. 
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     The approximate ranges for force measurements reported in the literature for 
comparable scales of muscle constructs range from 3.8 µN/mm
2
 [144] to 2.3 mN/mm
2
 
[123] for absolute values ranging from 6 µN to 28 mN. An analog force transducer to 
 
 
Figure 17: (A) Photo of the sensor element from Kronex. (B) Schematic of sensor 
dimensions. (C) Measurement setup featuring sensor mounted on base and protected 
by a clear shield. (D) Close-up of the sensor with attached hook, stationary arm, and 
immersed in solution. (E) Schematic representation of loading the hydrogels, where 
toroids are placed on the hooks using the central hole.  
     
      
       
           
               
                   
                    
     
     
       
              
             
                      





make these measurements needed to support at least 28 mN forces and have the 
sensitivity to detect changes in the µN scale. We chose the Kronex AE 801 Sensor, a 
silicon strain gauge, for its 120 mN upper limit and high sensitivity.  
     When the tip of the silicon beam is deflected due to force, the areas where the resistors 
are located experience mechanical stress. Due to the piezoresistive effect in silicon, these 
resistors change value, modulating the output voltage of the sensor. The output voltage, 
as a function of change in resistance, is also determined by extent of deflection and other 
beam dimensions, in a linear fashion, shown in Equation 1, with further dimensions as 
described in Figure 17.  














𝑷 =  
4 𝐸 𝐼
𝑉 𝜆 ℎ (𝑙 −
Δ𝑙
2 )
∗ Δ𝑉 = 𝐶1 ∗ Δ𝑉  
Equation 1: Relationship between change in voltage (Δ𝑉), and force of deflection (P). 
Also involved are: the gauge factor of the resistors (𝜆), length of the beam (𝑙), thickness 
of the beam (ℎ), deflection (𝑑), modulus of elasticity for silicon (𝐸), and moment of 
inertia of the beam cross-section (𝐼). All these values are either provided by the 
manufacturer (Figure 17B), or easily calculated from the provided values. The sensor was 
calibrated using a 40mg weight on the horizontal beam surface to check the theoretical 
conversion rate and add a constant coefficient or ‘correction factor’ when converting 
from voltage change to force experienced 
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     The bread boarded circuit (Figure 18) featured a Precision Adjustable Shunt Regulator 
(voltage regulator), Catalog # UC39431B, (Texas Instruments, Dallas, USA) to supply a 
regulated 5V input voltage to the sensor; and a Precision Instrumentation Amplifier 
(Product # AD 524, Analog Devices, MA, USA) to amplify the output voltage one of 
three ways: by 10,100, or 1000 times. Here, the 1000 level gain was employed. The 
power supply used was Elenco Precision Deluxe Regulated Power Supply (Specs: 0-20 
Volts, 3Amps or 0-40 volts, 1.5Amps), used for this purpose at: 15V, 1.5A.  
     The WaveForms program (Digilent Inc., Pullman, WA, USA) was used to interface 
with the Analog Discovery DAQ (Digilent Inc., Pullman, WA, USA), which also 
functioned as an oscilloscope and voltmeter. 
     The sampling frequency, as the default of the DAQ is 100 MHz, and the cutoff 
frequency used was 60 kHz. A Savitzky-Golay filter, which functions as a moving 
average filter, was applied to all signals using MATLAB, with polynomial of order 2 and 
frame size of 199. This acted as a low pass filter and cleared the signal for peak detection. 
Peak force produced was translated to total force produced as observed within a 30 
second acquisition window. The values used for the filter application were chosen based 
 
Figure 18: Bread board and corresponding circuit diagram 
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upon the fast Fourier transform (FFT) and spectrogram analysis of output voltage 
readings. 
     A hook fashioned out of wire was attached to the silicon beam as a means of holding 
on to the hydrogels during testing. The entire sensor element was protected from short-
circuiting by coating conductive portions in small amounts of transparent cyanoacrylate 
gel (Figure 17C&D). The cyanoacrylate gel does not coat the silicon beam on the force 
transducer and does not change its stiffness. The opposing hook was attached to a 
stationary arm. For future studies, this portion can link to an external motor for finely 
controlled mechanical stimulation or isometric contraction studies [155]. The Analog 
Discovery DAQ recorded voltage over time from the strain gauge sensor. Readings were 
converted to text files that could be imported and analyzed in MATLAB.  
 
Contractility Studies 
     Contractility experiments were conducted on day 12 of construct culture (3 days in 
GM, 9 days in DM). Hydrogel volumes of 25 µL were used as 12.5 µL were unable to be 
handled consistently. The experimental design is detailed in the table below, where 
contractile agonists refer to ACh (100 µM) or caffeine (50 mM) and the myosin inhibitor, 
blebbistatin (100 µM). All solutions were warmed to 37
o
C prior to use, as this was 
deemed necessary for caffeine-mediated cellular activation [4]. Constructs were removed 
from spire-molds and mounted in measurement setup with PBS solution for up to 5 
minutes to stabilize. Tension upon mounting was maintained consistent to tension of 
fabricated hydrogel by using the toroidal hydrogel outer diameter on the mold prior to 
mounting as the starting length. For 2.0, 1.0 and 0.5 mm spire-toroids these lengths were 
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5.0 mm, 4.5 mm and 3.0 mm respectively. Voltage signal was monitored visually during 
this time. Constructs remained on the setup, attached to hooks, for remaining solution 
changes. Signal was recorded from time of solution 1 exchange with solution 2, and 
solution 3, where relevant, or returned to solution 1. Five or more samples were used for 
each condition (n ≥ 5).  
Table 6: Experimental design setup for contractility studies (PBS is with calcium 
and magnesium, Blebb = Blebbistatin). 
 Hydrogel 
Geometry 
Solution 1  
(5 min) 
Solution 2  
(1 min) 







PBS  PBS  Baseline 
2 PBS Agonist  Contraction assessment  
3 PBS Blebb  Myosin inhibition check 
4 PBS Agonist PBS Reversibility check 
5 PBS PBS PBS Reversibility (Negative) control  
6 PBS Agonist Blebb Myosin dependence assessment 





PBS PBS  Geometric control baseline 
9 PBS Agonist  Geometric control 
10 PBS Blebb  Myosin inhibition check 
11 PBS PBS  Cell-free control baseline 
12 Cell-free, 
torus gels 
PBS Agonist  Cell-free control 
13 PBS Blebb  Myosin inhibition check 
 
Statistics 
     Data are expressed as mean ± standard error of the mean (SEM). Statistical analysis 
was performed using t-test for comparison of two different groups, one-way ANOVA for 
comparisons among different groups, and two-way ANOVA for comparisons between 
different groups at different time points, using GraphPad Prism software. Significance 







Characterization of Different Gel Configurations by Surface Area to Volume ratios         
Different gel volumes were utilized in the generation of toroidal hydrogels as they were 
found to degrade within 3-6 days when cast with a volume below 10 µL, while alignment 
was not observed until day 7 with gel volumes greater than 40 µL. To examine this 
phenomenon, swollen hydrogel dimension (day 1) measurements were used to calculate 
empirical volume and surface areas for 12.5 µL and 25 µL hydrogels (Table 7). For 
controls, we also cast free-floating and linear hydrogels.  
     Significant differences in empirical volume were observed between controls (linear 
and free) and the 2.0 mm spire-toroids, with the toroidal gels exhibiting higher post-
swelling volume, for both volume conditions (12.5 µL and 25 µL). The volume 
difference between original casting and post-swelling hydrogels may arise due to the 
different physical hydrogel configurations.  Hydrogel swelling is a function of several 
factors: physical properties of the hydrogel itself as well as those modulated due to 
cellular behavior. The effect of physical geometry, or volume, reflects an association 
between osmotic pressure and tension generated within the gel matrix. As described 
previously, even 1 polymer w/v % change resulted in a 20% shift in cell viability, so it is 
likely that the converse, a change in cell behavior experienced due to differential stresses 
in varying geometries would affect the extent of hydrogel swelling or compaction  [6]. 
Secondarily, the hydrogel macrostructure may impact cellular behaviors such as 
contractility, further changing the final volume, though these effects should be minimal at 
such a short time after gel casting. For surface area, differences were observed for free, 
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1.0, 2.0 mm spire-toroidal gels compared to linear gel configurations of 12.5 µL. For 25 
µL hydrogel volumes all gel configurations were different to linear hydrogels.  
     Surface area and volume were lowest for the linear hydrogels, yet the ratio of surface 
area to volume was the highest for this hydrogel configuration. We have further observed 
that linear gels cannot withstand more than 3 days in culture, quickly degrading and 
leaving cells on the 2D dish rather than encapsulated in a 3D hydrogel. The configuration 
with the second highest surface area to volume ratio is 0.5 mm spires. These toroids were 
found to be difficult to handle by day 7, in comparison to 1.0 mm and 2.0 mm spire-
toroids, but did not degrade to the extent of gel loss as in the case of linear gels. This 
suggests a potential correlation with the surface area to volume ratio and longevity of the 
hydrogel configuration. Tractability issues of this extent were not encountered by 1.0, 2.0 
mm spire-toroids. 
     Overall, surface area to volume ratios are consistently highest for 0.5mm and linear 
hydrogels, while 1.0mm, 2.0mm spires and free floating hydrogels were calculated to 
have the lowest ratios.  
Table 7: Dimensional characterization of PEG-4MAL hydrogel configurations. Day 1, 
after complete swelling in growth media. Dimensions measured from macroscopic 
hydrogel images taken on squared graph paper (n=6), during media exchange. Two 
hydrogel volumes examined: 12.5 µL and 25 µL, in 3 spire configurations with free-
floating and linear geometric control. 
     For the empirical volume data: * indicates significant differences between the 
empirical volume of 12.5 µL of free and linear hydrogels compared to 2.0 mm spire-
toroidal gels. 
#
 indicates significant differences between the empirical volume of 25 µL of 
1.0, 2.0 mm spires and free hydrogels compared to 0.5 mm spires. 
## 
Indicates significant 
differences between the empirical volume of 25 µL of free and linear hydrogels 
compared to 2.0mm spires 
     For the surface area data: ** indicates significant differences between the surface area 
of 12.5 µL of free, 1.0, 2.0 mm spire-toroidal hydrogels compared to linear gels. *** 
indicates significant differences between the surface area of 12.5 µL of 0.5 mm spires 
and 2.0 mm spires. 
$
 indicates significant differences between the surface area of 25 µL 
of free, 0.5, 1.0, 2.0 mm spire-toroidal hydrogels compared to linear hydrogels, that is, 
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the surface area of linear gels is significantly different from all other configurations. 
$$ 
indicates significant differences between the surface area of 25 µL of 0.5 mm spire-
toroidal gels and 2.0 mm spire-toroidal gels (all p<0.05).  
Cast Hydrogel 
Volume 












1.0 S 100.8±17.1 
**
 52.0±11.9 1.94 
2.0 S 131.3±35.8 
**, ***
 72.3±17.1  1.82 
Free-floating 111.8±6.4 
**
 55.6±4.84 2.00 
Linear 44.2±17.9 17.3±9.8 
*
 2.54 
25 µL   0.5 S 144.3±26.2 
$$
 58.7±12.3 2.46 
1.0 S 192.8±23.6 138.8±34.2 
#, ##
 1.39 
2.0 S 197.3±35.2 126.8±22.9 
#, ##
 1.57 





 34.4±12.4  2.43 
 
Optimization of Spire-Toroid Hydrogels with 12.5µL and 25µL Volumes 
     To examine the impact of different hydrogel volumes and spire configurations on 
proliferation and viability over time, we analyzed DNA content (Figure 19) and 
percentage of live cells over a period of 14 days (Figure 20). The two volume 
configurations tested could be expected to produce differences in cell behavior, 
a consequence of the material swelling (due to high affinity of the PEG chain for water 
and resisted by crosslinks) which is affected by the configuration, cell-mediated 
proteolysis of the gel (increase swelling), and cell contractility. We have previously 
asserted that a highly viable cell population, at a reasonable cell density, is a pre-requisite 
to efficient differentiation, and in this case, alignment of C2C12 cells. 
     DNA content increased over time, most notably for the spire configurations (Figure 
19A) compared to free floating and linear gel controls. The trend of relative increases in 
 85 
DNA content was seen for both gel volumes. Absolute differences between 12.5 µL and 
25 µL were expected due to differences in volume with a consistent seeding density of 
8 × 10
6
 cells/mL. There were significant differences between DNA content at day 14 
and/or day 7 for all the spire-toroid hydrogel configurations compared to day 3 for both 
volumes of hydrogel used. Changes in DNA content from days 0 to 3 were not significant 
in any case, as were the changes between days 0 to 14 for free hydrogels and days 0 to 3 
for linear. Linear hydrogels were completely degraded or not workable by days 7 and 14, 
as indicated by unavailable data (#) on graphs. Specifically, 12.5 µL hydrogels cast as 
spire-toroid hydrogels supported 0.5 –1.8 µg DNA per hydrogel (from here on: µg/gel) 
for days 1 and 3. After day 7 there was a significant, up to twofold increase in DNA 
content not exceeding 4 µg/gel. A similar trend of increasing DNA content was seen in 
25 µL spire-toroid hydrogels, with initial DNA content ranging from 1.5 – 2 µg/gel and 
final concentration as high as 7 µg/gel (Figure 19A-C). DNA content remained steady in 
the free floating hydrogels between 0.5 – 1.8 µg/gel for 12.5 µL volumes and 1.8 – 4 
µg/gel for the 25 µL volume (Figure 19D). Linear hydrogels supported DNA content 
until day 3 in the ranges of 0.4 – 1.7 µg/gel for 12.5 µL volumes, and 1.8 – 4.0 µg/gel for 
25 µL volumes, before degrading (Figure 19E). Given the only source of DNA were the 
encapsulated C2C12 cells, knowing that the majority of cells stayed encapsulated and 
could not exit the gel easily, and finally, knowing that no cells are being added to the gel, 
we can attribute any changes in DNA content to encapsulated cells only. Increases in 
DNA content over time for the spire-toroid configurations suggest the occurrence of cell 
proliferation. Meanwhile, the maintenance of DNA levels over time, as seen in linear and 
free hydrogels, suggest a lower level of cell proliferation, if at all. These differences in 
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cellular behavior could be explained by the concept of different stresses experienced by 
encapsulated cells in varying geometries. 
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Figure 19: DNA content over time: quantification of comparison between 2.0 mm, 
1.0 mm, and 0.5 mm spire-toroid configurations with 12.5 µL and 25 µL gel volumes 
(A-C) different spire configurations, (D) free hydrogels, (E) and linear controls. ‘#’ 
indicates no data available due to gel degradation. (n ≥ 6). ‘*’ for 25 µL, ‘$’ for 12.5 
µL indicates significance between day 14 and/or day 7 for spire-toroids compared to 
day 3 and day 0. Change from days 0 to 3 was not significant for all conditions. No 
significant change between days 0 to 14 for free gels and days 0 to 3 for linear, all p 




 percentiles of data; whiskers extend from 
minimum to maximum data values.  
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     The next metric studied was percentage of live cells: the proportion of cells stained for 
Calcein, as live cells, compared to total number of cells (Calcein-positive + TOTO-3 
iodide-positive). As Figure 20 shows, the percentage of live cells stayed constant 
(majority between 60 – 80%) over time with a small drop at day 3, as previously 
observed [6]. Consistent with DNA content trends, there were significant differences 
between the percentage of live cells at day 7 for all the spire-toroid configurations, free 
and linear hydrogels compared to day 1, for both volume conditions. At day 14, 
significant differences existed between all configurations of 25 µL volume hydrogels 
only compared to day 1 (Figure 20B). There were no differences between configurations 
at any given time point for the same gel volume. The lack of significant differences 
between the 12.5 µL gels at day 14 compared to day 7 suggest that the viability is better 
supported in the hydrogel of smaller volume. This difference between the two hydrogel 
 
Figure 20: Percentage of live cells over time: quantification of comparison 
between 2.0 mm, 1.0 mm, and 0.5 mm spire-toroids, free, and linear hydrogel 
configurations with 12.5 µL (A) and 25 µL (B) hydrogel volumes (n ≥ 6). ‘*’ 
indicates significant differences exist between all groups at day 7 compared to day 1, 
for both volume conditions. ‘$’ indicates significant differences between all 
configurations at day 14 compared to day 1 for 25 µL volume hydrogels only. No 
significant differences between configurations at any given time point for a 
consistent gel volume 
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volumes at day 14 may exist due to smaller diffusion distances for mass transport in 12.5 
µL hydrogels compared to 25 µL. There were an overall higher number of cells in 25 µL 
hydrogels as all gels were seeded with the same cell density at day 0 but with different 
volumes. Hence, the larger gels supported a higher absolute value of live cells at day 14 
(quantitatively, the number of live cells in 25 µL hydrogels was 1.5-2-fold higher than 
12.5µL gels at all time points). Additionally, a higher number of cells in the 25 µL 
hydrogel likely increased nutrient demand, which was limited by diffusion, further 
contributing to the lower reported percentage viability. 
    Taken together, the data for DNA content and percent live cells suggests that 
immediately post-casting, cells encapsulated in hydrogels were at a higher proportion of 
live to dead (between 70-90%). From day 1 to day 3 the percent live cells dropped though 
DNA content was maintained. This suggests that although the number of dead cells 
increased, a relatively constant DNA profile indicated that the total number of cells was 
constant. The live cells that survived day 3 proliferated from day 3 to 7 to significantly 
increase DNA content. This trend then continued with proliferating cells increasing the 
DNA content by day 14 while percent live cells was maintained at a constant, high level 
(between 60-80%). Differences are most notable over time for individual hydrogel 
configurations, although not explicit between them for the same time point. This lack of 
variation among hydrogel geometries suggests that the optimized polymer hydrogel 
utilized supports cell viability, regardless of hydrogel volumes and configuration. Yet it 
appears that additional factors are involved in increasing the cell count over time in the 
toroidal gels. This may be explained by the existence of varying stress distributions 
between bulk, linear, and toroidal hydrogels that modulate cell proliferation and 
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alignment behavior, but do not impact survival.   
 
Differences in Alignment Extent between Hydrogel Volumes and Spire Configurations  
     We observed that the extent of alignment varied with spire configuration and gel 
volume. To quantify, we utilized the metric “Alignment Index” (AI) to describe the 
extent of cellular alignment (Materials and Methods, Figure 15). Completely random 
structures produce an AI of 1.0, while perfect alignment produces an AI of 4.5. This scale 
is adapted from Swartz et al.[199], where 2D collagen matrices were used for fibroblast 
alignment. AI ranges from 1.5 to 2.5 were reported in Swartz’s work. Using this method 
of image processing and analysis, we report indices ranging from 1.0 (random) to 3.0 
(max value is 4.5 for perfectly aligned). For the spire configurations, alignment extent 
increased from day 1 to day 14, with the highest alignment indices were measured in days 
7 and 14. For 1.0 mm and 0.5 mm spire-toroid configurations, (Figure 21B&C) with 
12.5µL gel volume, there was a significant difference between days 1 or 3 compared to 
days 7 and 14. There were no significant differences for the 2.0 mm spire-toroids 
between days 7 and 14 for the different volumes (Figure 21A), though a significant 
increase from day 1 to day 7 was observed. The AI measured from free gels did not 
exhibit significant differences, for either volume tested, between days 1, 3, 7, or 14 
(Figure 21D). Additionally, 0.5 mm spire-toroids showed significant differences between 
the two different gel volumes, at days 7 and 14. All spire configurations produced 
significantly more locally aligned cells compared to free gel controls. Day 14 summary 
graphs (Figure 21E&F) show 1.0 mm spire-toroid of 25 µL gel volume were found to 
have a significantly higher AI than other groups, while 12.5 µL (Figure 21F) free gels 
exhibited the lowest AI, significantly lower than the three spire-toroid configurations 
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(p<0.05). The interesting outcome to be noted here is that 1.0 mm spire-toroids result in 
the highest extent of alignment, unaffected by seeding volume.  From our data it appears 
that hydrogel geometry influences alignment and that alignment increases with time until 
day 14. 
     Taking the AI produced by free hydrogels to be a baseline random average for our 
system (~1.8), we deduced the following gels have better comparative final alignment 
between days 7 and 14: 12.5 µL for 2.0 mm, 1.0 mm, 0.5 mm spires; 25 µL for 1.0mm 
spires only. Based on our experiences handling these constructs in lab, it is very apparent 
that 25 µL hydrogels are more tractable to work with than 12.5 µL. Hence, we decided to 





Figure 21: Quantification of extent of alignment in gel configurations between (A) 2.0 
mm, (B) 1.0 mm, (C) 0.5 mm spire configurations, and (D) free gels with 12.5 µL and 
25 µL toroidal gel volumes by image analysis over time. (E) At day 14, 25 µL gels 
show differing extents of alignment, as measured by AI, between spire-toroids and 
free gels. 1.0 mm spire-toroids produce significantly higher AI than all other groups, 
while differences between 2.0 or 0.5 mm spire toroids, and free gels were not 
significant. (F) Also at day 14, 12.5 µL gels exhibit differing extent of alignment 
between the AI for freely-cast, bulk hydrogels compared to all other spire-toroids 






ACh and caffeine-stimulated force production 
 
     To generate cell-laden hydrogels, four-arm PEG–MAL macromers were 
functionalized with RGD, followed by the addition of cells, then crosslinker, and 
immediately cast around 2.0, 1.0, and 0.5 mm spires. After 12 days in culture, the gels 
were carefully placed on the measurement setup and immersed in PBS for stabilization, 
followed by agonists, as described in Materials and Methods. ‘Baseline’ values for each 
condition (aligned, unaligned and cell-free hydrogels) when hydrogels did not contract 
were obtained from constructs exposed to physiological conditions as PBS solution. 
Agonists ACh and caffeine were used to stimulate force production. Exposure to 
blebbistatin was used as an inhibitory condition to show that the force generation was 
myosin mediated. Gels exposed to PBS instead of agonist were used as controls. Cell-
laden toroidal hydrogels, cell-laden free-floating bulk hydrogels, and cell-free toroid 
hydrogels were utilized as test conditions. After PBS stabilization on the measurement 
setup, constructs were either tested in one, or two additional solutions as described in 
Table 6. The stabilized measured voltage signal, converted to force values in µNewtons, 
(hereby referred to as ‘signal’), is shown in Figure 22, when the hydrogel is exposed to 
contractile agonists and placed under physiological conditions. 
     There are several ways in which a hydrogel-cell composite of the nature generated in 
this study could shorten in length, or contract. The first is osmotic, where the difference 
in ion concentration can affect hydrogel swelling or de-swelling, in the case of 
macroscopic gel contraction. Second, cell-mediated contraction as a result of the 
contractile machinery present in all living cells as core functionality. Although this type 
of contraction could be enhanced by stimuli or the cell’s microenvironment, it is an 
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intrinsic property of the cell, and will occur consistently in strength for a given cell type 
in controlled culture conditions [201]. The type of specialized contraction significant for 
this study of muscle tissue-constructs is cell-mediated sarcomeric myosin based 
contraction. We showed that all hydrogel configurations in physiological conditions did 
not contract as signal measured was not significantly different to baseline readings 
(Figure 22A). Agonistic and blebbistatin solutions were produced using physiological 
PBS buffer to ensure osmotic gradients are controlled and do not impact contraction. The 
lack of contraction in cell-free hydrogels compared to cell-encapsulated hydrogels in 
response to agonists, acetylcholine and caffeine, suggests the contraction of hydrogels is 
cell-driven by processes that respond to said agonists. The significant differences 
observed between the two cell-encapsulated conditions: bulk (randomly aligned) and 
toroidal (aligned) configuration suggest the positive impact of alignment on the extent of 
contraction. Finally, the use of blebbistatin as a myosin inhibitor confirms the contraction 
is myosin mediated and inhibited in the presence of the agent.  
     Traces in Figure 22A show force development over the course of different 
experimental solutions: PBS, agonist, and blebbistatin shown across three panels. The 
traces are shown for 1.0 mm spire-toroids but are comparable to those observed in other 
hydrogel configurations that produced contraction. First, no force production is observed 
for the total time spent in PBS (Figure 22A, panel 1). Peak force production occurs in the 
presence of the agonists occurs within first 20-30 seconds, with an average duration of 16 
± 5 seconds (Figure 22A, panel 2). This time to peak and duration of response is 
comparable to past work [128, 129], as also previously discussed. Suggested reasoning 
for this behavior can be drawn from the limited resources available to the tissue-
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engineered construct. It is likely that myosin units contract until they fatigue by depleting 
internal calcium ion stores [148], and are unable to recover within the remaining 30-40 
seconds in agonist to contract again. After the duration of time spent in agonist, 
constructs placed in blebbistatin do not contract, resulting in a baseline force reading 
(Figure 22A). Contraction forces are inhibited in the presence of blebbistatin applied 
before (Figure 22B) as well as after the agonist solution. In the presence of PBS or 









Figure 22: Quantification of contraction forces produced upon activation. (A) Shows 
traces for 1.0mm spire-toroid samples subjected to three different conditions: PBS for 
stabilization solution #1, testing solution #2 (60 second duration), and blebbistatin as 
solution #3. (B) Shows summary data of the spire-toroids, free floating bulk and cell-
free gels exposed to different test conditions.  No significant differences were found 
between free-2.0 and 1.0mm toroids under all conditions. Significant differences exist 
between cell-free hydrogels and all cell encapsulated hydrogel configurations for 
exposure to each agonist (*). Significance was assessed using p < 0.05 and a minimum 
of five gels were tested per condition (n ≥ 5).  
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     We observed that contraction is stimulated in the presence of agonists that have been 
shown to depolarize the cell membrane and enable ion flux for the myosin and actin 
filaments within sarcomeric units to slide along each other, thereby generating force [14, 
198]. When stimulated using ACh, 1.0 and 2.0 mm spire toroids produced the highest 
forces of 48 µN (Figure 22B) and 36 µN respectively. The free floating hydrogels with 
cells produced significantly lower forces compared to the 1.0 and 2.0 mm spire-toroid 
conditions (Figure 22B). When exposed to 50 mM caffeine, 1.0 mm spire-toroids 
produce forces of up to 53 µN, while 2.0 mm spire-toroids generate 39 µN. The forces 
generated in 1.0 mm spire-toroids are significantly higher than those generated by free-
floating bulk gels and 0.5 mm spire-toroids (Figure 22B). The consistently highest forces 
measured for 25 µL hydrogel volumes were in 1.0 mm spire-toroids in caffeine (46.8 ± 
7.9 µN) and ACh (44.8 ± 4.7 µN). 1.0 mm had previously been shown to have the highest 
relative alignment index (2.4) of all groups tested. The contraction forces produced by 
free gels, with encapsulated cells are expected to be the result of randomly aligned cells 
(previously measured AI for this condition: 1.3) responding to the activating solution. 
 
 Discussion  
 
     Cellular alignment is a crucial aspect of functional skeletal muscle generation [115]. 
Yet in vitro methods to create 3D aligned skeletal muscle tissue with synthetic scaffolds 
are limited, or utilize overly complicated methods of dynamic signaling that vary with 
setup and choice of biomaterial. Specifically, past efforts to impose mechanical tension 
on skeletal muscle constructs have relied on externally generated, applied forces. Such 
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works have suffered from complexity associated with maintaining that tension as the 
muscle construct develops. In this study, we demonstrate the use of a static geometric cue 
to generate circumferential stresses in toroids for the development of alignment.  
    We previously identified an optimal hydrogel configuration using the established PEG 
hydrogel formulation (5% w/v four-arm PEG–MAL macromers functionalized with 
2.0 mm RGD adhesion peptide, and cross-linked by a MMP-degradable peptide) that 
supported C2C12 mouse myoblast viability and intrinsic-level, random, alignment.  
     We attribute the physical differences (hydrogel volumes and surface area ratios) 
between toroidal configurations and free or linear hydrogels to the physical stability and 
differential stresses experienced by the encapsulated cells as they form alignment. The 
consistency of cellular viability, as shown using % live cells, however, suggests that 
viability is generally unaffected by geometry with use of the consistent, previously 
established, PEG hydrogel formulation. 
     2D micropatterning techniques have enabled researchers to print organic molecules on 
substrates, providing geometrical cues that regulate the location, shape and even 
alignment of C2C12 cells on surfaces [153, 202, 203]. Similarly, the use of geometrical 
cues in 3D have to some extent replicated this directionality and allowed researchers to 
study the effect of the physiologically complex microenvironment on cell fate as 
experienced in vivo [204]. 
     It has been shown that physical cues, in 2D and 3D, lead to different tractional stress 
patterns and promote cytoskeletal reorganization [82]. Particularly, Piyush et al. show 
that different physical structures (linear vs. toroidal shapes) induce different stress 
patterns [205] from differential activation of the Rho/ROCK pathway [206], which 
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together impact the extent of C2C12 differentiation [207]. It was shown that von Mises 
stresses vary throughout different gel configurations, where free gels exhibited the 
highest stress at outer edges, linear gels showed highest stress at the corners of the linear 
portion and torus shapes (though on an order of magnitude smaller size scale than those 
generated here with a diameter of 200 µm) showed highest stresses on the outer convex 
outer edge than the concave inner edge. A positive correlation was found to exist between 
stress distribution  and cellular alignment [82]. It is likely that these physical 
characteristics impacted cell proliferation and alignment resulting in differences between 
groups, specifically DNA content and alignment, between the free and spire-toroids 
hydrogels. 
     Figure 23 shows the theoretical non-dimensional stresses experienced within a toroid. 
This model is obtained from the work of Tanner et al, and modified based on findings 
from Sutcliffe et al and Veličković et al [1, 208, 209]. Though the model is based on the 
assumption of a circular toroidal cross-section, it demonstrates the changes in stress over 
distance in the circumferential and radial, or, meridional, directions in a manner similar to 
toroids with elliptical cross section [208].  
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The graph depicting the toroidal reconstruction shows non-dimensional stresses in the 
circumferential direction to be greater than those in the radial one. If the ratio of the 
ID:OD were to increase (Figure 23C), these stress patterns would change to maintain the 
integrity of the toroidal shape. The model shows that for a given phase angle on the 
periphery of the torus, both radial and von Mises stresses decrease proportionally to the 
increase in ID:OD ratio [209]. This scenario would be analogous to increasing the 
  
 
Figure 23: Normalized stress patterns in a toroid, as published by Tanner et al, 2010 
[1]. (A)  Shows contour lines representing predicted circumferential stress in a toroid 
(c=2/3, where c is the ratio of minor to major radii), as solved using Sanders’ non-
linear theory for accurately predicting torus stresses in both the meridional and 
circumferential directions. Image was generated using finite element method (FEM) 
analysis in the LS_DYNA stimulation software package. (B) Depicts the change in 
non-dimensional stress over phase angle from the outer periphery of the circular cross 
section of the toroid (-90 deg) to the inner radius [1]. (C) Demonstrates the increase 
in non-dimensional radial and circumferential von Mises stresses, for ϕ = 0 degrees, 
as the ratio between the minor radius, (ID) and the major radius, (OD) increases with 
OD held constant, derived from the model described by Tanner et al [1]. 
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diameter of the central spire diameter in our study, suggesting that the larger the spire-
toroid, the smaller the non-dimensional stresses in the circumferential direction. This 
model would suggest the alignment indices in 1.0 and 0.5 mm spire-toroids be higher 
than those in 2.0 mm spire-toroids. However, we have observed lower alignment in 0.5 
mm spire-toroids, comparable to those of 2.0 mm spire-toroids. This leads us to consider 
that while geometric cues and resultant stress patterns play a significant role in the 
development of alignment within toroidal muscle construct, it is likely that a dominant 
factor in alignment modulation, surface area to volume ratios, and gel swelling and 
compaction can be attributed to the cellular behavior. Namely, their density, viability, 
extent of differentiation, and the time spent in culture. Theoretically, higher stress regions 
should enable greater alignment, even prior to differentiation of cells, as known through 
the link between matrix environment and cellular behavior [204]. However, as 
encapsulated cells grow and remodel their matrix, it is expected that these stress patterns 
change over time.  
     We have previously detailed how varying hydrogel formulations with different cell 
densities can modulate encapsulated cell growth and proliferation [6]. However, the 
effect of these formulations and consequent cellular behavior to study macroscopic 
changes in hydrogel swelling and compaction were not discussed. In this study we have 
observed hydrogel configurations impact the ratios of swelling and compaction, through 
the development of internal stresses that modulate cell proliferation, and in turn, cell 
spreading, contractility, and hydrogel degradation. A suggested order for this process is 
(i) initial hydrogel swelling, (ii) cellular proliferation and development, which leads to 
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(iii) hydrogel remodeling, and finally (iv) long-term stable hydrogel compaction for the 
support of the cellular structures with their self-generated matrix. 
 
     Physical characteristics important for hydrogel longevity and end construct tractability 
are related to cell density, and the ratio between hydrogel surface area and volume.  We 
observed that a high (above 2.4) surface area to volume ratio, such as those with linear 
hydrogels increases the rate of hydrogel degradation. A higher ratio of surface area to 
volume values is known to increase diffusion rate and efficiency [210]. This correlates 
with increased degradation and loss of tractability of the linear hydrogels possibly 
through improved transport of degradative enzymes, such as matrix metalloproteases 
(MMPs) released by cells, and opportunity for cell motility. Additionally, it is possible 
that the linear gels in this configuration degrade due to their inability to produce internal 
stress or tension on a scale similar to the toroidal gel. 
     The increases in DNA content over time with constant percentages of live cells are 
likely indicators of cellular proliferation. Results show a higher rate of increase in cell 
numbers in spire-toroid hydrogels, while free and linear samples maintain the DNA 
content with which they were seeded. We posit the differences in DNA content between 
spire-toroids and free or linear hydrogels are likely due to the differences in geometrical 
configuration. It has been shown that physical cues are necessary and can influence the 
development of alignment [47, 123, 127]. We chose to continue using free floating 
hydrogels in the comparisons studied as a negative control that previously supported 
good cell viability but no alignment. The linear hydrogel configuration was intended as a 
uniaxial, geometrical control with two anchorage points. The use of two (or more) 
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anchorage points is common [132, 146, 169], though the translation of these constructs 
for soft robotics or SMTE is limited due to strong adhesion to secondary substrates, and 
the use of naturally derived scaffolds. 
 
     The advantages of the toroidal shaped hydrogel are twofold: (i) a single, constant 
physical cue allows minimal interference during culture for the production of anisotropy 
and (ii) the central hole of the torus allows facile attachment to a force-measuring 
apparatus for the next goal of this study in generating a functional muscle construct. The 
described technique to generate toroidal hydrogels is high throughput, scalable, and may 
be useful in when conducting repetitive studies with many groups in vitro, such as for 
drug screening assays.  
     It has been demonstrated that cells respond to cues in their microenvironment, and 
here we show how PEG-MAL hydrogels can be cast in a manner to induce embedded 
cells to circumferentially align. These methods can be translated to other cell lines that 
rely on anisotropy for function, or other scaffolds for the exploration of a wider range of 
biomaterials for tissue engineering.  
 
     Methods of contraction measurement vary greatly with the target scale of the tissue 
construct or cell structures. Myotubes or single cell measures can be made on cantilevers 
with patch-clamp stimulation [143], while whole muscle tissues can be stimulated with 
electrical signal , neuro-muscular activation, or biochemical agents,  and use 
commercially available or custom-built force measurement devices. The scale in between 
these two extremes poses many challenges to force measurement. First, the scale of the 
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construct is smaller than native tissue, often with weaker mechanical properties, lowering 
its ease of handleability, and second, the forces produced are on the order of micro-
Newtons, and extremely sensitive components are required for their detection. These 
issues are circumvented by attaching the construct to a stiffer substrate [10], or indirectly 
measuring force through the observation of secondary structure deflection (posts, 
anchors, and the like) associated with the tissue construct [132, 146, 154]. 
     For this study, we focused on building a construct measurement device that would 
characterize forces generated by an actuator not tethered to external materials or bound to 
permanent anchors. We chose the method of attaching a construct using hooks onto a 
measurement setup which would only be possible in a minimally invasive manner if there 
was an avenue for the hooks to be passed through the construct, a configuration provided 
by a torus shape. Hence, toroidal hydrogels with encapsulated circumferential cell 
alignment were developed. 
     Existing works do not provide enough detailed information to rebuild existing force 
measurement devices [121, 122, 148], resulting in different groups using custom built 
devices and force transducers to suit their needs. This increases the difficulty of 
comparing information across groups, highlighting the need for a common method of 
force measurement for tissue engineered constructs of specific size and force scales. For 
these reasons, we expect the utilization of this measurement device to span not only 
skeletal muscle constructs but also enable mechanical stimulation (using the ability of the 
stationary arm to connect with a motor) and isotonic force measurements. 
     Our results show that toroidal hydrogels respond to acetylcholine and caffeine when 
used as agonists in solution form. The highest peak force produced is 48 µN (0.4 kPa) by 
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the 25 µL toroid gels generated around the 1.0 mm diameter spire. The previously 
measured AI of 2.4 for the same hydrogel condition underscores the correlation between 
alignment and force production for engineered skeletal muscle constructs. Reductions 
back to baseline after continued treatment with agonist are likely due to the inability of 
the construct to sustain muscular contraction over longer periods of time [148]. Duration 
and peaks of forces produced are consistent with those previously seen in literature [128, 
129] and any differences are likely related to the nature of stimulation (diffusion of 
molecular agents as opposed to electrical stimulation) and differences in physical 
characteristics of developed C2C12 construct (dimensions, cell density). The lack of 
contraction produced by cell-free hydrogels suggests that all contraction is cell-mediated.  
The loss of force production in the presence of myosin-inhibiting blebbistatin 
demonstrates the utilization of cellular machinery in developing contraction for force.  
     Other constructs at this size scale produced with C2C12 cells have reported force 
values at peak tetanic contraction, in the range of 33.2 µN (2.35 kPa) [128, 129] to 45 µN 
(1.12 kPa) [146]. Although it is difficult to compare the higher forces generated by these 
constructs as they utilized biological matrices, and different culture conditions, our use of 
synthetic scaffolds to generate forces of a comparable scale is noteworthy. The 
limitations of biological scaffolds have been previously discussed (lack of 
reproducibility, high immunogenicity). In this study, we have developed a viable 
methodology for producing aligned and functional SMTE constructs that produce forces 
comparable to those previously published, but utilizing a synthetic scaffold in 
combination with a toroidal hydrogel configuration. 
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     It is likely that some portion of cells remained undifferentiated (up to 30% that do not 
produce sarcomeric myosin, as previously shown [6]). The lack of differentiation would 
result in diffuse presentation of nAChRs, underdeveloped t-tubules, and poorly connected 
sarcolemma [211, 212]. These factors likely contributed to decreasing the forces 
generated by our skeletal muscle constructs. It must be noted that it is unlikely that 
diffusion based delay affected transport efficiency as the hydrogels can be estimated to 
80-95% water, by day 14, resulting in diffusion times on the order of nanoseconds 
(Appendix B.3).  
     Functional output is an inherent and essential part to skeletal muscle tissue 
engineering. Here, we show that the optimal hydrogel configuration using the established 
PEG hydrogel formulation (5% w/v four-arm PEG–MAL macromers functionalized with 
2.0 mm RGD adhesion peptide, and crosslinked by a MMP-degradable peptide) that 
supports C2C12 mouse myoblast viability and alignment, is also capable of functional 
contraction. A custom built device enabled these measurements to be taken with a high 
sampling rate and signal to noise ratio. 
     Building a custom force measurement instrument in-house allows easy signal 
modulation at the circuit level, and is amenable for setup configuration modifications to 
accommodate other constructs, or the addition of dynamic mechanical or electrical 
signaling. Functional capability of the generated muscle construct encourages the 
continued exploration of PEG-based hydrogels for skeletal muscle tissue engineering and 





     The goal of this study was to develop a suitable configuration for the established 
synthetic scaffold as the second step towards building contractile muscle constructs. 
Previously, we determined synthetic PEG scaffolds that provide a consistent, 
engineerable, and modularly controllable starting material as a scaffold for skeletal 
muscle tissue development. Here, we enabled 3D alignment of C2C12 cells 
homogenously seeded within this biofunctional matrix. 
     With our increasing knowledge of myogenesis and tissue regeneration we can further 
engineer scaffolds that promote myogenesis by (i) utilizing dynamic signaling from 
mechanical or electrical stimulation, (ii) designing scaffolds for growth factor release, or 
(iii) further modelling materials to have physical features that promote desired properties 
of native tissue in vitro. 
    This study aimed to contribute to the current body of work replicating cellular 
anisotropy in vitro, leading to a better understanding of cellular developmental processes. 
The production of functional skeletal muscle tissue constructs, will aid as a regenerative 
solution to skeletal muscle loss, as well as a force actuator for cellular machines [9].  
     The secondary goal of this study was to develop a method of force measurement for 
the toroidal muscle cell-gel composites as the next step towards building contractile 
muscle constructs.  We tested the functionality of this alignment through the use of a 
custom-built measurement apparatus to find that the most force was generated from 
hydrogel conditions that had the highest alignment index, suggesting the positive 
correlation with structure and function for skeletal muscle tissue. 
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    This study aimed to develop a force measurement method that was easily replicable for 
use with skeletal muscle cell-hydrogels and other tissue constructs that exhibit 
contraction in the tens of µN to 100 mN range. In addition, the demonstration of 
contractility of the generated toroidal gel constructs shows the existence of functionality 
in the constructs produced. This contractile, toroidal cell-hydrogel  The production of 
functional skeletal muscle tissue constructs will aid as a regenerative solution to skeletal 
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     In this thesis we have detailed a specific skeletal muscle hydrogel construct, its 
fabrication techniques, and functionality; yet there are other challenges outside the scope 
of this study that would need to be tackled to move the field of skeletal muscle tissue 
engineering (SKMTE) and soft tissue robotics closer to the goals of generating (i) dense, 
innervated, and vascularized 3D muscle at the tissue scale [115] and (ii) a self-sustaining 
and self-controlled biological machine [213].  Current and future challenges to 3D 
SKMTE include a viable cell source; in vitro maintenance of constructs; vascularization 
and innervation strategies upon implantation [115]. To address these challenges, next 
steps could involve elucidating the effects of co-culture of cells for innervation and 
vascularization; multifunctional scaffold development for growth factor release; 
enhanced in vitro myogenesis through the use of mechanical and electrical stimulation, to 
name a few.  
 
Skeletal Muscle Tissue Engineering  
Cell Source 
 
     For this study, using C2C12 cells was a simple way to demonstrate the utility of static 
geometric cues, as well as develop translatable techniques to quantify alignment in 
complex 3D structures and measure forces on a µN scale. There are significant 
limitations of using cell lines in replicating in vivo myogenesis, namely, the risk that they 
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may behave differently to primary cells under stress. Yet the widespread use of C2C12 
myoblasts and their ease of use make them an ideal choice for technology development 
platforms such as those described in this study. Though constructs engineered using 
primary-derived skeletal muscle generate higher contractile forces, these cells are limited 
by their ability to be expanded in vitro and loss of myogenic potential with increasing 
passage number [115]. Ideally, future work would involve the development of an 
immortalized cell line that can be as easily propagated as C2C12s but with a capacity to 
differentiate into highly contractile myotubes, similar to those formed by primary-derived 
and muscle stem cells [115]. Finally, in considering the clinical application of muscle 
constructs for human volumetric muscle loss (VML) repair, primary myoblasts from 
humans must be studied for feasibility as a cell source. Derivation of new cell lines is 
associated with high financial and time costs. Obtaining cells from human tissues 
additionally raise ethical, legal, authentication, and pathogenicity concerns. Future work 
in this field would have to address these challenges in order to produce an effective 
bioengineered human VML solution.  
 
Relevance of Biomolecules 
     The biomolecules, RGD, RDG, VPM, for short, were used in this study for the 
development of a simple, reproducible hydrogel matrix for C2C12 support demonstrating 
the capability of the PEG hydrogel system for biological microenvironment generation. 
This system facilitates the modular comparison of hydrogel parameters (matrix density, 
degradation, swelling) in conjunction with cellular factors (survival, functionality) in the 
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development of biological niches. It must be noted that these parameters are not entirely 
independent to each other and this constraint must be considered when examining data.  
     The criteria for success for the translation of these biomolecules for use in other 
hydrogel systems, or with other cell types would involve testing the capability of system 
combinations for (i) cell viability, (ii) proliferation (iii) stability post-differentiation. The 
end goal of the utility of the optimized product: differentiated cells in a matrix, would 
dictate further application-specific success criteria. These may include, but are not 
limited to: the directionality of the constructs, cellular functionality (growth factor or 
cytokine release profiles), and the constructs ability to be implanted, interact with other 
tissues and integrate into the host. 
 
Long-term maintenance of in vitro Muscle Constructs  
     Cell culture support of in vitro generated muscle constructs involves operation in a 
narrow range of environmental conditions, as with any cell culture. However, the 
maintenance of muscle tissue in stable, differentiated state had proven difficult: in 2D, 
myotubes on micropatterned substrates peel off after one week of differentiation [153], 
and in 3D, the longevity of constructs has been described as 2-3 weeks [125-128, 197]. 
These lifetimes may not impact short-term purposes of soft-robotics (though cost of 
production could increase), but significantly limits the notion that muscle constructs can 
be generated to near-full differentiation in vitro before implantation for successful 
treatment of VML or muscular dystrophies. Future work may involve defining an 
acceptable time frame for partial differentiation of in vitro culture prior to successful 
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integration post-implantation, or the exploration of culture techniques, and cell sources 
that lengthen longevity of stable, differentiated myotubes.  
 
Vascularization and Innervation 
     Dense, engineered skeletal muscle tissue requires the support of a vascular network at 
a comparable density to that found in native tissue to meet the metabolic demands of 
muscle cells. Thickness of current muscle constructs are constrained by the limits of 
oxygen diffusion in the absence of vascular networks. However, current constructs 
operate in a large volume of media where this is not a primary concern. Advances in 
microfabrication and 3D printing have demonstrated that it is possible to build 
microvessel networks in in vitro[167]. Although these techniques are yet to be utilized for 
the development of vascular networks in 3D muscle constructs, they demonstrate the 
potential to do so. 
     At the cellular scale, recent work involving co-culture of skeletal muscle cells with 
neural cells has shown increased myotube activation and neuro-muscular junction 
formation [202]. Additionally, incorporating vasculature is vital to create self-sustained 
muscle actuators of greater dimensions. Muscle progenitor cells and myoblasts grown 
with endothelial cells produced tissue constructs displaying improved angiogenesis 
without the need for external growth factor signaling [214, 215]. Future work in this field 
seems to be headed in the direction of co-culture for the development of well-




The role of Biomaterials 
     To further generate tissue-scale skeletal muscle constructs in vitro that better replicate 
native tissue, multifunctional tissue scaffolds for growth factor release; bioreactor 
designs; and dynamic stimulation using mechanical and electrical signals become 
relevant. Materials used must be further considered to support the infiltration of host 
cells, such as macrophages, fibroblasts and endothelial cells, while promoting vasculature 
through the release of growth factors or soluble mediators to promote cell survival and 
engraftment for clinical applications [167].  
     Biomaterials can and will be exploited as tools that modulate cellular behaviors and 
fate through the presentation of physical and biochemical cues [13]. For instance, the 
treatment of volumetric muscle loss, or genetic disorders such as muscular dystrophy 
could be envisioned by using mechanically compatible, morphogen presenting, injectable 
hydrogels, which not only provide structural support, but also induce endogenous 
regeneration by selectively activating resident muscle cells [8]. Similarly, traumatized 
muscles could be repaired using fibrous meshes wrapped around the defect site, guiding 
muscle regeneration via topographical cues [8]. Fucoco et al demonstrated the ability of 
PEG-fibrinogen hydrogels to ‘rejuvenate’ adult skeletal muscle-derived pericytes, which 
typically have impaired myogenic differentiation in vitro, and enable muscle regeneration 
on a scale comparable to younger muscle-derived pericytes [103], suggesting the value of 
the choice of artificial matrices when developing muscle constructs. 
     Multifunctional or hybrid biomaterial scaffolds would modulate cellular behavior and 
enhance myogenic differentiation through the spatiotemporal release of growth factors. 
Growth factors tested for their efficacy on myotube formation, contraction, and stability 
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are VEGF [216],  HGF [137], insulin growth factor-1 (IGF-1) [217, 218], neural growth 
factor (NGF) [73, 216] , fibroblastic growth factor (FGF) [219], and transforming growth 
factor-beta (TGF-ß1). These growth factors are precisely orchestrated in vivo. HGF, for 
instance,  promotes muscle regeneration at early stages, but inhibits late-stage 
differentiation during muscle repair [137]. Further exploring growth factor delivery, dual 
delivery of HGF & VEGF [162] and FGF-2 & HGF have also been associated with 
improved myofiber generation. Hence, future work in biomaterials could involve 
engineering the key functional property of spatiotemporal (dual) drug release. 
     The PEG hydrogel platform described in this study has demonstrated functionality in 
other tissues, being used for 1) testing the effects of angiogenesis on bone reparation and 
stem cell survival in vivo and 2) engineering a biomaterial to sustain cell survival and 
engraftment in tissue engineered constructs [220, 221]. The next step for this SKMTE 
project would include development of an in vivo skeletal muscle ischemia model to 
further test its efficacy. It is already evident that biomaterials play a crucial role in muscle 
regeneration therapies, and material scientists are now working together with clinicians 
and stem cell biologists in interdisciplinary teams to translate existing biomaterial and 
cell based therapies into the clinic [8]. The use of methodologies developed here would 
enable translation to human-derived cells for use in regenerative therapies, or further 
studies on human disease states. 
 
Tissue Engineering Beyond Skeletal Muscle 
     From a clinical perspective, patients suffering from muscular dystrophy, also 
experience respiratory and cardiac function decline. There exists an interesting link 
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between cardiac and skeletal muscle health. Baum et al found that strength training is an 
important part of cardiac rehabilitation [222, 223]. While Heineke et al found that the 
ablation of the myostatin gene in cardiomyocytes prevented skeletal muscle atrophy in a 
pressure overload model of heart failure. Other muscle factors such as insulin-like growth 
factor are also suggested to be important for cardiac-mediated effects on skeletal muscle 
growth [222]. Although differing in morphology and alignment, cardiomyocytes and 
skeletal myofibers share a similar cellular architecture, notably through their common use 
of the protein dystrophin, that links transmembrane protein to the extracellular matrix 
[223]. Both cell types are found to be susceptible to contraction-induced disruption in the 
absence of dystrophin [224, 225] . In muscular dystrophy, the dysfunction of diaphragm, 
abdominal, and intercostal muscles necessary for respiration occurs early and results in 
decreased respiratory function [226, 227]. Hypoventilation and hypoxia increase 
pulmonary artery pressure, raising the workload of the right ventricle, and exacerbating 
cardiomyocte defects [223]. The identification and further experimentation of specific 
genes will shed further light on the interplay between muscle and heart function in the 
future, leading to new pathways to exploit for diagnostics and therapeutics.  
     Skeletal muscle insulin resistance is a characteristic pathology of type 2 diabetes 
[228]. A potential therapy could involve the restoration of insulin acceptance in skeletal 
muscle tissue through the in vitro development of muscle constructs with encapsulated 
engineered cells. In summary, the engineering of skeletal muscle constructs today could 
impact the fields of type 2 diabetes, respiratory and cardiac dysfunctions. 
     The development of vascularization techniques and neuronal activation are 
physiologically relevant to most tissues in the human body and the procedures developed 
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here to optimize hydrogel formulations for cellular behavior may enable the development 
of better tissue-engineered products.  
 
Soft Robotics for Biological Machines 
    There have been few notable muscle powered soft robots [10, 229]. Integration of 
cardiomyocyte muscle actuators into devices has led to basic muscle-powered devices 
such as grippers and pumps as well as more sophisticated muscle-powered soft robots 
that walk and swim [213]. These studies have primarily used neonatal rat cardiomyocytes 
that are already differentiated into contractile muscle cells. Future work should involve 
translating these techniques using skeletal muscle cells that are more amenable to 
stimulated, not spontaneous, contraction. For this purpose, optical methods of excitation 
are particularly interesting, as a non-invasive, and controlled stimulation [145, 169, 230]. 
The transition will require understanding the role of substrate stiffness and the 
mechanical environment, engineering the spatial organization of biochemical and 
physical cues to guide muscle alignment, and developing bioreactors for mechanical and 
electrical conditioning. Neuromuscular constructs formed by co-culturing or patterning 
skeletal muscle progenitor cells with neural cells are attractive components of biological 
machines as soft-actuators that can be specifically controlled [231]. Looking forward, 
current and future challenges include identifying the best source of muscle precursor cells 
to expand and differentiate into myotubes, replacing cardio myocytes with skeletal 
muscle tissue as the bio-actuator of choice for soft robots, and vascularization and 
innervation strategies to enable control and nourishment of larger muscle tissue 
constructs [115].   
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Innovative Uses for Muscle Tissue 
     Engineered muscle tissues can also be used for the large scale production of tissues to 
be used as a disease model for in vitro drug screenings of muscle-specific disease states 
[154]. Understanding endogenous regeneration cascades and their alteration in clinically 
relevant scenarios is essential to engineering biomaterials for therapies involving cells. In 
addition, artificially engineered muscle is becoming increasingly researched as a possible 




DUAL DELIVERY OF HEPATOCYTE AND VASCULAR 
ENDOTHELIAL GROWTH FACTORS VIA A PROTEASE-





     Acute myocardial infarction (MI) caused by ischemia and reperfusion (IR) is the most 
common cause of cardiac dysfunction due to local cell death and a temporally regulated 
inflammatory response. Current therapeutics are limited by delivery vehicles that do not 
address spatial and temporal aspects of healing. The aim of this study was to engineer 
biotherapeutic delivery materials to harness endogenous cell repair to enhance 
myocardial repair and function. We have previously engineered poly(ethylene glycol) 
(PEG)-based hydrogels to present cell adhesive motifs and deliver VEGF to promote 
vascularization in vivo. In the current study, bioactive hydrogels with a protease-
degradable crosslinker were loaded with hepatocyte and vascular endothelial growth 
factors (HGF and VEGF, respectively) and delivered to the infarcted myocardium of rats. 
Release of both growth factors was accelerated in the presence of collagenase due to 
hydrogel degradation. When delivered to the border zones following ischemia-
reperfusion injury, there was no acute effect on cardiac function as measured by 
echocardiography. Over time there was a significant increase in angiogenesis, stem cell 
_________________________________________ 
* Adapted from: Salimath AS, Phelps EA, Boopathy AV, Che P, Brown M, García AJ, 
et al. (2012) Dual Delivery of Hepatocyte and Vascular Endothelial Growth Factors via 
a Protease-Degradable Hydrogel Improves Cardiac Function in Rats. PLoS ONE 
7(11): e50980. doi:10.1371/journal.pone.0050980 
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recruitment, and a decrease in fibrosis in the dual growth factor delivery group that was 
significant compared with single growth factor therapy. This led to an improvement in 
chronic function as measured by both invasive hemodynamics and echocardiography. 
These data demonstrate that dual growth factor release of HGF and VEGF from a 
bioactive hydrogel has the capacity to significantly improve cardiac remodeling and 




     Cardiovascular disease is the leading cause of death in the United States, with 
estimates indicating 1 death every 39 seconds. Coronary heart disease, specifically 
myocardial infarctions (MI), accounts for 1 of every 6 deaths in the Unites States with 
over 1 million new, recurrent, and silent MI annually [233]. Following an occlusive 
coronary event, patients are treated with percutaneous coronary intervention to clear the 
affected vessel and restore blood flow [234]. While lifesaving, the ischemia and 
subsequent reperfusion (IR) induces massive regional necrosis and apoptosis, with 
billions of myocytes being lost over the first few days [235-237]. These lost cells are not 
replaced and a non-contractile scar is laid down, which will eventually lead to heart 
failure. Currently, the only definitive cure for heart failure is cardiac transplantation, and 
the number of donor hearts needed vastly outweighs availability. Thus, new therapies to 
treat this progressive disease and improve cardiac function are greatly needed. 
     Because the loss of tissue is highly localized, and the endogenous response is not 
sufficient for repair, recent efforts have focused on replacement of the lost cells using a 
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variety of treatment options[238]. In recent years, many clinical studies have been 
initiated to deliver localized therapy in the form of various cell types for reconstitution of 
the myocardium. However, there is much debate on the optimal cell type, whether or not 
stem cells can differentiate into functional myocardium and the long-term effects of these 
non-myocytes [239, 240]. In addition to exogenous cell delivery, paracrine effects arising 
from delivery of angiogenic factors and other biochemical agents suggest that the 
myocardium retains the ability to remodel and heal [241]. Understandably, there has been 
tremendous focus on both growth factor- and gene therapy-based therapeutics. Whereas a 
source of great promise, direct growth factor delivery to the myocardium will most likely 
be inefficient as several studies have noted that many of these proteins are carried away 
in the highly vascularized cardiac tissue thereby limiting the effective tissue dose [218, 
242, 243]. Gene therapy, while providing an excellent analytical tool, has not met with 
enthusiasm clinically, mostly due to the inability to quantify delivery and nonspecific 
targeting in vivo. 
     The need for spatiotemporal control to treat cardiac dysfunction is clear because 
ischemia/reperfusion (IR) injury is progressive with a distinct temporal and spatial 
response demanding distinct, controlled intervention [236]. Each of these processes is 
controlled by distinct mechanisms, and data suggest that therapeutics which may help at 
one phase may have no impact, or negative effects, at later time points. For example, 
small systemic doses of vascular endothelial growth factor (VEGF) improve regional 
blood flow following infarction; however, this did not lead to an improvement in cardiac 
function [244, 245]. However, large systemic doses of VEGF induce unfavorable side 
effects including hemangiomas, diabetic retinopathy, atherosclerosis, and rheumatoid 
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arthritis [246]. Thus, there is a compelling need for temporal and spatial control of 
therapeutic delivery as one therapeutic intervention is unlikely to be optimal for all 
phases of post-MI healing. 
      In this study, a bioactive, protease-degradable polyethylene glycol (PEG)-based 
hydrogel was used to deliver hepatocyte growth factor (HGF) and VEGF following acute 
myocardial infarction. The ability of the growth factor-laden hydrogels to improve 
angiogenesis, fibrosis, and progenitor cell infiltration was examined at chronic time 
points and functional parameters determined using clinical echocardiography and 
invasive hemodynamics. 
 
Materials and Methods 
 
Generation of PEG-hydrogel 
     Protease-degradable PEG-based hydrogels were prepared as previously described 
[12]. PEG-maleimide (PEG-MAL) 4-arm macromers (20 kDa, >95% maleimide 
functionalization; Laysan Bio) were pre-functionalized with GRGDSPC (RGD) adhesion 
peptide and growth factors (1% v/v) HGF and/or VEGF in 2.0 mM triethanolamine 
(TEA) solution. PEG polymer density used was 4% w/v and RGD density was 2.0 mM. 
The precursor molecules were cross-linked into a hydrogel by addition of a cysteine-
flanked protease-degradable peptide sequence GCRDVPMSMRGGDRCG (VPM) [76, 
247] (Fig. 1A). The final concentration of growth factors delivered was 1 µg VEGF 
(Gibco) and 1 µg HGF (US Biologicals) per 100 µl hydrogel. 
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In vitro Release Study 
     HGF and VEGF were tagged with Alexa Fluor 488, Carboxylic Acid, Succinimidyl 
Ester, mixed isomers (Life Technologies (Carlsbad, CA, USA) respectively), proteins 
were incubated at 0.1 mg/mL at a 1:50 protein to dye molar ratio in sodium bicarbonate 
buffer for 2 hours at 37°C, and purified into PBS by four passes through a desalting spin 
column (Zeba Spin Desalting Column, Pierce, 7K MWCO). Labeled protein was snap 
frozen in liquid N2 and stored at −80°C. Protein samples were confirmed to be labeled 
with respective Alexa Fluor tag, free from excess dye, by SDS-PAGE imaged on a 
BioRad system under Trans UV light. 
     To track the release of HGF and VEGF from PEG-MAL hydrogels, Alexa Fluor-
tagged growth factors were pre-incubated with 4-arm PEG-MAL macromer for 1 hour 
and incorporated into PEG-MAL hydrogels by crosslinking remaining unreacted MAL 
groups with VPM protease degradable peptide. Gels were incubated in PBS alone or with 
0.1 mg/mL or 0.01 mg/mL collagenase Type 1 (Worthington Biochemical) for 4 days at 
37°C. Individual hydrogel volumes were 50 µL and 5 uL of tagged growth factor was 
added such that final concentration in the gel was equal to 0.02 mg/mL. Samples of 
incubation media were taken every few hours for day 1 and then every 24 hours and read 
using a standard fluorescence plate reader (Perkin Elmer). Percent released was 
calculated as fraction of the dye released/maximum loaded as compared to a standard 




     A randomized and blinded study was conducted using adult Sprague-Dawley rats 
(Charles River) weighing 250 g. Rats were randomly assigned to treatment groups (n = 
7–10) using a random generator and the surgeon was only given letter codes to identify 
groups. While one group was subjected to sham surgery, the other eight groups received 
ischemia/reperfusion (IR) surgery (30 min. coronary artery ligation followed by 
reperfusion), with or without the injection of 100 µl (containing 1 µg) of the following: 
free VEGF, free HGF, free VEGF+HGF, PEG only, PEG/VEGF, PEG/HGF, or 
PEG/VEGF+HGF. Injections were made into the perimeter of cyanotic ischemic zone (3 
locations) through a 30-gauge needle immediately after reperfusion. The animals were 
allowed to recover and functional assessments were made at later time points. The 
animals were sacrificed 21 days following surgery and the hearts were fixed in 4% 
paraformaldehyde, dehydrated, embedded in paraffin, and sectioned for 
immunohistochemical analysis. This investigation conformed with the Guide for the Care 
and Use of Laboratory Animals published by the US National Institutes of Health (NIH 
Publication No. 85-23, revised 1996) and all animal studies were approved by Emory 




     Anesthetized rats were subjected to echocardiography at 7 and 21 days following IR 
surgery. Short axis values of left ventricular end systolic (ES) and end diastolic (ED) 
dimension were obtained using Acuson Sequoia 512 echocardiography workstation with 
14 MHz transducer. An average of 3 consecutive cardiac cycles was used for each 
measurement and was performed three times in an investigator-blinded manner. 
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Fractional shortening was calculated as (end-diastolic diameter – end-systolic 
diameter)/end-diastolic diameter and expressed as a percentage. 
 
Invasive Hemodynamics 
     Following echocardiography at 21 days, animals were subjected to invasive 
hemodynamic measurements using a Millar MPVS Pressure-Volume system and Power 
Lab software package. Following intubation, a 2-French catheter was inserted into the 
right jugular vein and advanced to the right ventricle for pressure measurements. After 
the catheter was removed from the right ventricle, a polyethylene catheter was inserted 
into the right jugular vein for the subsequent saline volume challenge. The pressure-
volume catheter was then inserted into the right carotid artery and advanced to the left 
ventricle. After stabilization, baseline left ventricular pressure-volume loops were 
recorded. To change preload, the inferior vena cava was transiently compressed (<30 
seconds) through an incision in the upper abdomen. Pressure-volume measurements were 
recorded for at least 10 cardiac cycles and data averaged to get mean values for each 
animal. Data extracted include +dP/dT, -dP/dT, left-ventricular end systolic and diastolic 
pressure and volume. 
 
Immunohistochemistry 
     Paraffin-embedded tissue was sectioned in to 5 mm sections and adhered to a glass 
slide. Following rehydration, tissue sections were probed with FITC-labeled isolectin B4 
(Molecular Probes) and imaged using fluorescence microscopy. Additionally, tissue 
sections were probed against c-kit using a commercially available antibody (Santa Cruz 
H-300) and a fluorescently labeled secondary antibody (Molecular Probes). To quantify 
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immunohistochemistry, 5 non-serial sections from each animal were analyzed by a 
blinded investigator and expressed as either vessels/mm2 (for isolectin) or cells/mm2 (for 
c-kit). 
     Collagen deposition was determined by picrosirius red (Sigma) staining as previously 
described [19]. Briefly, 5 µm tissue sections were stained with Sirius Red and imaged at 
2.5× using a light microscope. Overlapping images were taken and then stitched together 
using Adobe Photoshop to generate an image of the entire heart. Total collagen area (red 
staining) was normalized to total left ventricular area in 3 separate sections per animal 
using ImageJ. 
 
Migration assay of CPCs into hydrogel 
    Cardiac progenitor cells (CPCs) were isolated from adult rat hearts as described using 
anti-c-kit coated magnetic beads prior to clonal expansion [248]. The CPCs were 
characterized for expression of c-kit and only clones with >90% expression of c-kit and 
>80% expression of the cardiac transcription factors nkx2-5 and gata-4 were used in this 
study. CPCs were trypsinized and incubated with 5-chloromethylfluorescein diacetate 
(CMFDA; Molecular Probes) for 30 minutes at 37°C. Four percent PEG hydrogels of 50 
µL size containing 10 ng of VEGF, HGF or VEGF+HGF were generated as described 
above. The gels were laid flat into 8 well Labtek chamber slides with glass bottom 
(Nunc) for ease of imaging. The hydrogels were swollen in 100 µL PBS with 
Penicillin/Streptomycin for one hour at which point they completely covered the bottom 
of the well. CMFDA labeled CPCs (50,000 ) were seeded on top of the flat hydrogel 
surface. After 48 hours, the extent of CPC migration into the hydrogel was visualized on 
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a Nikon-C1 laser scanning confocal microscope with a 20× air objective. Five z-stack 
projections through a 90–450 µm thick section of the swollen hydrogel were rendered. 
The thickness of the imaged section was determined by the minimal thickness required to 
observe maximum cellular migration to reduce image capture and processing time. The 
maximum distance migrated by the cells into the hydrogel was calculated using ImageJ. 
 
Statistics 
     All statistical analyses were performed using Graphpad Prism 5 software as described 




Growth factor release from hydrogels is controlled by enzyme-mediated degradation          
     Bioactive hydrogels were synthesized as depicted in Figure 244A. To determine 
release of VEGF (Figure 24B) and HGF (Figure 24C) in vitro, fluorescently-labeled 
growth factors were chemically incorporated into PEG-MAL hydrogels. Modification of 
growth factors by PEG-MAL was verified by molecular weight increases of the protein 
band on SDS-PAGE. Hydrogels subjected to higher collagenase treatment were observed 
to degrade within the first 48 hours after treatment while hydrogels in PBS remained 
intact. Samples incubated with increasing levels of collagenase released loaded growth 
factor rapidly coinciding with gel degradation. PBS treated samples released protein 
much more slowly. These results show the rate of release of growth factors is dependent 





Figure 24: Hydrogel design and release studies. (A) PEG-maleimide (PEG-MAL) 4-
arm macromers were pre-functionalized with RGD adhesion peptide and growth 
factors HGF and/or VEGF. The precursor molecules were cross-linked into a 
hydrogel by addition of cysteine-flanked protease-degradable peptide sequence 
GCRDVPMSMRGGDRCG (VPM). (B) Fluorescently tagged VEGF and (C) HGF 
released from PEG-MAL hydrogel treated with either PBS or 2 doses of collagenase 
Type 1 as measured by fluorescent plate reader sampling of incubation media. One 
hundred percent of loaded VEGF and HGF were released by day four after 
collagenase treatment while lower doses of collagenase and PBS released up to 65% 
and 40%, respectively. Data are mean ± SEM from 6 samples per condition. 
Hyperbolic and linear curve fits indicate different release profiles behaviors for 






Figure 25: Angiogenesis following ischemia-reperfusion in treated rats. At 21 days 
following infarction, vessels were quantified by staining with isolectin-b4 
conjugated to FITC. (A) Representative images (green = isolectin; blue = DAPI; 
scale bar = 30 µm) of rats subjected to IR, IR + PEG, IR+PEG/VEGF, or IR + 
PEG/HGF/VEGF. (B) Grouped data (mean ± SEM; n≥7 per group) demonstrating a 
significant increase in vessels/mm2 in the PEG/VEGF rats compared with IR alone, 
and in the PEG/HGF/VEGF rats compared with either PEG/VEGF or IR alone 
(***p<0.001; *p<0.05; ANOVA followed by Student-Newman-Keuls post-test). 
PEG = polyethyleneglycol, VEGF = vascular endothelial growth factor, HGF = 
hepatocyte growth factor, IR = ischemia reperfusion. 
 129 
Angiogenesis is improved with the dual delivery of growth factors released from PEG 
hydrogels 
     Rats were subjected to ischemia-reperfusion (IR) surgery and free growth factors or 
growth factors embedded in protease-degradable hydrogels were injected in to the 
borderzones. To determine levels of angiogenesis, sections were probed with a FITC-
labeled isolectin conjugate and vessels were counted 21 days following infarction. In 
untreated animals, 8.3±0.5 vessels/mm2 were counted in the infarcted area (Figure 
25A top left). Infarcts treated with free VEGF, PEG hydrogel alone, or HGF-loaded PEG 
hydrogels (PEG/HGF) had equivalent levels of  angiogenesis as the untreated control. 
Treatment of animals with VEGF-loaded PEG hydrogels (PEG/VEGF) significantly 
increased vessel density in the infarct area (12.8±0.8 vessels/mm2; p<0.01 vs. IR 
alone; Figure 25A bottom left). Interestingly, PEG hydrogels loaded with VEGF and 
HGF (PEG/VEGF+HGF) further increased vessel density over PEG/VEGF (16.3±0.6 
vessels/mm2; p<0.05 vs. PEG/VEGF, p<0.001 vs. IR alone; Figure 25A bottom right). 
These grouped data (Figure 25B) demonstrate that PEG/VEGF is able to induce 
significant angiogenesis following MI, and that the presence of HGF along with VEGF 
induces a synergistic response. 
 
Fibrosis is reduced with the dual delivery of growth factors released from PEG hydrogels         
     To determine levels of fibrosis following MI, tissue sections were stained with 
picrosirius red 21 days following IR and fibrotic area was normalized to total LV area. 
Animals receiving no treatment had a fibrotic area of 41.5±3.3% of total LV area (Figure 
26A left). There was no significant decrease in groups treated with free growth factors or 
empty hydrogel. Only PEG/VEGF+HGF-treated animals demonstrated a significant 
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decrease in fibrosis compared with IR alone (13.9±3.5%; p<0.05; Figure 26A right). The 
grouped data in Figure 26B clearly demonstrates that only controlled release of both 
growth factors from the PEG hydrogel inhibited collagen deposition following IR. 
      
 
Figure 26: Fibrosis following ischemia-reperfusion in treated rats. At 21 days 
following infarction, fibrosis was measured by staining for collagen using picrosirius 
red (red stain, images taken at 20× magnification). (A) Shows 2 representative 
stitched heart sections used for quantification (IR alone and IR + PEG/VEGF/HGF. 
(B) Grouped data (mean ± SEM; n≥7 per group) demonstrating a significant decrease 
in fibrotic area in PEG/HGF/VEGF rats compared with IR alone (*p<0.05; ANOVA 
followed by Student-Newman-Keuls post-test). PEG = polyethyleneglycol, VEGF = 
vascular endothelial growth factor, HGF = hepatocyte growth factor, IR = ischemia 
reperfusion, LV = left ventricle. 
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Progenitor cell isolation and migration is increased with the dual delivery of growth 
factors released from PEG hydrogels 
     To determine the effect of growth factor treatment on progenitor cell migration, in 
vitro migration assays were performed in addition to in vivo staining of progenitor cells. 
As shown in the representative images and grouped data in Figure 27A, c-kit+ cardiac 
progenitor cells demonstrated significant increases in migration in response to both HGF 
and VEGF in vitro. Examination of migration in to the hydrogel showed a significant 
increase in VEGF-loaded hydrogels, but not HGF-loaded hydrogels (p<0.001 VEGF vs. 
PEG alone; p<0.05 vs. HGF). There was a further increase in migration in to hydrogels 
loaded with both growth factors (p<0.0001 vs. VEGF, HGF, and PEG alone). 
Additionally, a similar trend was seen in migration in a 2-dimensional transwell system 
(data not shown). To determine levels of progenitor cells in vivo, sections were stained 
with an anti-c-kit antibody and positive cells were counted in relation to total cells. While 
all other treatments were similar to IR alone, there was a significant increase (p<0.001) in 
c-kit+ cells in animals treated with PEG/VEGF+HGF (IR = 3.1 c-kit+/1000 nuclei, 




Figure 27: Progenitor cell recruitment. (A) Isolated, fluorescently-tagged cardiac 
progenitor cells (CPCs) were seeded on top of hydrogels containing nothing, VEGF, 
HGF, or HGF/VEGF and allowed to migrate for 48 hours. Gels were turned 
sideways and imaged using confocal microscopy and distance migrated was 
determined using ImageJ (scale bar = 100 µm). Data are mean ± SEM from 5 
separate experiments and demonstrate a non-significant increase in migration in to 
HGF-loaded gels, but a significant increase in migration in to VEGF-loaded gels 
(***p<0.001 compared to PEG alone, #p<0.05 compared to HGF). There was a 
further increase in migration between the single treatment groups and HGF/VEGF 
(****p<0.0001 vs. all groups; ANOVA followed by Student-Newman-Keuls post-
test). (B) Representative images of c-kit staining (red) in the infarct zone of rats with 
IR alone or treated with PEG/HGF/VEGF (blue = DAPI; scale bar = 30 µm). 
Grouped data (mean ± SEM; n≥7 per group) demonstrating a significant increase in 
c-kit+ cells in PEG/HGF/VEGF treated rats compared with IR alone (***p<0.001; 
ANOVA followed by Student-Newman-Keuls post-test). PEG = polyethyleneglycol, 
VEGF = vascular endothelial growth factor, HGF = hepatocyte growth factor, IR = 
ischemia reperfusion, RFU = relative fluorescent units. 
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Echocardiographic function assessment shows improvement with growth factor delivery 
     To determine the effects of the various treatments on cardiac function, 
echocardiography was performed at 7 and 21 days following infarction. Data were 
obtained from short-axis images, quantified, and presented in Figure 28A&B, 
respectively. At day 7, there was a significant decrease in function in IR animals 
(p<0.001). Of all the treatment groups, only empty PEG hydrogels significantly improved 
function 7 days following IR (p<0.05 vs. IR alone). In contrast, 21 days following IR, 
empty PEG hydrogels were no different from IR alone. Interestingly, only 
PEG/VEGF+HGF-treated animals demonstrated a significant improvement in function 
(p<0.05 vs. IR alone). These data show that long-term improvements in function were 
only evident following combined growth factor delivery from PEG hydrogels. 
 
Figure 28: Echocardiographic measurement of function. Grouped data (mean ± 
SEM; n≥7 per group) from (A) 7 days post-injury or (B) 21 days post-injury. At 7 
days there was a significant increase in function only in the empty PEG hydrogel 
treated rats. At 21 days, only the PEG/HGF/VEGF rats demonstrated a significant 
increase in function compared with untreated rats (*p<0.05; ANOVA followed by 
Student-Newman-Keuls post-test). PEG = polyethyleneglycol, VEGF = vascular 





Figure 29: Invasive hemodynamic measurement of function. Grouped data (mean ± 
SEM; n≥7 per group) taken 21 days following injury by cardiac catheterization. (A-
F) Various measures of function demonstrate a significant improvement in all but 1 
measurement (C, end-systolic developed pressure) in PEG/HGF/VEGF treated rats 
compared to IR alone (*p<0.05; **p<0.01; ANOVA followed by Student-Newman-
Keuls post-test). PEG = polyethyleneglycol, VEGF = vascular endothelial growth 
factor, HGF = hepatocyte growth factor, IR = ischemia reperfusion, ESDP = end-
systolic developed pressure, EDDP = end-diastolic developed pressure, ESV = end-
systolic volume, EDV = end-diastolic volume, ±dP/dT = change in pressure over 
time. 
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Invasive Hemodynamics confirms improved cardiac function from dual delivery of 
growth factors 
     To confirm echocardiographic assessments, invasive hemodynamics was performed to 
determine actual cardiac pressures and volumes 21 days following IR and summarized in 
Figure 29. Infarction induced a significant impairment in both positive and negative 
pressure changes over time (dP/dT; p<0.01 vs. sham). Of all the treatments, only 
PEG/VEGF+HGF-treated animals had significantly improved pressure changes (p<0.01 
for +dP/dT, p<0.05 for –dP/dT vs. IR alone). In addition to pressure changes, significant 
improvements in left-ventricular end diastolic pressure (p<0.01) and both end systolic 
(p<0.05) and end diastolic volumes (p<0.01) were seen in PEG/VEGF+HGF-treated 
animals. Whereas there was a 20% improvement in left-ventricular end systolic pressure, 
it was not considered significantly different. Taken together, these data confirm 
echocardiographic measurements of cardiac function, demonstrating a significant 
improvement in cardiac function in animals receiving both growth factors delivered from 
a protease-degradable PEG hydrogel. 
 
Discussion 
    Ischemia-reperfusion injury (IR) results in excessive local cell death, and in many 
patients eventually leads to heart failure as the lost tissue is not replaced. While current 
treatments such as ß-receptor antagonists and angiotensin receptor blockers are effective 
in improving contractility, there are few therapies that attempt to address the underlying 
mechanistic problems [234, 249]. While growth factor therapy holds great promise, the 
retention in the highly vascular myocardium is low and prevents sustained activation 
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needed for adequate cellular responses [218]. Biomaterial-based approaches for sustained 
therapeutic delivery hold great promise as many have shown little toxicity in animal 
studies, and they can be tailored in many cases to address tissue needs. 
In this report, we delivered a protease-degradable, bioactive PEG hydrogel loaded with 
VEGF and HGF to the infarct zone following IR for localized therapy. This material was 
chosen due to the low fouling properties of PEG, as well as excellent biocompatibility 
[80]. A recent publication with this novel material containing both RGD sequences to 
enhance cell adhesion, as well a dithiol protease-cleavable peptide cross-linker 
GCRDVPMSMRGGDRCG, demonstrate excellent cell compatibility as well as the 
ability to form in situ gels on tissue [12]. Timing of gel formation can be tuned by 
modifying the concentration of the buffering agent triethanolamine (TEA) in the reaction 
solution and thus proteins can be freshly added immediately prior to injection. The 
injected material is a liquid, yet gels rapidly in tissue. We examined VEGF and HGF 
release in vitro and show the hydrogel system is capable of controlled release due to 
protease-mediated degradation. 
Preliminary studies demonstrated excellent in situ gel formation in the myocardium, 
similar to other hydrogels used for post-infarct drug delivery. In vitro release studies 
demonstrated a slow release profile in PBS that was accelerated by increasing levels of 
collagenase treatment. Given the amount of MMPs released following IR, especially 
collagenase [250], this on-demand release system is ideal for the post-infarcted heart, 
triggering release of growth factors when active remodeling is occurring. Interestingly, 
when function was measured at 7 days, only the empty hydrogel demonstrated a 
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significant increase in function. While it is possible that the bioactive sequences aided in 
some manner, they are within the hydrogel and likely not diffusing away to enhance 
cellular function. Previous studies demonstrate that hydrogels themselves can acutely 
improve function due to mechanical support of the left ventricular (LV) wall [173, 174]. 
The bioactive PEG hydrogel has an elastic modulus of 0.5–1.0 kPa [12], within the range 
of most soft tissues and well below stiff substrates such as collagen that impede cardiac 
function  [251-253]. While there was no effect of embedded growth factors at this early 
time point, it was not surprising as neither HGF nor VEGF plays a major role in 
cardiomyocyte survival, the major contributor of early regulation of cardiac function 
[238]. It is also possible that the growth factors were not released fast enough to diffuse 
to the injured cardiac tissue, although our in vitro results would suggest otherwise. In 
contrast to the day 7 data, at day 21 there was a significant improvement in cardiac 
function only in the group that received the bioactive hydrogel embedded with VEGF and 
HGF. In keeping with the acute studies, there was no effect of free growth factors, or 
single growth factor hydrogel treatments. This was determined both via 2D 
echocardiography and invasive hemodynamic measurements. Dual growth factor delivery 
from the bioactive hydrogel resulted in a significant decrease in end-systolic and diastolic 
volume, as well as improved contractile performance as evidenced by improvements in 
end-systolic and diastolic pressures. 
     To determine potential mechanisms for these enhancements, several areas were 
examined. Due to the documented effect of VEGF on angiogenesis [254], vessel number 
was assessed in the infarcted tissue. Consistent with previous findings, sustained VEGF 
delivery induced a significant increase in vessel number with no effect for free VEGF. 
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Despite this increase in vessel number, this effect did not translate to increases in 
function. These data are supported by prior studies noting that angiogenesis alone may 
not be sufficient for long-term functional recovery [245, 255]. We saw no evidence of 
increased angiogenesis from HGF-loaded hydrogels, despite recent studies demonstrating 
the ability of HGF to induce angiogenesis following injury [256-259]. Interestingly, the 
majority of these reports are using HGF gene therapy or various HGF-overexpressing 
cells [260, 261], suggesting perhaps long-term release of HGF is required for improved 
angiogenesis. However, long-term HGF production may have negative side-effects, and 
recent efforts have focused on using HGF gene expression that can be turned off via 
suicide gene system, indicating the need for temporal control of HGF release [262]. 
While our HGF release was not sustained enough to induce angiogenesis on its own, co-
delivery of HGF with VEGF had a synergistic effect, significantly increasing 
angiogenesis over single hydrogel-growth factor delivery alone. This strategy of dual 
growth factor delivery has been used recently to co-deliver insulin-like growth factor-1 
(IGF-1) with HGF to improve angiogenesis [217]. Additionally, both VEGF and IGF 
were identified as being potential mediators of the paracrine effects of stem cell therapy, 
specifically for improving angiogenesis [263-265]. Recent studies demonstrate that 
hydrogel-mediated co-delivery of VEGF and platelet-derived growth factor (PDGF) for 
angiogenesis is synergistic as compared with single growth factor therapy[266, 267]. 
Finally, both VEGF and HGF have been delivered synergistically using poly(lactic-co-
glycolic) acid (PLGA) microspheres [268]. The authors made microspheres up to 100 µm 
in diameter and implanted them in the leg muscle of mice subjected to hindlimb 
ischemia. This interesting study found that dual factor-loaded microparticles themselves 
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enhanced angiogenesis, but the main finding was that dual-delivery of HGF and VEGF 
enhanced endothelial progenitor cell-induced function and recovery compared to cells 
alone. While this is interesting in that it may be a future avenue to use our PEG hydrogel 
to deliver cells, previous reports from our laboratory demonstrate that PLGA 
microspheres are not optimal for post-infarction delivery due to uncontrolled release and 
potential to induce inflammation from acidic degradation products [269]. Taken together, 
our data clearly show that dual growth factor release from a bioactive hydrogel is 
superior to single factor release for improving angiogenesis, but that other combinations 
may also be effective and remains an area for potential future study. 
     Similar to angiogenesis, we also examined collagen content via picrosirius red 
staining and found the dual growth factor delivery to be significantly improved over 
single factor hydrogel-mediated or soluble growth factor delivery. The effect of VEGF on 
fibrosis is not clear, with many studies linking the ability of VEGF to reduce fibrosis on 
its ability to increase angiogenesis [270, 271]. While angiogenesis and fibrosis are clearly 
tied, there is potential for altered signaling in myocytes independent of angiogenesis. An 
early study demonstrated increased Akt-mediated signaling in animals treated with 
chronic HGF following infarction [272]. While Akt is well known for its role in cell 
survival, many studies link activation of Akt to decreases in collagen production and 
assembly, especially in fibroblasts [273]. While we cannot separate the specific cell 
signaling effects from the benefits of increased angiogenesis, it is worth noting that 
hydrogel-mediated VEGF delivery did not result in a decrease in fibrosis, indicating 
angiogenesis by itself may not be sufficient. Likewise, another explanation is that VEGF 
did not induce enough angiogenesis to improve fibrosis. We also examined progenitor 
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cell infiltration by immunohistochemistry and found increased cell numbers only in the 
dual growth factor hydrogel group. Both VEGF [274] and HGF [275] are implicated in 
migration of c-kit+cardiac progenitor cells (CPCs). Our in vitro data confirms that CPCs 
show increased migration in response to the synergistic combination of VEGF and HGF 
over single growth factor alone. Studies demonstrate that CPCs respond to gradients in 
growth factor concentrations in vivo, and the use of a biodegradable hydrogel may 
facilitate this. Additionally, the hydrogel used in this study also contains RGD ligands, 
which may facilitate CPC retention or binding [276]. It is also possible that increased 
angiogenesis allowed for better access for circulating and bone marrow-derived 
progenitors expressing c-kit. We do not know the source of c-kit+ cells in this study and 
could be an interesting area for future investigation. Finally, VEGF and HGF may also 
improve the survival and growth of migrated progenitor cells. While we did not see co-
staining of c-kit with any vessels in our samples, it may be that c-kit expression was lost 
as the cells matured. Earlier studies demonstrated that bone-marrow-derived c-
kit+ clusters had improved cardiac differentiation potential in vitro [277]. While we 
examined the slides for evidence of clusters in vivo, we were unable to detect any within 
the infarcted tissue. As the source of these cells was not determined in our studies, the 
role of cell clustering in the healing response seen is unknown, but remains an interesting 
area for future studies. 
     Our data clearly demonstrates the ability of a bioactive, degradable hydrogel to deliver 
growth factors in vivo. There are very few reports of PEG hydrogels used to improve 
post-MI remodeling and angiogenesis [278, 279]. The use of a hydrogel containing 
adhesive sequences, as well as degradable linkages is promising, as it allows for potential 
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control over spatial and temporal aspects of healing and regeneration [12]. PEG 
hydrogels are promising in that they can be modified chemically, they have excellent 
biocompatibility, and do not bind proteins on their own. Thus, most parameters of drug 
delivery can be easily controlled. The processes following MI that contribute to the 
disease, inflammation, cell death, fibrosis, hypertrophy, all follow distinct time courses 
with varying locations [238]. Thus, it is unlikely that one factor will be optimal for all 
these events and multiple signals are needed. Our data demonstrate that dual growth 
factor delivery, sustained with bioactive PEG hydrogels is significantly better than free 
growth factors, or single-growth factor delivery attempts. While this seems rather 
intuitive, very few reports exist of dual growth factor delivery with biomaterials for MI. 
Thus the potential for creating even more complex delivery systems with control over 
growth factor release, cell migration, and scaffold degradation is quite promising 
 
Conclusion 
     In this study, we demonstrated the first in vivo use of a recently described bioactive, 
protease-degradable PEG hydrogel capable of delivering multiple growth factors. The 
hydrogel was delivered via intramyocardial injection following infarction, and loaded 
either with VEGF, HGF, or both factors. Only the hydrogels loaded with both factors 
demonstrated functional improvements, with animals showing increased cardiac function 
by invasive hemodynamics and echocardiography. Our data demonstrated that dual 
growth factor release, specifically controlled release of both HGF and VEGF was far 
superior to single-factor delivery at inducing angiogenesis, inhibiting fibrosis, and 
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stimulating migration of progenitor cells. These results may have clinical implications in 
the prevention of post-MI cardiac dysfunction and demonstrate the utility of synergistic, 






1. Free floating vs silanized surfaces comparison 
 
Figure 30: DNA content comparison shows no significant differences between free-
floating hydrogels cast on parafilm and cultured in TCP (‘TCP’) or cast and cultured 




Local correlation of actin (Ph 555) staining with sarcomeric myosin (MF20, Alexa Fluor 
488)  
  
2. Diffusion distances for agonists of contraction 
     For the external agonists: Acetylcholine (ACh) and Caffeine, diffusion time through a 
construct is inversely proportional to distance and directly related to a diffusion constant. 
Using Einstein’s approximation equation  𝑡 ≈  
𝑥2
2𝐷
  , where the diffusion time (t) is a 
function of the distance of diffusion (x) and the diffusion coefficient (D). Diffusion time 
increases with the square of diffusion distance.  As shown in Table 6, diffusion times for 
molecules of this size are in the nanosecond range, allowing us to assume that 
millisecond scale changes in readings are related to cellular structure contraction, and not 
molecular diffusion.   
Table 8: Diffusion times for agonists: ACh and Caffeine 
Agonist Diffusion Coefficient 
(cm
2









ACh 4.06 x 10
-6 
2.0 5.0 81.1 – 507.2 
Caffeine 5.39 x 10
-6 




Figure 31: Local correlation of actin (Ph 555) staining with sarcomeric myosin 
(MF20, Alexa Fluor 488)  to show that the differentiating cell alignment can be 
measured using the less diffuse actin staining for better agreement with existing 






AMENDMENTS & CLARIFICATIONS 
 
 
Clarification of influence of toroid shape on cellular alignment: hypotheses and 
discussion 
     We would like to clarify the manner in which alignment occurs, by correlating two 
key metrics: the change over time of the volume of the toroidal hydrogel and the 
alignment of cellular structures within the toroidal hydrogel. We agree this data and 
discussion portion was missing from the document.  
 
1. Quantification in the reduction in outer diameter over time  
     We observed that the factors affecting alignment within the hydrogel are a 
combination of interdependent factors. While passive cellular alignment may occur as a 
consequence of the construct deformation, notable construct deformation itself occurred 
due to cellular forces acting within the hydrogel in the first place. Quantification of one 
of the factors affecting alignment: change in hydrogel diameter over time, is shown in 
Figure 32. Hydrogels without cells cast around toroids do not significantly change after 
swelled volume (day 1) over 14 days. Hydrogels containing cells contract significantly 
from their volume at day 1 to day 14. The cell density in both hydrogel volumes is the 
same, yet, different rates of contraction are observed. This leads us to consider other 
factors that affect rate of contraction such as  the development of differing stress patterns 
due to geometrical variation and differences in cellular contribution.  
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We agree that our "constructs are constrained such that essentially all of the shape change 
over time occurs by reduction of the outer diameter of the toroid." This was visually 
observed. 
 
2. Estimation of diameter-change effect on embedded fiber orientation and comparison 
with observed development of alignment 
     Overlaying the development of AI over time, Figure 21, with Figure 1 above, can 
provide an understanding of how the two are related. Figure 21 shows steep increases in 
alignment between days 1 and 3 and between 3 and 7. Alignment continues to increase at 
a slower rate between days 7 and 14. In Figure 1, we observe toroidal hydrogels with 
cells begin to contract between days 1 and 3 and then continue to contract at a high rate 
from days 3, 7, through to 9. Beyond day 9, the toroid diameter decreases much less 
 
Figure 32: Change of spire -toroid outer diameter 'D', over time when cast around 1.0 mm 
spires and cultured for 14 days, with and without cells. OD was measured in cardinal directions 
and averaged for each spire-toroid. All gels swell overnight between casting (day 0) and day 1. 
After day 1, for a given volume, the presence of cells significantly decreases the diameter as 
cells spread and grow, contracting the hydrogel. (* indicates significance p < 0.05 between 
gels with or without cells, of a given volume, at day 14, n = 5). 
OD 
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rapidly. These data suggest that the development of alignment occurs between days 1 
through 7, during the phase of highest toroid contraction.  
 
3. Demonstration of stress development in Hydrogels 
     We have shown that contraction is mediated by cells within the hydrogel, and expect 
this contraction to be a result of cell-mediated traction forces [280, 281] . The extent of 
the traction forces developed that cause the macro-scale construct deformation may be 
related to differential stress patterns within toroidal hydrogels. These differences in stress 
patterns occur as a result of the geometry, but are in interplay with the cellular forces 
themselves. We believed it to be beyond the scope of this thesis to dissociate these 
interactive factors (cellular, physical, mechanical), their causes, spatio-temporal 
occurrence and determine their precise interdependence for the assessment of alignment 
development.  
 
     The use of Figure 23 is to demonstrate that there exist differences in stress patterns 
that cause deformation, and present one possible effect that may explain the development 
of alignment. The model assumes that the toroid structure has consistent density. 
Similarly, a toroid with homogenous cell density, where each cell exerts the same 
contraction force would produce the same relative stress patterns in a toroid 
configuration. We do not agree that "it is not the stress…[that] influences alignment, but 
the deformation of the construct in response to that stress", as these factors are 




     We do agree that the change in hydrogel contraction causes "fibers (even inactive, 
non-biological fibers) that were randomly embedded in the initial configuration to 
become circumferentially aligned...as a natural consequence of uniform tension 
developed by those initially randomly oriented cells interacting with the geometrical 
constraints on deformation." As the myotubes develop within the hydrogel, we expect 
they would produce biological ECM fibers of their own, further contributing to the 
simultaneous stress and alignment development.  
 
     Though the cells will contribute to their alignment, we agree that it is "qualitatively 
different for the cells to change the geometry of their environment and pull themselves 
into alignment than for the cells to rearrange themselves within a fixed construct." In this 
toroid cell-hydrogel system, we observed that the cells contribute to the changing 
environment of their construct, resulting in a construct with stable geometry by day 7, 
within which they continue to align. We understand the construct to be 'fixed' around the 
central spire, but constantly changing as remodeled by the developing cells contained 
within it.  
 
 4. Surface Area/Volume ratio measurements 
      Committee members raised valid concerns regarding the accurate measurement of the 
hydrogel and construct dimensions for Surface Area/Volume (SA/V) ratios and 
understanding their consequent importance in alignment of the cells within the hydrogels.  
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     To further clarify the note on cell density: there are no differences in cell density 
between hydrogel configurations and the differing volumes over time arise as a function 
of geometry during swelling and inter-dependent cell-mediated contraction and alignment 
of the myoblasts and myotubes. Past work with the hydrogel system has shown that 
swelling can be constrained (cast between tow cover-slips, in troughs) and is dependent 
upon the geometry in which the hydrogels are cast. 
 
     SA/V ratio is believed to be important to quantify our visual observations. We agree 
that it is not the best singular metric to determine a pre-requisite for alignment. Further, 
this claim would warrant deeper investigation into specific ratios. Hence, we would like 
to clarify the purpose of the SA/V ratio as a suggestion for the geometrical constraints 
that may enable alignment support. Though optimal for the scenarios studied here, 
developing other constructs would have to take into consideration scale of the hydrogels, 
cell density, swelling constraints, and other practical measures of construct generation. It 
cannot be concluded that "a 1 liter construct with a surface-volume ratio of 1.4" would 
generate a construct with optimized cell alignment.  
 
5. Dimensions used for AI analysis 
     We agree that the dimensions used for AI measurements are missing in the document. 
Referencing Figure 15, page 75: full images were taken at 20 x magnifications where the 




. These images were cropped 
to about 60 µm
2
, resulting in 6-8 images of 60000 – 45000 µm
2
 per original image for 
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analysis. The images needed to be cropped in this manner to avoid empty 'black-space' 




Acknowledgement of lack of comparability to Yamamoto (2011) 
     We acknowledge that the time to peak tension of 5-10 seconds, for total contraction 
duration of 20-30 seconds cannot be practically compared with the work by Yamamoto et 
al for the primary reason of the utilization of different modes to produce contraction: 
namely, electrical pulse stimulation compared to the diffusion of small molecules seen in 
this work. We compared our work with Yamamoto's due to the limited work in small 






1. Tanner, C.L., J.R. Cruz, and R.D. Braun, Structural Verification and Modeling of 
a Tension Cone Inflatable Aerodynamic Decelerator. 2010, Georgia Inst. of Tech. 
2. Powers, S.K. and E.T. Howley, Skeletal Muscle Structure and Function, in 
Excercise Physiology: Theory and Application to Fitness and Performance 2009, 
McGraw-Hill Companies. 
3. Stone, M.H., M. Stone, and W.A. Sands, Neuromuscular Physiology in Principles 
and Practice of Resistance Training. 2007. p. 384. 
4. Grassi, F., S. Fucile, and F. Eusebi, Ca2+ signalling pathways activated by 
acetylcholine in mouse C2C12 myotubes. Pflogers Archiv European Journal of 
Physiology, 1994. 428(3-4): p. 340-345. 
5. Kamm, R., et al., Emergent Behaviors of Integrated Cellular Systems (EBICS). 
2010, National Science Foundation: Science and Technology Center  
6. Salimath, A.S. and A.J. Garcia, Biofunctional hydrogels for skeletal muscle 
constructs. J Tissue Eng Regen Med, 2014. 
7. Trotter, J.A. and P.P. Purslow, Functional morphology of the endomysium in 
series fibered muscles. J Morphol, 1992. 212(2): p. 109-22. 
8. Qazi, T.H., et al., Biomaterials based strategies for skeletal muscle tissue 
engineering: Existing technologies and future trends. Biomaterials, 2015. 53: p. 
502-521. 
9. Roger Kamm, R.N., Jimmy Hsia, Cells into Systems, in Mechanical Engineering. 
2010. 
10. Kevin Kit Parker, J.O.D., Janna C Nawroth, A tissue-engineered jellyfish with 
biomimetic propulsion. Nature Biotechnology, 2012. 30(8): p. 792. 
11. Neill J Turner, S.B., Regeneration of skeletal muscle. Cell and Tissue Research, 
2011. 347(3): p. 759-774. 
12. Phelps, E.A., et al., Maleimide Cross-Linked Bioactive PEG Hydrogel Exhibits 
Improved Reaction Kinetics and Cross-Linking for Cell Encapsulation and In Situ 
Delivery. Advanced Materials, 2012. 24(1): p. 64-70. 
13. Cezar, C.A. and D.J. Mooney, Biomaterial-based delivery for skeletal muscle 
repair. Adv Drug Deliv Rev, 2014. 
14. Ruegg, J.C., Muscle Contraction: Molecular and Cellular Physiology, in 
Comprehensive Human Physiology. 1996, Springer-Verlag: Berlin, Heidelberg. 
15. Berne, R.M. and M.N. Levy, Contractile Mechanism of Muscle Cells, in 
Physiology, B.M. Koeppen, Editor. 1998, Mosby: St.Louis, MI. p. 269-277. 
16. Huxley, A.F. and R. Niedergerke, Structural changes in muscle during 
contraction; interference microscopy of living muscle fibres. Nature, 1954. 
173(4412): p. 971-3. 
17. Huxley, H. and J. Hanson, Changes in the Cross-Striations of Muscle during 
Contraction and Stretch and their Structural Interpretation. Nature, 1954. 
173(4412): p. 973-976. 
18. Rida, P.C., N. Le Minh, and Y.J. Jiang, A Notch feeling of somite segmentation 
and beyond. Dev Biol, 2004. 265(1): p. 2-22. 
 152 
19. Sheffield-Moore, M. and R.J. Urban, An overview of the endocrinology of skeletal 
muscle. Trends Endocrinol Metab, 2004. 15(3): p. 110-5. 
20. Guttridge, D.C., Signaling pathways weigh in on decisions to make or break 
skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care, 2004. 7: p. 7. 
21. Schulz, R.A. and K.E. Yutzey, Calcineurin signaling and NFAT activation in 
cardiovascular and skeletal muscle development. Dev Biol, 2004. 266(1): p. 1-16. 
22. Martin, P.T., Role of transcription factors in skeletal muscle and the potential for 
pharmacological manipulation. Curr Opin Pharmacol, 2003. 3(3): p. 300-8. 
23. Solloway, M.J. and R.P. Harvey, Molecular pathways in myocardial 
development: a stem cell perspective. Cardiovasc Res, 2003. 58(2): p. 264-77. 
24. Baylies, M.K. and A.M. Michelson, Invertebrate myogenesis: looking back to the 
future of muscle development. Curr Opin Genet Dev, 2001. 11(4): p. 431-9. 
25. Relaix, F., et al., A Pax3/Pax7-dependent population of skeletal muscle 
progenitor cells. Nature, 2005. 435(7044): p. 948-53. 
26. Charge, S.B. and M.A. Rudnicki, Cellular and Molecular Regulation of Muscle 
Regeneration, P. Rev, Editor. 2004, Physiol Rev: Ottawa. 
27. Cooper, R.N., et al., In vivo satellite cell activation via Myf5 and MyoD in 
regenerating mouse skeletal muscle. J Cell Sci, 1999. 112 ( Pt 17): p. 2895-901. 
28. Cornelison, D.D. and B.J. Wold, Single-cell analysis of regulatory gene 
expression in quiescent and activated mouse skeletal muscle satellite cells. Dev 
Biol, 1997. 191(2): p. 270-83. 
29. Fuchtbauer, E.M. and H. Westphal, MyoD and myogenin are coexpressed in 
regenerating skeletal muscle of the mouse. Dev Dyn, 1992. 193(1): p. 34-9. 
30. Grounds, M., et al., Identification of skeletal muscle precursor cells in vivo by use 
of MyoD1 and myogenin probes. Cell Tissue Res, 1992. 267: p. 5. 
31. Zhou, Z. and A. Bornemann, MRF4 protein expression in regenerating rat 
muscle. J Muscle Res Cell Motil, 2001. 22(4): p. 311-6. 
32. Kislinger, T., et al., Proteome dynamics during C2C12 myoblast differentiation. 
Mol Cell Proteomics, 2005. 4(7): p. 887-901. 
33. Decary, S., et al., Replicative potential and telomere length in human skeletal 
muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther, 
1997. 8(12): p. 1429-38. 
34. Silverthorn, D.U., et al., Muscles, in Human Physiology, H. Dinsey, Editor. 2001, 
Prentice-Hall: NJ. p. 352-356. 
35. Ornatsky, O.I. and J.C. McDermott, MEF2 protein expression, DNA binding 
specificity and complex composition, and transcriptional activity in muscle and 
non-muscle cells. J Biol Chem, 1996. 271(40): p. 24927-33. 
36. Di Lisi, R., et al., Combinatorial cis-acting elements control tissue-specific 
activation of the cardiac troponin I gene in vitro and in vivo. J Biol Chem, 1998. 
273(39): p. 25371-80. 
37. Yang, C.C., et al., Interaction of myocyte enhancer factor 2 (MEF2) with a 
mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res, 1998. 26(20): 
p. 4771-7. 
38. Youn, H.D., C.M. Grozinger, and J.O. Liu, Calcium regulates transcriptional 
repression of myocyte enhancer factor 2 by histone deacetylase 4. J Biol Chem, 
2000. 275(29): p. 22563-7. 
 153 
39. Youn, H.D. and J.O. Liu, Cabin1 represses MEF2-dependent Nur77 expression 
and T cell apoptosis by controlling association of histone deacetylases and 
acetylases with MEF2. Immunity, 2000. 13(1): p. 85-94. 
40. Gillies, A.R. and R.L. Lieber, Structure and function of the skeletal muscle 
extracellular matrix. Muscle Nerve, 2011. 44(3): p. 318-31. 
41. Purslow, P.P. and J.A. Trotter, The morphology and mechanical properties of 
endomysium in series-fibred muscles: variations with muscle length. J Muscle Res 
Cell Motil, 1994. 15(3): p. 299-308. 
42. Gawlik, K.I. and M. Durbeej, Skeletal muscle laminin and MDC1A: pathogenesis 
and treatment strategies. Skelet Muscle, 2011. 1(1): p. 9. 
43. Andrade, F.H., et al., Effect of hydrogen peroxide and dithiothreitol on contractile 
function of single skeletal muscle fibres from the mouse. J Physiol, 1998. 509 ( Pt 
2): p. 565-75. 
44. Knudson, D.V., Mechanics of the Muscoskeletal system, in Fundamentals of 
Biomechanics. 2007, Springer: Chico, CA. p. 84-88. 
45. Global burden of musculoskeletal disease revealed in new WHO report. Bull 
World Health Organ, 2003. 81(11): p. 853-4. 
46. Burden of Musculoskeletal Disease Overview. The Burden of Musculoskeletal 
Diseases in the United States: Prevalence, Societal and Economic Cost, in United 
States Bone and Joint Initiative. 2011, American Academy of Orthopaedic 
Surgeons: Rosemont, IL. p. pp 1-20. 
47. Juhas, M. and N. Bursac, Engineering skeletal muscle repair. Current Opinion in 
Biotechnology, 2013. 24(5): p. 880-886. 
48. Turner, N.J. and S.F. Badylak, Regeneration of skeletal muscle. Cell Tissue Res, 
2012. 347(3): p. 759-74. 
49. Sandri, M., Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda), 
2008. 23: p. 160-70. 
50. Chinnery PF, G.L., Schafer AI, eds, Muscle Diseases, in Cecil Medicine. 2011, 
Saunders Elsevier: Philadelphia, Pa. 
51. Uhrig, B.A., et al., Models of Composite Bone and Soft Tissue Limb Trauma, in 
Biomaterials and Regenerative Medicine 2014. 
52. Grogan, B.F. and J.R. Hsu, Volumetric Muscle Loss. Journal of American 
Academy of Orthopaedic Surgeons, 2011. 19: p. S35-S37. 
53. Mase, V.J., Jr., et al., Clinical application of an acellular biologic scaffold for 
surgical repair of a large, traumatic quadriceps femoris muscle defect. 
Orthopedics, 2010. 33(7): p. 511. 
54. Huard, J., Y. Li, and F.H. Fu, Muscle injuries and repair: current trends in 
research. J Bone Joint Surg Am, 2002. 84-A(5): p. 822-32. 
55. Styf, J., The effects of functional knee bracing on muscle function and 
performance. Sports Med, 1999. 28(2): p. 77-81. 
56. Atala, A., F.K. Kasper, and A.G. Mikos, Engineering Complex Tissues. Tissue 
Eng, 2012. 
57. Giannoudis, P.V., et al., Long-term quality of life in trauma patients following the 
full spectrum of tibial injury (fasciotomy, closed fracture, grade IIIB/IIIC open 
fracture and amputation). Injury, 2009. 40(2): p. 213-9. 
 154 
58. Castillo, R.C., et al., Prevalence of chronic pain seven years following limb 
threatening lower extremity trauma. Pain, 2006. 124(3): p. 321-9. 
59. Matsuoka, T., et al., Long-term physical outcome of patients who suffered crush 
syndrome after the 1995 Hanshin-Awaji earthquake: prognostic indicators in 
retrospect. J Trauma, 2002. 52(1): p. 33-9. 
60. Mimata, Y., et al., Limb function after excision of a deltoid muscle sarcoma. J 
Shoulder Elbow Surg, 2013. 22(12): p. e1-5. 
61. Borrelli, J., Jr., Management of soft tissue injuries associated with tibial plateau 
fractures. J Knee Surg, 2014. 27(1): p. 5-9. 
62. Crow, B.D., et al., Evaluation of a novel biomaterial for intrasubstance muscle 
laceration repair. J Orthop Res, 2007. 25(3): p. 396-403. 
63. Papadakis, M., et al., Growth hormone replacement in healthy older men 
improves body composition but not functional ability. Ann Intern Med, 1996. 124: 
p. 8. 
64. Miller, K.J., et al., Hepatocyte growth factor affects satellite cell activation and 
differentiation in regenerating skeletal muscle. Am J Physiol Cell Physiol, 2000. 
278(1): p. C174-81. 
65. Barnard, W., et al., Leukemia inhibitory factor (LIF) infusion stimulates skeletal 
muscle regeneration after injury: injured muscle expresses lif mRNA. J Neurol 
Sci, 1994. 123(1-2): p. 108-13. 
66. Lee, C., et al., Biological intervention based on cell and gene therapy to improve 
muscle healing after laceration. J Musculoskeletal Res, 2000. 4: p. 13. 
67. Menetrey, J., et al., Suturing versus immobilization of a muscle laceration. A 
morphological and functional study in a mouse model. Am J Sports Med, 1999. 
27(2): p. 222-9. 
68. Zein, N.N., Interferons in the management of viral hepatitis. Cytokines Cell Mol 
Ther, 1998. 4(4): p. 229-41. 
69. Kloen, P., et al., Suramin inhibits growth and transforming growth factor-beta 1 
(TGF-beta 1) binding in osteosarcoma cell lines. Eur J Cancer, 1994. 30A(5): p. 
678-82. 
70. Crisco, J.J., et al., A muscle contusion injury model. Biomechanics, physiology, 
and histology. Am J Sports Med, 1994. 22(5): p. 702-10. 
71. Garrett, W.E., Jr., et al., Recovery of skeletal muscle after laceration and repair. J 
Hand Surg Am, 1984. 9(5): p. 683-92. 
72. Jarvinen, M. and T. Sorvari, Healing of a crush injury in rat striated muscle. 1. 
Description and testing of a new method of inducing a standard injury to the calf 
muscles. Acta Pathol Microbiol Scand A, 1975. 83(2): p. 259-65. 
73. Kasemkijwattana, C., et al., Development of approaches to improve the healing 
following muscle contusion. Cell Transplant, 1998. 7(6): p. 585-98. 
74. Hurme, T., et al., Healing of skeletal muscle injury: an ultrastructural and 
immunohistochemical study. Med Sci Sports Exerc, 1991. 23(7): p. 801-10. 
75. Raeber, G.P., M.P. Lutolf, and J.A. Hubbell, Molecularly engineered PEG 
hydrogels: a novel model system for proteolytically mediated cell migration. 
Biophys J, 2005. 89(2): p. 1374-88. 
 155 
76. Patterson, J. and J.A. Hubbell, Enhanced proteolytic degradation of molecularly 
engineered PEG hydrogels in response to MMP-1 and MMP-2. Biomaterials, 
2010. 31(30): p. 7836-7845. 
77. Raab, M., J.W. Shin, and D.E. Discher, Matrix elasticity in vitro controls muscle 
stem cell fate in vivo. Stem Cell Res Ther, 2010. 1(5): p. 38. 
78. Engler, A.J., et al., Myotubes differentiate optimally on substrates with tissue-like 
stiffness: pathological implications for soft or stiff microenvironments. Journal of 
Cell Biology, 2004. 166(6): p. 877-87. 
79. Lutolf MP, R.G., Zisch AH, Tirelli N, Hubbell JA, Cell-responsive synthetic 
hydrogels. Advanced Materials, 2003. 15: p. 888-92. 
80. Phelps, E.A., et al., Bioartificial matrices for therapeutic vascularization. Proc 
Natl Acad Sci U S A, 2010. 107(8): p. 3323-8. 
81. Miller, J.B., et al., Cellular and molecular diversity in skeletal muscle 
development: news from in vitro and in vivo. Bioessays, 1993. 15(3): p. 191-6. 
82. Bajaj, P., et al., Patterning the differentiation of C2C12 skeletal myoblasts. Integr 
Biol (Camb), 2011. 3(9): p. 897-909. 
83. Buck, C.A. and A.F. Horwitz, Cell surface receptors for extracellular matrix 
molecules. Annu Rev Cell Biol, 1987. 3: p. 179-205. 
84. Huijing, P.A., Muscle as a collagen fiber reinforced composite: a review of force 
transmission in muscle and whole limb. Journal of Biomechanics, 1999. 32(4): p. 
329-345. 
85. Purslow, P.P., The structure and functional significance of variations in the 
connective tissue within muscle. Comparative Biochemistry and Physiology a-
Molecular and Integrative Physiology, 2002. 133(4): p. 947-966. 
86. Wolf, M.T., et al., Naturally derived and synthetic scaffolds for skeletal muscle 
reconstruction. Adv Drug Deliv Rev, 2014. 
87. Page, R.L., et al., Restoration of skeletal muscle defects with adult human cells 
delivered on fibrin microthreads. Tissue Eng Part A, 2011. 17(21-22): p. 2629-40. 
88. Janmey, P.A., J.P. Winer, and J.W. Weisel, Fibrin gels and their clinical and 
bioengineering applications. Journal of the Royal Society Interface, 2009. 6(30): 
p. 1-10. 
89. Hill, E., T. Boontheekul, and D.J. Mooney, Designing scaffolds to enhance 
transplanted myoblast survival and migration. Tissue Eng, 2006. 12(5): p. 1295-
304. 
90. Takahashi, H., et al., The use of anisotropic cell sheets to control orientation 
during the self-organization of 3D muscle tissue. Biomaterials, 2013. 34: p. 7372-
7380. 
91. Tomblyn, S., et al., Keratin hydrogel carrier system for simultaneous delivery of 
exogenous growth factors and muscle progenitor cells. J Biomed Mater Res B 
Appl Biomater, 2015. 
92. Fujita, H., K. Shimizu, and E. Nagamori, Novel method for fabrication of skeletal 
muscle construct from the C2C12 myoblast cell line using serum-free medium 
AIM-V. Biotechnology and Bioengineering, 2009. 103(5): p. 1034-1041. 
93. Kroehne, V., et al., Use of a novel collagen matrix with oriented pore structure 
for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med, 2008. 
12(5a): p. 1640-1648. 
 156 
94. Choi, J., et al., The influence of electrospun aligned poly(epsilon-
caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal 
muscle myotubes. Biomaterials, 2008. 29(19): p. 2899-906. 
95. Hoque, M.E., et al., Processing of polycaprolactone and polycaprolactone-based 
copolymers into 3D scaffolds, and their cellular responses. Tissue Eng Part A, 
2009. 15(10): p. 3013-24. 
96. Saxena, A., et al., Skeletal muscle tissue engineering using isolated myoblasts on 
synthetic biodegradable polymers: preliminary studies. Tissue Eng, 1999. 5(6): p. 
525-532. 
97. Saxena, A., G. Willital, and J. Vacanti, Vascularized three-dimensional skeletal 
muscle tissue-engineering. Biomed Mater Eng, 2001. 11(4): p. 275-81. 
98. Mulder, M., R. Hitchcock, and P. Tresco, Skeletal myogenesis on elastomeric 
substrates: implications for tissue engineering. J Biomater Sci Polym Ed., 1998. 
9(7): p. 731-48. 
99. Riboldi, S., et al., Electrospun degradable polyesterurethane membranes: 
potential scaffolds for skeletal muscle tissue engineering. Biomaterials, 2005. 
26(22): p. 4606-15. 
100. Peyton, S.R., et al., The emergence of ECM mechanics and cytoskeletal tension as 
important regulators of cell function. Cell Biochem Biophys, 2007. 47: p. 300-
320. 
101. Place, E.S., et al., Synthetic polymer scaffolds for tissue engineering. Chemical 
Society Reviews, 2009. 38(4): p. 1139-1151. 
102. Gilbert, P.M., et al., Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-
Renewal in Culture. Science, 2010. 329(5995): p. 1078-1081. 
103. Fuoco, C., et al., 3D hydrogel environment rejuvenates aged pericytes for skeletal 
muscle tissue engineering. Front Physiol, 2014. 5: p. 203. 
104. Fuoco, C., et al., Injectable polyethylene glycol-fibrinogen hydrogel adjuvant 
improves survival and differentiation of transplanted mesoangioblasts in acute 
and chronic skeletal-muscle degeneration. Skelet Muscle, 2012. 2(1): p. 24. 
105. Costa, K.D., E.J. Lee, and J.W. Holmes, Creating alignment and anisotropy in 
engineered heart tissue: role of boundary conditions in a model three-
dimensional culture system. Tissue Eng, 2003. 9(4): p. 567-77. 
106. Colton, C.K., Implantable biohybrid artificial organs. Cell Transplant, 1995. 4(4): 
p. 415-36. 
107. Ilievski, F., et al., Soft robotics for chemists. Angew Chem Int Ed Engl, 2011. 
50(8): p. 1890-5. 
108. Ueoka, Y., J. Gong, and Y. Osada, Chemomechanical Polymer Gel with Fish-like 
Motion. Journal of Intelligent Material Systems and Structures, 1997. 8(5): p. 
465-471. 
109. Hamlen, R.P., C.E. Kent, and S.N. Shafer, Electrolytically Activated Contractile 
Polymer. Nature, 1965. 206(4989): p. 1149-1150. 
110. Shiga, T. and T. Kurauchi, Deformation of polyelectrolyte gels under the 
influence of electric field. Journal of Applied Polymer Science, 1990. 39(1112): p. 
2305-2320. 
 157 
111. Robert Shepherd, F.I., Wonjae Choi, Stephen A Morin, Adam Stokes, Aaron 
Mazzeo, Xin Chen, Michael Wang, George Whitesides, Multigait soft robot. 
PNAS, 2011. 108(51): p. 20400-20403. 
112. Ribuan, M.N., K. Suzumori, and S. Wakimoto, New Pneumatic Rubber Leg 
Mechanism for Omnidirectional Locomotion. International Journal of Automation 
Technology, 2014. 8(2): p. 8. 
113. Breger, J.C., et al., Self-folding thermo-magnetically responsive soft 
microgrippers. ACS Appl Mater Interfaces, 2015. 7(5): p. 3398-405. 
114. Suzumori, K., Elastic materials producing compliant robots. Robotics and 
Autonomous Systems, 1996. 18(1-2): p. 135-140. 
115. Duffy, R.M. and A.W. Feinberg, Engineered skeletal muscle tissue for soft 
robotics: fabrication strategies, current applications, and future challenges. 
Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2014. 6(2): p. 178-95. 
116. Ham, R., et al., Compliant actuator designs. IEEE Robotics & Automation 
Magazine, 2009. 16(3): p. 81-94. 
117. Pette, D. and G. Vrbova, Neural control of phenotypic expression in mammalian 
muscle fibers. Muscle Nerve, 1985. 8(8): p. 676-89. 
118. Hu, W., et al., Hydrogel microrobots actuated by optically generated vapour 
bubbles. Lab Chip, 2012. 12(19): p. 3821-6. 
119. Mahmut Selman Sakar, D.N., Harry Asada, Chris Chen, Ron Weiss, Roger 
Kamm, Formation and optogenetic control of engineered 3D skeletal muscle 
bioactuators. Lab on a Chip, 2012. 
120. Fujita, H., K. Shimizu, and E. Nagamori, Novel Method for Measuring Active 
Tension Generation by C2C12 Myotube Using UV-Crosslinked Collagen Film. 
Biotechnology and Bioengineering, 2010. 
121. Dennis, R.G. and P.E. Kosnik, 2nd, Excitability and isometric contractile 
properties of mammalian skeletal muscle constructs engineered in vitro. In Vitro 
Cell Dev Biol Anim, 2000. 36(5): p. 327-35. 
122. Lam, M.T., et al., Microfeature guided skeletal muscle tissue engineering for 
highly organized 3-dimensional free-standing constructs. Biomaterials, 2009. 
30(6): p. 1150-5. 
123. Juhas, M., et al., Biomimetic engineered muscle with capacity for vascular 
integration and functional maturation in vivo. Proc Natl Acad Sci U S A, 2014. 
111(15): p. 5508-13. 
124. Bian, W., et al., Mesoscopic hydrogel molding to control the 3D geometry of 
bioartificial muscle tissues. Nat Protoc, 2009. 4(10): p. 1522-34. 
125. Bian, W. and N. Bursac, Engineered skeletal muscle tissue networks with 
controllable architecture. Biomaterials, 2009. 30(7): p. 1401-12. 
126. Hinds, S., et al., The role of extracellular matrix composition in structure and 
function of bioengineered skeletal muscle. Biomaterials, 2011. 32(14): p. 3575-83. 
127. Bian, W., et al., Local tissue geometry determines contractile force generation of 
engineered muscle networks. Tissue Eng Part A, 2012. 18(9-10): p. 957-67. 
128. Yamamoto, Y., et al., Functional evaluation of artificial skeletal muscle tissue 
constructs fabricated by a magnetic force-based tissue engineering technique. 
Tissue Eng Part A, 2011. 17(1-2): p. 107-14. 
 158 
129. Yamamoto, Y., et al., Preparation of artificial skeletal muscle tissues by a 
magnetic force-based tissue engineering technique. J Biosci Bioeng, 2009. 
108(6): p. 538-43. 
130. David Yaffe, O.S., Serial Passaging and differentiation of myogenic cells isolated 
frm dystrophic mouse muscle. Nature, 1977. 270(22/29). 
131. Lawson, M.A. and P.P. Purslow, Differentiation of myoblasts in serum-free 
media: effects of modified media are cell line-specific. Cells Tissues Organs, 
2000. 167(2-3): p. 130-7. 
132. Dennis, R.G., et al., Excitability and contractility of skeletal muscle engineered 
from primary cultures and cell lines. Am J Physiol Cell Physiol, 2001. 280(2): p. 
C288-95. 
133. García, A.J., M.D. Vega, and D. Boettiger, Modulation of cell proliferation and 
differentiation through substrate-dependent changes in fibronectin conformation. 
Molecular Biology of the Cell, 1999. 10(3): p. 785-798. 
134. Rowley, J.A. and D.J. Mooney, Alginate type and RGD density control myoblast 
phenotype. Journal of Biomedical Materials Research, 2002. 60(2): p. 217-223. 
135. Peng-Yuan Wang, H.T., Wei-Bor Tsai, The Roles of RGD and Grooved 
Topography in the Adhesion, Morphology, and Differentiation of C2C12 Skeletal 
Myoblasts. Biotechnology and Bioengineering, 2012. 109(8). 
136. Zhao, Y., et al., Fabrication of skeletal muscle constructs by topographic 
activation of cell alignment. Biotechnol Bioeng, 2009. 102(2): p. 624-31. 
137. Weist, M.R., et al., TGF-beta1 enhances contractility in engineered skeletal 
muscle. J Tissue Eng Regen Med, 2013. 7(7): p. 562-71. 
138. Pedrotty, D.M., et al., Engineering skeletal myoblasts: roles of three-dimensional 
culture and electrical stimulation. Am J Physiol Heart Circ Physiol, 2005. 288(4): 
p. H1620-6. 
139. Marquette, M.L., D. Byerly, and M. Sognier, A novel in vitro three-dimensional 
skeletal muscle model. In Vitro Cell Dev Biol Anim, 2007. 43(7): p. 255-63. 
140. Haraguchi, Y., et al., Fabrication of functional three-dimensional tissues by 
stacking cell sheets in vitro. Nat Protoc, 2012. 7(5): p. 850-8. 
141. Takahashi, H., et al., The use of anisotropic cell sheets to control orientation 
during the self-organization of 3D muscle tissue. Biomaterials, 2013. 34(30): p. 
7372-80. 
142. Shimizu, T., et al., Cell sheet engineering for myocardial tissue reconstruction. 
Biomaterials, 2003. 24(13): p. 2309-16. 
143. Shimizu, K., H. Fujita, and E. Nagamori, Evaluation systems of generated forces 
of skeletal muscle cell-based bio-actuators. J Biosci Bioeng, 2013. 115(2): p. 115-
21. 
144. Fujita, H., et al., Evaluation of Serum-Free Differentiation Conditions for C2C12 
Myoblast Cells Assessed as to Active Tension Generation Capability. 
Biotechnology and Bioengineering, 2010. 107(5). 
145. Sakar, M.S., et al., Formation and optogenetic control of engineered 3D skeletal 
muscle bioactuators. Lab Chip, 2012. 12(23): p. 4976-85. 
146. Vandenburgh, H., et al., Drug-screening platform based on the contractility of 
tissue-engineered muscle. Muscle Nerve, 2008. 37(4): p. 438-47. 
 159 
147. Barton, E.R., G. Lynch, and T.S. Khurana, Measuring isometric force of isolated 
mouse muscles in vitro. 2008, Wellstone Muscular Dystrophy Center: 
Washington, DC. p. 14. 
148. Head, S.I., B. Greenaway, and S. Chan, Incubating isolated mouse EDL muscles 
with creatine improves force production and twitch kinetics in fatigue due to 
reduction in ionic strength. PLoS One, 2011. 6(8): p. e22742. 
149. Kabumoto, K., et al., Voluntary movement controlled by the surface EMG signal 
for tissue-engineered skeletal muscle on a gripping tool. Tissue Eng Part A, 2013. 
19(15-16): p. 1695-703. 
150. Wendel, J.S., et al., Functional consequences of a tissue-engineered myocardial 
patch for cardiac repair in a rat infarct model. Tissue Eng Part A, 2014. 20(7-8): 
p. 1325-35. 
151. Ferenczi, M.A., et al., Fluorescence Lifetime Imaging Reveals that the 
Environment of the ATP Binding Site of Myosin in Muscle Senses Force. Biophys 
J, 2010. 99: p. 2163-69. 
152. Feinberg, A.W., et al., Muscular thin films for building actuators and powering 
devices. Science, 2007. 317(5843): p. 1366-70. 
153. Sun, Y., et al., Optimizing the structure and contractility of engineered skeletal 
muscle thin films. Acta Biomater, 2013. 9(8): p. 7885-94. 
154. Cvetkovic, C., et al., Three-dimensionally printed biological machines powered 
by skeletal muscle. Proc Natl Acad Sci U S A, 2014. 111(28): p. 10125-30. 
155. Nichols, R., J. Malamud, and R. Godt, Relationship between short-range stiffness 
and yielding in type-identified, chemically skinned muscle fibers from the cat 
triceps surae muscles. J. Neurophysiology, 1996. 76: p. 2280-2289. 
156. Lamb, G.D. and G.S. Posterino, Effects of oxidation and reduction on contractile 
function in skeletal muscle fibres of the rat. J Physiol, 2003. 546(Pt 1): p. 149-63. 
157. Oba, T., et al., A novel phasic contraction induced by dithiothreitol in frog 
skeletal muscle. Gen Pharmacol, 1996. 27(8): p. 1361-6. 
158. Zhao, R., C.S. Chen, and D.H. Reich, Force-driven evolution of mesoscale 
structure in engineered 3D microtissues and the modulation of tissue stiffening. 
Biomaterials, 2014. 
159. Bond, L.M., et al., Small-molecule inhibitors of myosin proteins. Future Med 
Chem, 2013. 5(1): p. 41-52. 
160. Wenningmann, I. and J.P. Dilger, The kinetics of inhibition of nicotinic 
acetylcholine receptors by (+)-tubocurarine and pancuronium. Mol Pharmacol, 
2001. 60(4): p. 790-6. 
161. Phelps, E.A., et al., Vasculogenic bio-synthetic hydrogel for enhancement of 
pancreatic islet engraftment and function in type 1 diabetes. Biomaterials, 2013. 
162. Salimath, A.S., et al., Dual delivery of hepatocyte and vascular endothelial 
growth factors via a protease-degradable hydrogel improves cardiac function in 
rats. PLoS One, 2012. 7(11): p. e50980. 
163. Gersbach, C.A., et al., Runx2/Cbfa1 stimulates transdifferentiation of primary 
skeletal myoblasts into a mineralizing osteoblastic phenotype. Exp.Cell Res, 
2004. 300(2): p. 406-417. 
 160 
164. Lamont, C. and D.J. Miller, Calcium sensitizing action of carnosine and other 
endogenous imidazoles in chemically skinned striated muscle. J Physiol, 1992. 
454: p. 421-34. 
165. Purslow, P.P., The structure and functional significance of variations in the 
connective tissue within muscle. Comparative Biochemistry and Physiology Part 
A: Molecular & Integrative Physiology, 2002. 133(4): p. 947-966. 
166. Charrasse, S., et al., N-cadherin-dependent cell-cell contact regulates Rho 
GTPases and beta-catenin localization in mouse C2C12 myoblasts. J Cell Biol, 
2002. 158(5): p. 953-65. 
167. Jordan S. Miller, S.N.B., Christopher S. Chen, Rapid casting of patterned 
vascular networks for perfusable engineered three-dimensional tissues. Nature 
Materials, 2012. 
168. Madden, L., et al., Bioengineered human myobundles mimic clinical responses of 
skeletal muscle to drugs. Elife, 2014. 4: p. e04885. 
169. Neal, D., et al., Mechanical Characterization and Shape Optimization of 
Fascicle-Like 3D Skeletal Muscle Tissues Contracted with Electrical and Optical 
Stimuli. Tissue Eng Part A, 2015. 21(11-12): p. 1848-1858. 
170. Neal, D., et al., Formation of elongated fascicle-inspired 3D tissues consisting of 
high-density, aligned cells using sacrificial outer molding. Lab on a Chip, 2014. 
14(11): p. 1907-1916. 
171. van der Schaft, D.W., et al., Engineering skeletal muscle tissues from murine 
myoblast progenitor cells and application of electrical stimulation. J Vis Exp, 
2013(73): p. e4267. 
172. Hume, S.L., et al., Alignment of multi-layered muscle cells within three-
dimensional hydrogel macrochannels. Acta Biomaterialia, 2012. 8(6): p. 2193-
2202. 
173. Ifkovits, J.L., et al., Injectable hydrogel properties influence infarct expansion 
and extent of postinfarction left ventricular remodeling in an ovine model. Proc 
Natl Acad Sci U S A, 2010. 107(25): p. 11507-12. 
174. Wall, S.T., et al., Biomimetic matrices for myocardial stabilization and stem cell 
transplantation. J Biomed Mater Res A, 2010. 95(4): p. 1055-66. 
175. Kannan, R.Y., et al., The roles of tissue engineering and vascularisation in the 
development of micro-vascular networks: a review. Biomaterials, 2005. 26(14): p. 
1857-75. 
176. Bian, W. and N. Bursac, Tissue engineering of functional skeletal muscle: 
challenges and recent advances. IEEE Eng Med Biol Mag, 2008. 27(5): p. 109-
13. 
177. Agarwal, A., et al., Micropatterning Alginate Substrates for In Vitro 
Cardiovascular Muscle on a Chip. Advanced Functional Materials, 2013. 23(30): 
p. 3738-3746. 
178. Li, J.Y., et al., Preparation of micron/submicron hybrid patterns via a two-stage 
UV-imprint technique and their dimensional effects on cell adhesion and 
alignment. Biofabrication, 2013. 5(3). 
179. Wang, P.Y., H.T. Yu, and W.B. Tsai, Modulation of alignment and differentiation 
of skeletal myoblasts by submicron ridges/grooves surface structure. Biotechnol 
Bioeng, 2010. 106(2): p. 285-94. 
 161 
180. Yang, H.S., et al., Nanopatterned muscle cell patches for enhanced myogenesis 
and dystrophin expression in a mouse model of muscular dystrophy. Biomaterials, 
2014. 35(5): p. 1478-86. 
181. Kroehne, V., et al., Use of a novel collagen matrix with oriented pore structure 
for muscle cell differentiation in cell culture and in grafts. J Cell Mol Med, 2008. 
12(5A): p. 1640-8. 
182. Jana, S., A. Cooper, and M. Zhang, Chitosan scaffolds with unidirectional 
microtubular pores for large skeletal myotube generation. Adv Healthc Mater, 
2013. 2(4): p. 557-61. 
183. Legant, W.R., et al., Microfabricated tissue gauges to measure and manipulate 
forces from 3D microtissues. Proc Natl Acad Sci U S A, 2009. 106(25): p. 10097-
102. 
184. Ahadian, S., et al., Hybrid hydrogels containing vertically aligned carbon 
nanotubes with anisotropic electrical conductivity for muscle myofiber 
fabrication. Sci Rep, 2014. 4: p. 4271. 
185. VanDusen, K.W., et al., Engineered skeletal muscle units for repair of volumetric 
muscle loss in the tibialis anterior muscle of a rat. Tissue Eng Part A, 2014. 
20(21-22): p. 2920-30. 
186. Rangarajan, S., L. Madden, and N. Bursac, Use of Flow, Electrical, and 
Mechanical Stimulation to Promote Engineering of Striated Muscles. BMES, 
2013. 
187. Jun, I., S. Jeong, and H. Shin, The stimulation of myoblast differentiation by 
electrically conductive sub-micron fibers. Biomaterials, 2009. 30(11): p. 2038-47. 
188. Gilmore, K.J., et al., Skeletal muscle cell proliferation and differentiation on 
polypyrrole substrates doped with extracellular matrix components. Biomaterials, 
2009. 30(29): p. 5292-304. 
189. Ahmed, W.W., et al., Myoblast morphology and organization on biochemically 
micro-patterned hydrogel coatings under cyclic mechanical strain. Biomaterials, 
2010. 31(2): p. 250-258. 
190. Bayati, V., et al., The evaluation of cyclic uniaxial strain on myogenic 
differentiation of adipose-derived stem cells. Tissue Cell, 2011. 43(6): p. 359-66. 
191. Nagamine, K., et al., Spatiotemporally controlled contraction of micropatterned 
skeletal muscle cells on a hydrogel sheet. Lab Chip, 2011. 11(3): p. 513-7. 
192. Ahadian, S., et al., A contactless electrical stimulator: application to fabricate 
functional skeletal muscle tissue. Biomed Microdevices, 2013. 15(1): p. 109-15. 
193. Uzel, S.G., A. Pavesi, and R.D. Kamm, Microfabrication and microfluidics for 
muscle tissue models. Prog Biophys Mol Biol, 2014. 
194. Choi, Y.S., et al., Mechanical derivation of functional myotubes from adipose-
derived stem cells. Biomaterials, 2012. 33(8): p. 2482-91. 
195. Munoz-Pinto, D.J., et al., Relative impact of form-induced stress vs. uniaxial 
alignment on multipotent stem cell myogenesis. Acta Biomater, 2012. 8(11): p. 
3974-81. 
196. Tanaka, T., et al., Alignment of Skeletal Muscle Cells Cultured in Collagen Gel by 
Mechanical and Electrical Stimulation. International Journal of Tissue 
Engineering, 2014. 2014: p. 1-5. 
 162 
197. Powell, C.A., et al., Mechanical stimulation improves tissue-engineered human 
skeletal muscle. Am J Physiol Cell Physiol, 2002. 283(5): p. C1557-65. 
198. Sandow, A., Excitation-contraction coupling in muscular response. Yale J Biol 
Med, 1952. 25(3): p. 176-201. 
199. Ng, C.P., B. Hinz, and M.A. Swartz, Interstitial fluid flow induces myofibroblast 
differentiation and collagen alignment in vitro. J Cell Sci, 2005. 118(Pt 20): p. 
4731-9. 
200. Stein, A.M., et al., An algorithm for extracting the network geometry of three-
dimensional collagen gels. J Microsc, 2008. 232(3): p. 463-75. 
201. Chrzanowska-Wodnicka, M. and K. Burridge, Rho-stimulated contractility drives 
the formation of stress fibers and focal adhesions. Journal of Cell Biology, 1996. 
133(6): p. 1403-15. 
202. Ostrovidov, S., et al., Three-dimensional co-culture of C2C12/PC12 cells 
improves skeletal muscle tissue formation and function. J Tissue Eng Regen Med, 
2014. 
203. Ilaria E. Palama, S.D.A., Addolorata M.L. Coluccia, Giuseppe Gigli, 
Micropatterned Polyelectrolyte Nanofilms Promote Alignment and Myogenic 
Differentiation of C2C12 Cells in Standard Growth Media. Biotechnology and 
Bioengineering, 2012. 
204. Ostrovidov, S., et al., Myotube formation on gelatin nanofibers e Multi-walled 
carbon nanotubes hybrid scaffolds. Biomaterials, 2014. 
205. Nishiyama, T., I. Kii, and A. Kudo, Inactivation of Rho/ROCK signaling is 
crucial for the nuclear accumulation of FKHR and myoblast fusion. J Biol Chem, 
2004. 279(45): p. 47311-9. 
206. Castellani, L., et al., Fine regulation of RhoA and Rock is required for skeletal 
muscle differentiation. J Biol Chem, 2006. 281(22): p. 15249-57. 
207. Maekawa, M., Signaling from Rho to the Actin Cytoskeleton Through Protein 
Kinases ROCK and LIM-kinase. Science, 1999. 285(5429): p. 895-898. 
208. Sutcliffe, W.J., Stress analysis of toroidal shells of elliptical cross-section. 
International Journal of Mechanical Sciences, 1971. 13(11): p. 951-958. 
209. Veličković, V., Stress and Strain States in the Material of the Stressed Toroidal 
Container for Liquefied Petroleum Gas. 2007, Military Technical Institute: 
Belgrade, Serbia. 
210. Latour, L.L., et al., Time-dependent diffusion of water in a biological model 
system. Proceedings of the National Academy of Sciences, 1994. 91(4): p. 1229-
1233. 
211. Klinge, L., et al., From T-tubule to sarcolemma: damage-induced dysferlin 
translocation in early myogenesis. FASEB J, 2007. 21(8): p. 1768-76. 
212. Flucher, B.E., et al., Biogenesis of transverse tubules in skeletal muscle in vitro. 
Dev Biol, 1991. 145(1): p. 77-90. 
213. Chan, V., H.H. Asada, and R. Bashir, Utilization and control of bioactuators 
across multiple length scales. Lab Chip, 2014. 14(4): p. 653-70. 
214. van der Schaft, D.W., et al., Mechanoregulation of vascularization in aligned 
tissue-engineered muscle: a role for vascular endothelial growth factor. Tissue 
Eng Part A, 2011. 17(21-22): p. 2857-65. 
 163 
215. Criswell, T.L., et al., The role of endothelial cells in myofiber differentiation and 
the vascularization and innervation of bioengineered muscle tissue in vivo. 
Biomaterials, 2013. 34(1): p. 140-9. 
216. Shvartsman, D., et al., Sustained delivery of VEGF maintains innervation and 
promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling. Mol 
Ther, 2014. 22(7): p. 1243-53. 
217. Ruvinov, E., J. Leor, and S. Cohen, The promotion of myocardial repair by the 
sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in 
a model of acute myocardial infarction. Biomaterials, 2011. 32(2): p. 565-78. 
218. Davis, M.E., et al., Local myocardial insulin-like growth factor 1 (IGF-1) delivery 
with biotinylated peptide nanofibers improves cell therapy for myocardial 
infarction. Proc Natl Acad Sci U S A, 2006. 103(21): p. 8155-60. 
219. Hill, E., T. Boontheekul, and D.J. Mooney, Regulating activation of transplanted 
cells controls tissue regeneration. Proc Natl Acad Sci U S A, 2006. 103(8): p. 
2494-9. 
220. Shekaran, A., et al., Bone regeneration using an alpha 2 beta 1 integrin-specific 
hydrogel as a BMP-2 delivery vehicle. Biomaterials, 2014. 35(21): p. 5453-61. 
221. Lee, T.T., et al., Light-triggered in vivo activation of adhesive peptides regulates 
cell adhesion, inflammation and vascularization of biomaterials. Nat Mater, 2015. 
14(3): p. 352-60. 
222. Baum, K., et al., Comparison of skeletal muscle strength between cardiac patients 
and age-matched healthy controls. Int J Med Sci, 2009. 6(4): p. 7. 
223. McNally, E.M. and J.A. Goldstein, Interplay between heart and skeletal muscle 
disease in heart failure: the 2011 George E. Brown Memorial Lecture. Circ Res, 
2012. 110(5): p. 749-54. 
224. Petrof, B.J., et al., Dystrophin protects the sarcolemma from stresses developed 
during muscle contraction. Proc Natl Acad Sci U S A, 1993. 90(8): p. 3710-4. 
225. Danialou, G., et al., Dystrophin-deficient cardiomyocytes are abnormally 
vulnerable to mechanical stress-induced contractile failure and injury. FASEB J, 
2001. 15(9): p. 1655-7. 
226. D'Angelo, M.G., et al., Respiratory pattern in an adult population of dystrophic 
patients. J Neurol Sci, 2011. 306(1-2): p. 54-61. 
227. Ugalde, V., et al., Respiratory abdominal muscle recruitment and chest wall 
motion in myotonic muscular dystrophy. J Appl Physiol (1985), 2001. 91(1): p. 
395-407. 
228. DeFronzo, R.A. and D. Tripathy, Skeletal muscle insulin resistance is the primary 
defect in type 2 diabetes. Diabetes Care, 2009. 32 Suppl 2: p. S157-63. 
229. Ionov, L., Biomimetic Hydrogel-Based Actuating Systems. Advanced Functional 
Materials, 2013. 23(36): p. 4555-4570. 
230. Bryson, J.B., et al., Optical control of muscle function by transplantation of stem 
cell-derived motor neurons in mice. Science, 2014. 344(6179): p. 94-7. 
231. Morimoto, Y., et al., Three-dimensional neuron-muscle constructs with 
neuromuscular junctions. Biomaterials, 2013. 34(37): p. 9413-9. 
232. Langelaan, M.L.P., et al., Meet the new meat: tissue engineered skeletal muscle. 
Trends in Food Science & Technology, 2010. 21(2): p. 59-66. 
 164 
233. Roger, V.L., et al., Heart disease and stroke statistics--2012 update: a report 
from the American Heart Association. Circulation, 2012. 125(1): p. e2-e220. 
234. Almeda, F.Q., R.J. Snell, and J.E. Parrillo, The Contemporary Management of 
Acute Myocardial Infarction. Critical Care Clinics, 2001. 17(2): p. 411-434. 
235. Anversa, P., Myocyte Death in the Pathological Heart. Circulation Research, 
2000. 86(2): p. 121-124. 
236. Anversa, P., et al., Cellular mechanisms of cardiac failure in the infarcted heart. 
Cardiologia, 1995. 40(12): p. 909-20. 
237. Kajstura, J., et al., Apoptotic and necrotic myocyte cell deaths are independent 
contributing variables of infarct size in rats. Lab Invest, 1996. 74(1): p. 86-107. 
238. Anversa, P., A. Leri, and J. Kajstura, Cardiac regeneration. J Am Coll Cardiol, 
2006. 47(9): p. 1769-76. 
239. Assmus, B., et al., Transcoronary transplantation of progenitor cells after 
myocardial infarction. N Engl J Med, 2006. 355(12): p. 1222-32. 
240. Kang, H.-J., et al., Effects of intracoronary infusion of peripheral blood stem-cells 
mobilised with granulocyte-colony stimulating factor on left ventricular systolic 
function and restenosis after coronary stenting in myocardial infarction: the 
MAGIC cell randomised clinical trial. The Lancet, 2004. 363(9411): p. 751-756. 
241. Sy, J.C. and M.E. Davis, Delivering regenerative cues to the heart: cardiac drug 
delivery by microspheres and peptide nanofibers. J Cardiovasc Transl Res, 2010. 
3(5): p. 461-8. 
242. Engel, F.B., et al., FGF1/p38 MAP kinase inhibitor therapy induces 
cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial 
infarction. Proc Natl Acad Sci U S A, 2006. 103(42): p. 15546-51. 
243. Hsieh, P.C., et al., Controlled delivery of PDGF-BB for myocardial protection 
using injectable self-assembling peptide nanofibers. J Clin Invest, 2006. 116(1): 
p. 237-48. 
244. Ozawa, C.R., et al., Microenvironmental VEGF concentration, not total dose, 
determines a threshold between normal and aberrant angiogenesis. J Clin Invest, 
2004. 113(4): p. 516-27. 
245. Schwarz, E.R., et al., Evaluation of the effects of intramyocardial injection of 
DNA expressing vascular endothelial growth factor (VEGF) in a myocardial 
infarction model in the rat—angiogenesis and angioma formation. Journal of the 
American College of Cardiology, 2000. 35(5): p. 1323-1330. 
246. Epstein, S.E., et al., Angiogenesis Therapy : Amidst the Hype, the Neglected 
Potential for Serious Side Effects. Circulation, 2001. 104(1): p. 115-119. 
247. Patterson, J. and J.A. Hubbell, SPARC-derived protease substrates to enhance the 
plasmin sensitivity of molecularly engineered PEG hydrogels. Biomaterials, 2011. 
32(5): p. 1301-10. 
248. French, K.M., et al., A naturally derived cardiac extracellular matrix enhances 
cardiac progenitor cell behavior in vitro. Acta Biomater, 2012. 8(12): p. 4357-64. 
249. Guerra, S., et al., Myocyte Death in the Failing Human Heart Is Gender 
Dependent. Circulation Research, 1999. 85(9): p. 856-866. 
250. Christian Danielsen, C., Increased Amounts of Collagenase and Gelatinase in 
Porcine Myocardium Following Ischemia and Reperfusion. Journal of Molecular 
and Cellular Cardiology, 1998. 30(7): p. 1431-1442. 
 165 
251. Jacot, J.G., et al., A simple microindentation technique for mapping the 
microscale compliance of soft hydrated materials and tissues. J Biomed Mater 
Res A, 2006. 79(3): p. 485-94. 
252. Jacot, J.G., et al., Cardiac myocyte force development during differentiation and 
maturation. Ann N Y Acad Sci, 2010. 1188: p. 121-7. 
253. Jacot, J.G., A.D. McCulloch, and J.H. Omens, Substrate stiffness affects the 
functional maturation of neonatal rat ventricular myocytes. Biophys J, 2008. 
95(7): p. 3479-87. 
254. Nakagawa, K., et al., Angiogenesis and Its Regulation: Roles of Vascular 
Endothelial Cell Growth Factor. Seminars in Thrombosis and Hemostasis, 2000. 
Volume 26(Number 01): p. 061-066. 
255. Kloner, R.A., et al., Intramyocardial injection of DNA encoding vascular 
endothelial growth factor in a myocardial infarction model. J Thromb 
Thrombolysis, 2000. 10(3): p. 285-9. 
256. Cho, K.R., et al., Therapeutic angiogenesis using naked DNA expressing two 
isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction 
model. Eur J Cardiothorac Surg, 2008. 34(4): p. 857-63. 
257. Morishita, R., et al., Therapeutic Angiogenesis using Hepatocyte Growth Factor 
(HGF). Current Gene Therapy, 2004. 4(2): p. 199-206. 
258. Ruvinov, E., J. Leor, and S. Cohen, The effects of controlled HGF delivery from 
an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a 
hindlimb ischemia model. Biomaterials, 2010. 31(16): p. 4573-82. 
259. Yamaguchi, T., et al., Therapeutic angiogenesis induced by injecting hepatocyte 
growth factor in ischemic canine hearts. Surg Today, 2005. 35(10): p. 855-60. 
260. Siltanen, A., et al., hHGF overexpression in myoblast sheets enhances their 
angiogenic potential in rat chronic heart failure. PLoS One, 2011. 6(4): p. 
e19161. 
261. Zhu, X.Y., et al., Transplantation of adipose-derived stem cells overexpressing 
hHGF into cardiac tissue. Biochem Biophys Res Commun, 2009. 379(4): p. 
1084-90. 
262. Miyagawa, S., et al., Angiogenic gene cell therapy using suicide gene system 
regulates the effect of angiogenesis in infarcted rat heart. Transplantation, 2006. 
81(6): p. 902-7. 
263. Angoulvant, D., et al., Mesenchymal stem cell conditioned media attenuates in 
vitro and ex vivo myocardial reperfusion injury. J Heart Lung Transplant, 2011. 
30(1): p. 95-102. 
264. Fatma, S., et al., Factors Released from Embryonic Stem Cells Stimulate c-kit-
FLK-1(+ve) Progenitor Cells and Enhance Neovascularization. Antioxid Redox 
Signal, 2010. 13(12): p. 1857-65. 
265. Perez-Ilzarbe, M., et al., Characterization of the paracrine effects of human 
skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail, 2008. 
10(11): p. 1065-72. 
266. Chen, R.R., et al., Spatio-temporal VEGF and PDGF delivery patterns blood 
vessel formation and maturation. Pharm Res, 2007. 24(2): p. 258-64. 
 166 
267. Sun, Q., et al., Sustained release of multiple growth factors from injectable 
polymeric system as a novel therapeutic approach towards angiogenesis. Pharm 
Res, 2010. 27(2): p. 264-71. 
268. Saif, J., et al., Combination of injectable multiple growth factor-releasing 
scaffolds and cell therapy as an advanced modality to enhance tissue 
neovascularization. Arterioscler Thromb Vasc Biol, 2010. 30(10): p. 1897-904. 
269. Sy, J.C., et al., Sustained release of a p38 inhibitor from non-inflammatory 
microspheres inhibits cardiac dysfunction. Nat Mater, 2008. 7(11): p. 863-8. 
270. Samuel, S.M., et al., Coadministration of adenoviral vascular endothelial growth 
factor and angiopoietin-1 enhances vascularization and reduces ventricular 
remodeling in the infarcted myocardium of type 1 diabetic rats. Diabetes, 2010. 
59(1): p. 51-60. 
271. Zentilin, L., et al., Cardiomyocyte VEGFR-1 activation by VEGF-B induces 
compensatory hypertrophy and preserves cardiac function after myocardial 
infarction. FASEB J, 2010. 24(5): p. 1467-78. 
272. Wang, Y., et al., Hepatocyte growth factor prevents ventricular remodeling and 
dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol, 2004. 
37(5): p. 1041-52. 
273. Vilahur, G., et al., Molecular and cellular mechanisms involved in cardiac 
remodeling after acute myocardial infarction. J Mol Cell Cardiol, 2011. 50(3): p. 
522-33. 
274. Tang, J., et al., Vascular endothelial growth factor promotes cardiac stem cell 
migration via the PI3K/Akt pathway. Exp Cell Res, 2009. 315(20): p. 3521-31. 
275. Linke, A., et al., Stem cells in the dog heart are self-renewing, clonogenic, and 
multipotent and regenerate infarcted myocardium, improving cardiac function. 
Proc Natl Acad Sci U S A, 2005. 102(25): p. 8966-71. 
276. Chimenti, I., et al., Human cardiosphere-seeded gelatin and collagen scaffolds as 
cardiogenic engineered bioconstructs. Biomaterials, 2011. 32(35): p. 9271-81. 
277. Xaymardan, M., et al., c-Kit function is necessary for in vitro myogenic 
differentiation of bone marrow hematopoietic cells. Stem Cells, 2009. 27(8): p. 
1911-20. 
278. Kadner, K., et al., The beneficial effects of deferred delivery on the efficiency of 
hydrogel therapy post myocardial infarction. Biomaterials, 2012. 33(7): p. 2060-
6. 
279. Rane, A.A., et al., Increased infarct wall thickness by a bio-inert material is 
insufficient to prevent negative left ventricular remodeling after myocardial 
infarction. PLoS One, 2011. 6(6): p. e21571. 
280. Choquet, D., D.P. Felsenfeld, and M.P. Sheetz, Extracellular matrix rigidity 
causes strengthening of integrin-cytoskeleton linkages. Cell, 1997. 88(1): p. 39-
48. 
281. Galbraith, C.G., K.M. Yamada, and M.P. Sheetz, The relationship between force 
and focal complex development. Journal of Cell Biology, 2002. 159(4): p. 695-
705. 
 
